data_2mka_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mka _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.825 0.26 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.04 -32.28 73.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.12 -55.68 29.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -52.36 -50.92 61.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.35 -46.46 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -71.47 -26.34 62.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.2 mtt -74.09 -58.99 2.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -58.04 -37.95 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -46.68 -33.94 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.24 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.5 mt -57.58 -36.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -67.32 -51.87 47.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.43 -38.18 83.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.0 mt -60.03 -56.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.4 ' HB3' HD21 ' B' ' 117' ' ' LEU . 0.1 OUTLIER -65.76 -47.53 74.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.8 mt -56.65 -48.32 80.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -70.74 -52.45 20.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.7 mt -48.39 -52.86 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.41 -51.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.6 mt -55.86 -45.65 78.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 30' ' ' GLU . 2.6 mp -54.51 -59.07 5.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.444 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -56.63 -49.69 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -48.03 -36.16 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -97.74 -18.21 18.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.5 tm-20 -71.61 -2.18 16.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.92 49.81 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.58 18.63 14.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.73 0.3 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.68 36.82 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -154.46 116.0 4.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -113.98 37.03 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.476 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.56 -60.28 3.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 111.105 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 53.7 Cg_endo -69.71 -34.93 13.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.69 -34.42 78.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.09 -54.64 44.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -52.6 -49.58 64.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -51.09 -47.05 61.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -70.97 -26.16 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.4 mtt -74.46 -59.92 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 mp -56.27 -40.54 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.78 -59.69 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 87.8 m -54.34 -36.44 63.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -60.94 -63.14 1.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 61.6 mt -50.26 -46.1 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 20' ' ' PHE . 0.6 OUTLIER -62.71 -57.03 12.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 23.9 mt -53.32 -32.74 50.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 22.7 mt -63.64 -55.58 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -62.67 -42.71 99.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 27.0 mt -62.87 -53.6 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.139 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.64 -52.21 61.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 13.4 mt -46.26 -48.44 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.37 -52.25 63.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.12 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.3 -42.02 85.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -56.73 15.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -51.95 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -47.5 -35.05 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -95.01 -22.02 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -72.57 -0.96 14.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.96 45.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -133.02 18.73 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.85 36.68 1.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.146 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.814 0.34 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -63.89 -63.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 58.8 mt -51.83 -39.56 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -58.86 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 19.0 mt -51.56 -33.68 33.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 23.3 mt -64.47 -59.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -42.66 99.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 221' ' ' ILE . . . . . . . . . . . . . 94.4 mt -55.12 -52.25 46.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.838 0.266 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -63.39 -34.67 78.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.48 -57.97 10.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -52.63 -47.16 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -51.11 -46.32 61.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -72.83 -25.74 61.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.824 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.5 mtt -71.17 -30.47 66.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.35 -55.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -53.06 -47.83 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -54.79 -27.3 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -64.6 -64.21 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.1 mp -54.14 -40.85 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -55.85 13.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.7 mt -54.84 -31.58 59.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.7 mt -66.05 -56.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.103 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -62.95 -39.05 93.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.1 mt -63.88 -52.52 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.03 -53.75 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.8 mt -45.5 -44.2 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.91 -55.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.4 mt -55.65 -43.4 76.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.7 tp -53.87 -56.52 16.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -51.94 66.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -48.16 -32.09 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -96.5 -22.91 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.14 -2.5 15.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 44.98 0.24 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.44 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.6 18.13 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -105.3 35.87 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.088 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -155.29 117.22 4.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 74.9 p -125.68 36.54 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.475 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -71.54 -60.46 2.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 111.094 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.72 -36.83 10.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.752 2.302 . . . . 0.0 112.302 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.32 -34.21 77.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.93 -57.96 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -52.81 -47.08 67.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.5 -46.25 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -72.7 -25.96 61.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 7.5 mtt -70.98 -30.38 66.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 2.9 mt -84.39 -55.15 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -53.25 -47.88 68.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -54.8 -27.18 39.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.79 -64.22 0.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 2.1 mp -54.24 -40.63 48.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.52 -55.95 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 25.2 mt -54.99 -31.35 60.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 20.6 mt -66.19 -56.37 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -63.13 -38.86 92.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 61.8 mt -64.04 -52.45 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.115 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.29 -53.52 35.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 22.6 mt -45.55 -44.32 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 42.1 t -64.01 -55.43 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.1 mt -55.21 -43.52 74.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.92 -56.77 14.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -51.5 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -48.42 -32.17 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.835 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -96.66 -22.63 16.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.02 -2.76 16.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.852 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.08 45.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.14 18.17 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.775 0.321 . . . . 0.0 110.953 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -105.92 35.82 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.794 0.331 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -64.8 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 2.0 mp -54.25 -40.47 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.144 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -56.03 12.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 24.3 mt -54.57 -31.91 57.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 20.9 mt -65.84 -56.69 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.84 -39.13 93.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 221' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.91 -52.16 60.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.818 0.258 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.92 -34.84 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.51 -50.79 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.4 -48.43 79.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.41 -41.62 63.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -77.09 -26.98 53.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.96 -29.67 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mt -83.78 -45.99 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -60.64 -55.61 31.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.0 m -51.12 -36.25 39.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.172 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.44 -64.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.0 mt -52.07 -39.18 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -58.94 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.16 -30.98 18.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.7 mt -68.13 -60.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -34.09 75.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.42 -55.24 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -65.68 -54.58 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.3 mt -46.21 -56.76 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -52.77 -48.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 mt -63.36 -36.19 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.24 -47.76 84.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.583 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.12 -50.19 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -50.43 -33.45 20.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -97.56 -20.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 11.1 mt-10 -70.48 -3.67 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 50.06 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.476 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.7 20.51 10.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -98.91 35.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.16 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -147.18 114.64 6.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -114.45 39.56 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.03 -60.29 3.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 111.145 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 53.0 Cg_endo -69.81 -32.72 17.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -68.44 -34.66 76.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.13 -49.69 76.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.08 -49.49 75.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -51.92 -43.11 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -75.02 -27.16 59.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -72.9 -29.61 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 49.6 mt -81.66 -46.73 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.62 -54.73 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 86.4 m -52.97 -37.68 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.96 -61.91 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 66.1 mt -51.34 -50.27 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.04 -51.94 67.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 25.9 mt -57.16 -33.55 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 18.5 mt -64.13 -60.69 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.134 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.455 ' CZ ' ' HA ' ' C' ' 221' ' ' ILE . 7.8 t80 -62.7 -40.07 96.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.44 -54.86 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -63.42 -52.52 61.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 31.1 mt -46.38 -45.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.26 -52.92 54.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.79 -36.74 77.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.22 -48.3 82.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.584 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.0 -50.94 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -49.74 -32.86 14.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.86 -20.73 17.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . 0.584 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.9 mt-10 -71.09 -2.86 17.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.47 49.19 0.19 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -123.54 20.47 9.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -102.08 36.69 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.798 0.333 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -60.58 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 46.8 mt -52.31 -35.56 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.86 -59.65 3.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 35.8 mt -53.77 -32.37 52.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 30.9 mt -64.08 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -61.1 -39.85 91.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 221' ' ' ILE . . . . . 0.455 ' HA ' ' CZ ' ' B' ' 120' ' ' PHE . 88.7 mt -65.37 -57.16 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.808 0.254 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -72.64 -38.31 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.38 -46.42 76.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.28 -50.03 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -51.76 -40.58 60.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -78.2 -26.5 47.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.1 mtt -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 52.5 mt -84.72 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -51.46 -55.42 18.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -52.1 -32.81 36.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 t -65.63 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.827 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mt -52.56 -39.27 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.76 -56.62 7.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.4 mt -55.87 -35.47 66.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.2 mt -62.38 -57.01 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -41.53 98.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.5 mt -59.3 -52.53 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.104 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -68.49 -48.21 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.2 mt -49.55 -47.01 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.07 -52.84 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.21 -39.14 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.07 -49.23 77.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -66.51 -51.09 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -49.29 -33.12 12.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.44 -20.91 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 3.7 mt-10 -71.49 -2.33 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.31 48.16 0.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 19.24 8.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.961 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -114.08 41.6 2.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.2 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 34.9 ttm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -154.52 117.66 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 30.5 p -101.56 36.96 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.474 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -69.2 -60.05 4.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.582 0.706 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.74 -28.59 25.14 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.82 -37.86 70.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.44 -47.25 76.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.08 -48.87 79.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -52.28 -40.69 62.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -78.64 -26.03 45.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -77.13 -28.88 54.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 56.4 mt -83.94 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -52.12 -55.47 20.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 97.7 m -52.2 -30.26 26.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 3.6 mt -54.84 -41.11 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.66 -54.74 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.61 -34.02 66.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 22.5 mt -62.54 -56.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -63.49 -46.86 84.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 80.7 mt -53.94 -52.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.72 -49.97 54.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 mt -49.64 -42.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.61 -53.39 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 18.0 mt -58.85 -41.02 85.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.23 -49.03 77.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.605 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -67.0 -49.01 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.135 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -51.25 -32.45 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.827 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -99.22 -19.78 16.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 3.8 mt-10 -70.1 -3.75 18.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.13 50.18 0.19 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -113.98 21.07 15.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.755 0.312 . . . . 0.0 110.892 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -117.96 41.38 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.781 0.324 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -63.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 5.6 mt -52.93 -42.68 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -56.55 11.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.88 -34.45 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 21.0 mt -63.88 -57.34 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.132 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -62.75 -42.48 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 221' ' ' ILE . . . . . . . . . . . . . 89.7 mt -57.9 -52.92 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.787 0.245 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -51.69 65.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.4 -46.14 86.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -51.85 -43.91 63.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -74.16 -26.16 60.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.0 mtt -70.3 -36.17 74.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mp -82.53 -44.39 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -51.82 -50.88 59.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -51.32 -30.22 17.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.29 -63.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.3 mt -54.93 -38.7 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.168 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.14 -55.14 15.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.24 -35.4 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.0 mt -62.2 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -45.18 92.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 51.5 mt -58.37 -51.88 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -66.79 -53.99 27.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mt -46.77 -50.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.6 t -57.56 -52.21 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt -58.91 -42.35 89.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -53.2 -56.65 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -51.11 72.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -48.65 -33.5 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -97.55 -19.41 18.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 26' ' ' LEU . 2.6 pt-20 -71.06 -3.99 22.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 46.05 0.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.35 17.61 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.49 35.93 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 12.8 mmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -135.12 8.54 3.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.1 p -93.94 39.1 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.62 -60.49 3.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.554 0.692 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 52.8 Cg_endo -69.77 -31.22 20.88 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.655 2.236 . . . . 0.0 112.307 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.26 -35.5 76.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.74 -52.1 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.1 -48.07 76.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.964 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.05 -45.4 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -73.13 -25.42 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -73.25 -40.45 64.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.33 -52.12 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -51.4 -59.11 4.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 99.9 m -49.35 -30.97 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 15.5 mt -58.91 -35.1 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.128 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 mt -68.79 -50.92 46.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 28.2 mt -61.41 -37.37 83.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 23.1 mt -62.22 -55.72 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -45.09 85.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.39 -49.06 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -69.13 -52.8 24.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 23.9 mt -47.54 -52.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 75.2 t -57.77 -51.55 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.19 -44.27 79.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.36 -57.53 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.39 -50.38 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -48.49 -33.59 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -97.61 -20.02 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.17 -4.07 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.74 46.7 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -119.83 18.72 12.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 110.919 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.3 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 98.6 m . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.825 0.345 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -64.95 -64.1 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.9 mt -56.88 -38.62 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -52.14 50.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.4 mt -61.37 -33.84 74.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 21.0 mt -61.32 -57.35 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.24 -46.16 90.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 221' ' ' ILE . . . . . . . . . . . . . 32.0 mt -60.25 -52.67 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.872 0.28 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -56.91 -40.01 75.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.74 -59.08 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.88 -43.99 73.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.907 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -51.49 -41.5 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -73.68 -30.43 62.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.845 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.06 -35.39 64.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.4 mp -84.31 -47.87 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -58.54 -57.81 11.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.4 m -51.76 -32.16 29.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.78 -64.32 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 60.7 mt -51.86 -40.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -57.94 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.5 mt -53.0 -33.62 52.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.41 -59.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.112 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.51 -38.44 87.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.414 HG12 ' CE2' ' C' ' 220' ' ' PHE . 87.1 mt -63.88 -53.49 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -66.93 -55.14 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.5 mt -45.77 -53.72 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.172 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.1 t -55.73 -48.6 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -63.68 -36.06 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.53 -48.04 83.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.4 -49.25 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -51.41 -32.9 28.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.41 -20.01 17.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.1 mm-40 -70.0 -4.06 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.79 50.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.52 19.83 13.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -118.05 36.27 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 28.1 mmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.33 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -158.04 116.24 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -102.19 43.89 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.482 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.83 -59.78 3.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.573 0.701 . . . . 0.0 111.095 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.75 -42.22 3.6 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -56.24 -41.04 75.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.24 -59.24 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.86 -44.54 74.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.04 -40.98 59.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.58 -29.6 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.4 mtm -75.93 -29.09 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.1 -50.65 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.118 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.81 -57.56 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 95.9 m -50.19 -36.51 30.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -61.44 -61.93 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 66.2 mt -50.66 -49.85 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.82 -53.35 58.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 mt -56.39 -33.64 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 19.7 mt -63.89 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' C' ' 221' ' ' ILE . 7.1 t80 -62.31 -39.91 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.31 -54.68 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -63.64 -52.28 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 32.9 mt -46.03 -46.09 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.92 -52.09 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 18.1 mt -59.92 -36.41 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.957 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.6 tp -59.96 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.563 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.62 -50.14 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.135 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -51.02 -32.4 21.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.59 -20.87 17.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . 0.563 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.7 mm-40 -70.62 -3.88 20.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.9 50.87 0.16 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 20.36 8.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -110.69 38.65 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 89.9 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.786 0.327 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -64.78 -63.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.9 mt -52.95 -33.87 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.06 -59.94 2.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 31.3 mt -55.88 -32.57 63.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 35.0 mt -63.55 -59.38 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . 0.414 ' CE2' HG12 ' A' ' 21' ' ' ILE . 6.8 t80 -61.89 -41.1 97.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 221' ' ' ILE . . . . . 0.43 ' HA ' ' CZ ' ' B' ' 120' ' ' PHE . 87.9 mt -64.83 -55.55 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.21 0 CA-C-O 120.791 0.246 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -66.13 -35.64 81.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.66 -53.39 58.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.44 -47.81 78.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -51.2 -43.15 61.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -75.17 -26.15 58.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.8 mtt -70.21 -32.64 70.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.61 -41.88 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -63.65 -40.3 96.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 t -50.2 -29.04 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -63.75 -64.8 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.4 mt -53.14 -36.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -59.78 2.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.7 mt -52.15 -29.71 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.8 mt -68.14 -60.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.02 -35.79 79.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' C' ' 220' ' ' PHE . 51.7 mt -67.42 -53.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -66.45 -55.68 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 mt -46.08 -56.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.73 -48.12 49.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.05 -36.81 85.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -48.08 82.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.587 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -65.94 -51.19 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -49.66 -33.79 16.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.14 -20.44 17.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.2 mt-10 -71.32 -2.84 17.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 49.19 0.19 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.454 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -124.94 20.21 8.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.792 0.33 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -101.4 38.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.5 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 7.4 ttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.49 3.19 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 15.0 m -112.64 37.79 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.48 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.05 -60.21 3.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.573 0.701 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.74 -32.98 17.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -67.59 -35.75 79.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.9 -52.69 64.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.97 -51.61 63.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -50.17 -44.51 52.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -73.83 -25.57 60.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.8 mtt -75.41 -32.63 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 3.1 mt -77.27 -48.52 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.67 -55.7 27.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -50.88 -31.58 17.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.48 -62.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.891 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 3.4 mt -50.12 -45.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.147 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.48 -55.71 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.6 mt -57.44 -22.07 40.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 16.2 mt -73.76 -60.71 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' C' ' 221' ' ' ILE . 10.9 t80 -68.63 -37.23 79.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 82.1 mt -63.35 -48.94 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -72.1 -54.95 8.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 48.1 mt -47.69 -48.19 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 32.0 t -61.44 -51.47 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.96 -39.72 78.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.88 -48.3 81.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.593 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -68.59 -48.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -50.78 -32.74 20.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.58 -20.59 16.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . 0.593 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 9.4 mt-10 -70.51 -2.97 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.899 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.84 49.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.467 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -121.77 21.66 10.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -104.37 41.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.83 0.348 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.92 -63.86 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 7.0 mt -53.33 -33.54 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 1.3 mt -70.84 -60.13 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -54.35 -32.8 57.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 28.3 mt -64.96 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . 0.447 ' CZ ' HG12 ' A' ' 21' ' ' ILE . 4.5 t80 -61.41 -39.27 90.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 221' ' ' ILE . . . . . 0.452 ' HA ' ' CE2' ' B' ' 120' ' ' PHE . 64.2 mt -65.54 -55.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.815 0.256 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.32 -34.83 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.62 -53.21 60.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.74 -46.85 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.939 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -53.02 -46.98 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -71.6 -27.39 63.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.4 mtt -71.09 -28.6 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.34 -36.78 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.099 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -74.51 -29.85 61.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -50.7 -28.34 8.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mt -53.87 -37.25 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -58.0 4.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -53.33 -28.17 27.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.6 mt -70.28 -60.12 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -35.02 78.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.405 HG12 ' CZ ' ' C' ' 220' ' ' PHE . 80.6 mt -65.99 -52.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -70.0 -55.67 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mt -44.27 -51.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.176 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.45 -54.66 31.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.141 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -54.94 -44.41 74.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.95 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 30' ' ' GLU . 14.0 tp -53.32 -57.2 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.52 -50.22 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.077 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -48.79 -33.43 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -99.12 -17.75 18.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -68.24 -7.25 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.23 48.53 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.84 19.34 17.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.915 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -167.51 89.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.132 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.753 0.311 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.75 3.35 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 2.4 m -105.68 37.24 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -71.16 -60.57 2.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 0.0 111.11 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.7 -32.74 18.21 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.755 2.303 . . . . 0.0 112.354 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.01 -34.19 76.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.02 -52.97 63.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.89 -49.13 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -51.63 -47.84 63.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.2 -26.93 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -73.79 -28.0 61.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 54.2 mt -81.65 -42.94 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -69.75 -51.98 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -52.96 -30.94 37.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.145 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.53 -62.57 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 5.0 mt -50.48 -44.85 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.159 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 mt -66.37 -55.72 14.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.4 mt -57.81 -22.65 48.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 16.5 mt -72.87 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.455 ' CE2' ' HA ' ' C' ' 221' ' ' ILE . 12.5 t80 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.97 -49.58 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -71.93 -54.17 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 37.7 mt -47.34 -45.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 32.4 t -63.37 -54.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.18 -44.68 75.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.91 -56.05 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -49.86 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.158 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -48.97 -32.74 9.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.32 -19.32 17.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.1 -7.01 25.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 127.33 48.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.46 19.57 20.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.817 0.341 . . . . 0.0 110.964 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -170.4 86.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.121 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.807 0.337 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.91 -64.25 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 13.4 mt -55.03 -32.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.102 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -70.57 -58.89 3.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -55.37 -32.8 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 26.8 mt -64.87 -61.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . 0.405 ' CZ ' HG12 ' A' ' 21' ' ' ILE . 4.9 t80 -62.06 -39.41 92.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 221' ' ' ILE . . . . . 0.455 ' HA ' ' CE2' ' B' ' 120' ' ' PHE . 83.9 mt -64.35 -53.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.931 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.79 0.246 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.34 -38.52 87.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.18 -58.36 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.95 -43.25 86.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -51.52 -41.05 60.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -76.81 -28.26 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mtt -70.67 -32.65 69.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -79.84 -52.27 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -51.87 -33.83 38.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -51.18 -32.4 23.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -64.75 -65.27 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.1 mt -53.82 -34.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -70.85 -59.05 3.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.0 mt -53.28 -27.47 22.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.6 mt -71.07 -60.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.18 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -34.34 77.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.44 -52.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.139 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -68.56 -55.6 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mt -45.62 -54.16 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.5 -49.28 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.122 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.37 -38.79 84.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.91 -48.36 81.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.612 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -67.17 -48.05 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -51.54 -33.63 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -98.53 -19.35 17.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.6 mm-40 -70.47 -3.43 17.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.92 50.06 0.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -114.23 24.21 12.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.737 0.303 . . . . 0.0 110.927 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.12 36.97 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 21.1 mtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.97 126.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -105.47 38.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.2 -59.77 3.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 53.6 Cg_endo -69.77 -37.55 8.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.58 -38.41 87.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.52 -57.76 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.65 -47.55 76.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.18 -42.03 38.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -73.57 -32.01 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 2.3 mtm -74.82 -25.72 59.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mt -81.89 -62.77 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -52.04 -53.29 43.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 89.9 m -52.3 -31.08 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.9 -64.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 3.5 mt -49.75 -43.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.8 mt -66.36 -56.08 12.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 19.8 mt -58.26 -22.17 51.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 19.5 mt -72.81 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' C' ' 221' ' ' ILE . 15.9 t80 -68.74 -38.85 80.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 79.7 mt -61.29 -49.29 85.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.07 -54.25 10.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 45.1 mt -48.33 -45.53 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.94 -52.19 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.86 -38.72 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.88 -48.1 82.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.6 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -67.75 -49.35 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' HIS . . . . . 0.408 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 29.1 t60 -50.46 -33.37 20.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -97.93 -20.4 17.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . 0.6 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 1.7 mm-40 -70.59 -3.07 16.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.19 50.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.533 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.408 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.5 OUTLIER -119.44 24.75 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -92.57 41.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 98.3 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.789 0.328 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -63.87 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 5.8 mt -51.22 -36.42 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.126 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -59.71 2.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.38 -32.59 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 27.9 mt -63.78 -61.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -61.15 -40.47 93.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 221' ' ' ILE . . . . . 0.428 ' HA ' ' CE2' ' B' ' 120' ' ' PHE . 88.8 mt -64.14 -55.03 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.8 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.849 0.27 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -56.41 -41.86 77.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.5 -59.88 3.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.98 -43.03 73.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -53.13 -37.41 61.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -78.32 -28.83 47.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 mtm -77.59 -30.98 52.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.2 mt -80.19 -51.75 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -52.49 -34.84 51.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 m -48.26 -33.18 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.57 -64.37 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 66.0 mt -56.9 -36.2 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -69.11 -51.91 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.96 -35.25 72.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.0 mt -63.64 -57.95 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -43.88 92.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.08 -51.98 64.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -68.43 -51.74 40.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mt -48.08 -49.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.135 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.8 t -58.91 -51.21 75.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 mt -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.19 -47.67 62.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.609 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -67.3 -46.89 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.112 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -52.36 -34.03 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -98.39 -19.01 17.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.609 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.3 mm-40 -70.56 -3.79 19.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 51.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -115.87 20.26 14.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.07 38.72 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.89 126.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 58.5 p -93.18 41.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ALA . . . . . 0.498 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -69.5 -59.22 5.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 53.4 Cg_endo -69.77 -39.85 6.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.695 2.263 . . . . 0.0 112.322 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -58.05 -42.62 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.31 -58.65 6.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.44 -43.78 79.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -52.73 -36.75 58.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -79.88 -27.0 40.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.5 mtm -79.71 -27.98 40.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mt -84.29 -57.33 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -50.99 -51.18 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 94.1 m -56.5 -39.26 72.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -62.3 -62.5 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 62.8 mt -50.17 -47.59 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.14 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.18 -57.22 11.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 26.3 mt -52.75 -32.46 43.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 19.8 mt -64.17 -57.36 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.137 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -63.77 -43.05 97.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 22.4 mt -61.76 -52.75 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -65.6 -47.99 73.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 13.0 mt -49.77 -44.61 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.71 -52.03 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.77 -47.3 86.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -47.5 63.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ILE . . . . . 0.57 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.9 OUTLIER -66.83 -48.94 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' HIS . . . . . 0.403 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 4.0 t60 -51.5 -33.52 31.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.826 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -97.81 -19.67 18.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.86 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' GLU . . . . . 0.57 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.8 mm-40 -70.8 -3.9 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.37 50.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' TRP . . . . . 0.403 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.6 OUTLIER -119.32 20.32 12.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.27 39.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.766 0.317 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -63.03 -63.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 69.7 mt -51.46 -39.54 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -59.22 3.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 25.3 mt -51.26 -30.59 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 24.2 mt -68.15 -59.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.52 -37.87 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 221' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.62 -53.89 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.2 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.836 0.351 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -154.3 114.68 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.6 p -115.04 36.95 3.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 5' ' ' PRO . . . -71.09 -60.54 2.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 0.0 111.109 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 54.1 Cg_endo -69.76 -35.93 11.74 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.38 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.04 -32.28 73.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.12 -55.68 29.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -52.36 -50.92 61.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.35 -46.46 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -71.47 -26.34 62.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.2 mtt -74.09 -58.99 2.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -58.04 -37.95 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -46.68 -33.94 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.24 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 56.5 mt -57.58 -36.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.103 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.3 mt -67.32 -51.87 47.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.43 -38.18 83.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.0 mt -60.03 -56.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.4 ' HB3' HD21 ' B' ' 117' ' ' LEU . 0.1 OUTLIER -65.76 -47.53 74.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.8 mt -56.65 -48.32 80.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -70.74 -52.45 20.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.7 mt -48.39 -52.86 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.6 t -57.41 -51.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.6 mt -55.86 -45.65 78.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 30' ' ' GLU . 2.6 mp -54.51 -59.07 5.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.444 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -56.63 -49.69 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -48.03 -36.16 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -97.74 -18.21 18.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.5 tm-20 -71.61 -2.18 16.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.92 49.81 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.58 18.63 14.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.73 0.3 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.68 36.82 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -154.46 116.0 4.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -113.98 37.03 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.476 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.56 -60.28 3.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 111.105 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 53.7 Cg_endo -69.71 -34.93 13.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.69 -34.42 78.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.09 -54.64 44.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -52.6 -49.58 64.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -51.09 -47.05 61.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -70.97 -26.16 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.4 mtt -74.46 -59.92 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 mp -56.27 -40.54 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.78 -59.69 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 87.8 m -54.34 -36.44 63.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -60.94 -63.14 1.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 61.6 mt -50.26 -46.1 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . 0.4 HD21 ' HB3' ' A' ' 20' ' ' PHE . 0.6 OUTLIER -62.71 -57.03 12.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 23.9 mt -53.32 -32.74 50.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 22.7 mt -63.64 -55.58 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -62.67 -42.71 99.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 27.0 mt -62.87 -53.6 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.139 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.64 -52.21 61.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 13.4 mt -46.26 -48.44 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 70.4 t -59.37 -52.25 63.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.12 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 10.9 mt -58.3 -42.02 85.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -56.73 15.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -57.02 -51.95 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -47.5 -35.05 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -95.01 -22.02 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -72.57 -0.96 14.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.96 45.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -133.02 18.73 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.85 36.68 1.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.146 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.745 0.307 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -153.53 115.3 4.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 96.1 p -114.69 37.57 3.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.472 ' N ' ' HD2' ' C' ' 205' ' ' PRO . . . -70.88 -60.52 2.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.611 0.72 . . . . 0.0 111.073 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 205' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' C' ' 204' ' ' ALA . 53.9 Cg_endo -69.74 -34.67 14.17 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.665 2.243 . . . . 0.0 112.367 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.98 -33.97 77.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -59.55 -54.39 47.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -52.79 -49.66 65.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -51.37 -46.88 62.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -71.05 -26.1 62.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.3 mtt -74.27 -58.65 3.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 2.7 mp -58.74 -36.7 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.52 -63.0 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 92.2 m -51.53 -37.49 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.168 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -63.89 -63.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 58.8 mt -51.83 -39.56 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.2 -58.86 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 19.0 mt -51.56 -33.68 33.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 23.3 mt -64.47 -59.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -42.66 99.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' ILE . . . . . . . . . . . . . 94.4 mt -55.12 -52.25 46.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -71.95 -54.7 9.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' ILE . . . . . . . . . . . . . 26.7 mt -50.28 -58.48 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.084 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 92.5 t -54.74 -44.68 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.28 -45.29 95.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.91 -55.34 31.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.19 -52.22 63.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -47.93 -33.25 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.818 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -94.83 -24.16 17.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -72.45 -0.54 12.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 125.42 44.04 0.27 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -136.87 19.36 3.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.342 . . . . 0.0 110.926 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.35 38.45 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 179.95 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -155.91 118.53 4.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 p -124.86 36.79 4.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.477 ' N ' ' HD2' ' A' ' 5' ' ' PRO . . . -71.37 -60.34 2.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 0.0 111.119 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.477 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 54.1 Cg_endo -69.76 -36.71 10.32 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.615 2.21 . . . . 0.0 112.38 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -63.39 -34.67 78.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.48 -57.97 10.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -52.63 -47.16 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -51.11 -46.32 61.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -72.83 -25.74 61.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.824 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.5 mtt -71.17 -30.47 66.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.35 -55.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -53.06 -47.83 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -54.79 -27.3 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -64.6 -64.21 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.1 mp -54.14 -40.85 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -55.85 13.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.7 mt -54.84 -31.58 59.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 20.7 mt -66.05 -56.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.103 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -62.95 -39.05 93.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 60.1 mt -63.88 -52.52 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.03 -53.75 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.8 mt -45.5 -44.2 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 42.6 t -63.91 -55.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.4 mt -55.65 -43.4 76.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.7 tp -53.87 -56.52 16.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -51.94 66.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -48.16 -32.09 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -96.5 -22.91 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.14 -2.5 15.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 44.98 0.24 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.44 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.6 18.13 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -105.3 35.87 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.088 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -155.29 117.22 4.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 74.9 p -125.68 36.54 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.475 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -71.54 -60.46 2.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 111.094 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.72 -36.83 10.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.752 2.302 . . . . 0.0 112.302 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.32 -34.21 77.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.93 -57.96 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -52.81 -47.08 67.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.5 -46.25 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -72.7 -25.96 61.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 7.5 mtt -70.98 -30.38 66.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 2.9 mt -84.39 -55.15 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -53.25 -47.88 68.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -54.8 -27.18 39.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.79 -64.22 0.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 2.1 mp -54.24 -40.63 48.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.52 -55.95 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 25.2 mt -54.99 -31.35 60.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 20.6 mt -66.19 -56.37 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -63.13 -38.86 92.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 61.8 mt -64.04 -52.45 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.115 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.29 -53.52 35.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 22.6 mt -45.55 -44.32 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 42.1 t -64.01 -55.43 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.1 mt -55.21 -43.52 74.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.92 -56.77 14.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -51.5 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -48.42 -32.17 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.835 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -96.66 -22.63 16.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.02 -2.76 16.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.852 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.08 45.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.14 18.17 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.775 0.321 . . . . 0.0 110.953 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -105.92 35.82 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.797 0.332 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -155.9 118.03 4.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 78.0 p -124.88 36.34 4.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.463 ' N ' ' HD2' ' C' ' 205' ' ' PRO . . . -71.28 -60.25 2.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.708 . . . . 0.0 111.128 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 205' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' C' ' 204' ' ' ALA . 53.8 Cg_endo -69.76 -37.42 9.19 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.713 2.276 . . . . 0.0 112.366 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.7 -34.65 77.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.21 -58.0 10.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -52.77 -47.08 67.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -51.36 -45.72 62.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.44 -25.94 60.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 7.6 mtt -70.89 -30.47 66.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 2.9 mt -84.23 -54.94 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.157 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -53.56 -48.19 69.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 8.3 t -54.31 -26.95 32.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.126 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -64.8 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 2.0 mp -54.25 -40.47 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.144 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -56.03 12.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 24.3 mt -54.57 -31.91 57.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 20.9 mt -65.84 -56.69 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.84 -39.13 93.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 221' ' ' ILE . . . . . . . . . . . . . 64.0 mt -63.91 -52.16 60.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -66.25 -53.74 33.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 223' ' ' ILE . . . . . . . . . . . . . 25.1 mt -45.43 -44.38 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 44.3 t -63.87 -55.15 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 14.5 mt -55.67 -43.5 76.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 15.6 tp -53.7 -56.15 19.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -51.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.099 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -48.23 -31.77 6.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -96.37 -23.48 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -71.47 -2.07 15.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.14 43.92 0.26 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.547 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.34 18.49 4.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -105.05 37.54 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.758 0.313 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -146.1 114.49 6.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.3 m -119.09 39.52 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.479 ' N ' ' HD2' ' A' ' 5' ' ' PRO . . . -70.22 -60.33 3.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.583 0.706 . . . . 0.0 111.133 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 53.8 Cg_endo -69.77 -32.26 18.89 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.337 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.92 -34.84 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.51 -50.79 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.4 -48.43 79.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.41 -41.62 63.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -77.09 -26.98 53.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.96 -29.67 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mt -83.78 -45.99 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -60.64 -55.61 31.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.0 m -51.12 -36.25 39.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.172 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.44 -64.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.0 mt -52.07 -39.18 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.36 -58.94 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.7 mt -51.16 -30.98 18.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.7 mt -68.13 -60.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.64 -34.09 75.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 87.7 mt -67.42 -55.24 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -65.68 -54.58 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 30.3 mt -46.21 -56.76 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.0 t -52.77 -48.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.2 mt -63.36 -36.19 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.24 -47.76 84.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.583 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.12 -50.19 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -50.43 -33.45 20.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -97.56 -20.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.583 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 11.1 mt-10 -70.48 -3.67 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 50.06 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.476 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.7 20.51 10.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -98.91 35.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.16 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -147.18 114.64 6.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -114.45 39.56 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.03 -60.29 3.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 111.145 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 53.0 Cg_endo -69.81 -32.72 17.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -68.44 -34.66 76.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.13 -49.69 76.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.08 -49.49 75.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -51.92 -43.11 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -75.02 -27.16 59.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -72.9 -29.61 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 49.6 mt -81.66 -46.73 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.62 -54.73 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 86.4 m -52.97 -37.68 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.96 -61.91 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 66.1 mt -51.34 -50.27 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.04 -51.94 67.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 25.9 mt -57.16 -33.55 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 18.5 mt -64.13 -60.69 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.134 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.455 ' CZ ' ' HA ' ' C' ' 221' ' ' ILE . 7.8 t80 -62.7 -40.07 96.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 86.8 mt -64.44 -54.86 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -63.42 -52.52 61.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 31.1 mt -46.38 -45.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 42.3 t -62.26 -52.92 54.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.79 -36.74 77.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.22 -48.3 82.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.584 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.0 -50.94 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -49.74 -32.86 14.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.86 -20.73 17.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . 0.584 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.9 mt-10 -71.09 -2.86 17.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.47 49.19 0.19 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -123.54 20.47 9.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -102.08 36.69 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.777 0.322 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -146.21 109.18 4.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 69.4 m -136.48 40.94 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.465 ' N ' ' HD2' ' C' ' 205' ' ' PRO . . . -70.31 -60.65 3.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.613 0.721 . . . . 0.0 111.073 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 205' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' C' ' 204' ' ' ALA . 53.6 Cg_endo -69.71 -33.54 16.55 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.711 2.274 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -68.19 -32.92 73.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -62.35 -54.34 41.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.51 -50.39 73.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -51.79 -39.75 59.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -79.06 -27.38 43.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.1 mtt -74.65 -30.23 61.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 56.2 mt -84.03 -44.43 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.128 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.76 -53.55 56.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 84.8 m -48.55 -42.61 33.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -60.58 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 46.8 mt -52.31 -35.56 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -67.86 -59.65 3.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 35.8 mt -53.77 -32.37 52.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 30.9 mt -64.08 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -61.1 -39.85 91.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 221' ' ' ILE . . . . . 0.455 ' HA ' ' CZ ' ' B' ' 120' ' ' PHE . 88.7 mt -65.37 -57.16 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -60.61 -52.12 66.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 223' ' ' ILE . . . . . . . . . . . . . 29.4 mt -46.94 -47.65 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.087 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 41.6 t -59.18 -51.0 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 19.7 mt -62.26 -36.37 81.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.42 -47.2 84.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . 0.502 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.6 OUTLIER -67.58 -52.09 44.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -49.12 -32.74 10.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -96.01 -22.81 17.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 230' ' ' GLU . . . . . 0.502 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 12.4 mt-10 -72.5 -1.3 15.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 125.93 46.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.463 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.87 20.01 3.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.0 110.957 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -100.59 39.38 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 ttm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.78 0.324 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -154.1 117.56 4.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.8 p -102.83 37.48 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.482 ' N ' ' HD2' ' A' ' 5' ' ' PRO . . . -70.12 -60.26 3.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 54.0 Cg_endo -69.72 -27.65 26.41 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.694 2.263 . . . . 0.0 112.33 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -72.64 -38.31 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.38 -46.42 76.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.28 -50.03 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -51.76 -40.58 60.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -78.2 -26.5 47.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.1 mtt -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 52.5 mt -84.72 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -51.46 -55.42 18.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -52.1 -32.81 36.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 t -65.63 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.827 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mt -52.56 -39.27 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.76 -56.62 7.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.4 mt -55.87 -35.47 66.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 33.2 mt -62.38 -57.01 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -41.53 98.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 71.5 mt -59.3 -52.53 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.104 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -68.49 -48.21 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 11.2 mt -49.55 -47.01 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.0 t -63.07 -52.84 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.21 -39.14 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.07 -49.23 77.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -66.51 -51.09 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -49.29 -33.12 12.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.44 -20.91 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.566 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 3.7 mt-10 -71.49 -2.33 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.31 48.16 0.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 19.24 8.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.961 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -114.08 41.6 2.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.2 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 34.9 ttm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -154.52 117.66 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 30.5 p -101.56 36.96 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.474 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -69.2 -60.05 4.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.582 0.706 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.74 -28.59 25.14 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.82 -37.86 70.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.44 -47.25 76.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.08 -48.87 79.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -52.28 -40.69 62.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -78.64 -26.03 45.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -77.13 -28.88 54.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 56.4 mt -83.94 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -52.12 -55.47 20.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 97.7 m -52.2 -30.26 26.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 3.6 mt -54.84 -41.11 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.66 -54.74 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 24.1 mt -56.61 -34.02 66.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 22.5 mt -62.54 -56.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -63.49 -46.86 84.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 80.7 mt -53.94 -52.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.72 -49.97 54.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 9.2 mt -49.64 -42.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 73.5 t -65.61 -53.39 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 18.0 mt -58.85 -41.02 85.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.23 -49.03 77.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.605 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -67.0 -49.01 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.135 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -51.25 -32.45 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.827 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -99.22 -19.78 16.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . 0.605 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 3.8 mt-10 -70.1 -3.75 18.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.13 50.18 0.19 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -113.98 21.07 15.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.755 0.312 . . . . 0.0 110.892 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -117.96 41.38 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 35.7 ttm . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.778 0.323 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -153.45 116.54 4.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 31.7 p -103.23 38.19 1.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.464 ' N ' ' HD2' ' C' ' 205' ' ' PRO . . . -70.41 -60.53 3.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.585 0.707 . . . . 0.0 111.062 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 205' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' C' ' 204' ' ' ALA . 54.0 Cg_endo -69.8 -28.64 24.79 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.665 2.243 . . . . 0.0 112.321 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -71.92 -36.67 70.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.47 -47.15 79.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.6 -51.14 71.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -51.73 -40.4 60.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -77.93 -25.22 48.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.0 mtt -78.66 -28.23 45.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 51.8 mt -84.65 -60.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.155 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -51.59 -56.52 13.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m -51.36 -30.05 17.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -63.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 5.6 mt -52.93 -42.68 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.082 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.37 -56.55 11.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 17.8 mt -52.88 -34.45 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 21.0 mt -63.88 -57.34 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.132 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -62.75 -42.48 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 221' ' ' ILE . . . . . . . . . . . . . 89.7 mt -57.9 -52.92 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -67.48 -49.86 61.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 223' ' ' ILE . . . . . . . . . . . . . 14.1 mt -49.19 -45.16 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 59.9 t -63.14 -52.75 54.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.5 mt -59.25 -37.6 78.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.937 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.89 -49.06 79.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . 0.55 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.6 OUTLIER -66.76 -51.0 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -49.66 -33.09 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -96.84 -21.48 17.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 230' ' ' GLU . . . . . 0.55 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 4.2 mt-10 -71.56 -2.37 16.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.916 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.01 49.71 0.18 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.95 21.03 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -108.32 43.27 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mmt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.774 0.321 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -135.07 51.04 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.4 p -88.57 41.28 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.456 ' N ' ' HD2' ' A' ' 5' ' ' PRO . . . -72.68 -60.71 1.89 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.562 0.696 . . . . 0.0 111.113 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 53.8 Cg_endo -69.75 -31.66 20.15 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.674 2.25 . . . . 0.0 112.329 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -51.69 65.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -58.4 -46.14 86.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -51.85 -43.91 63.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -74.16 -26.16 60.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.0 mtt -70.3 -36.17 74.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.5 mp -82.53 -44.39 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -51.82 -50.88 59.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -51.32 -30.22 17.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.29 -63.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 17.3 mt -54.93 -38.7 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.168 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.14 -55.14 15.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.24 -35.4 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 22.0 mt -62.2 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.21 -45.18 92.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 51.5 mt -58.37 -51.88 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -66.79 -53.99 27.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 mt -46.77 -50.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 65.6 t -57.56 -52.21 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.0 mt -58.91 -42.35 89.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -53.2 -56.65 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -51.11 72.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -48.65 -33.5 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -97.55 -19.41 18.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 26' ' ' LEU . 2.6 pt-20 -71.06 -3.99 22.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 46.05 0.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.35 17.61 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.49 35.93 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 12.8 mmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -135.12 8.54 3.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.1 p -93.94 39.1 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.62 -60.49 3.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.554 0.692 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 52.8 Cg_endo -69.77 -31.22 20.88 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.655 2.236 . . . . 0.0 112.307 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.26 -35.5 76.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.74 -52.1 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.1 -48.07 76.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.964 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.05 -45.4 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -73.13 -25.42 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -73.25 -40.45 64.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.33 -52.12 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -51.4 -59.11 4.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 99.9 m -49.35 -30.97 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 15.5 mt -58.91 -35.1 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.128 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.4 mt -68.79 -50.92 46.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 28.2 mt -61.41 -37.37 83.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 23.1 mt -62.22 -55.72 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -45.09 85.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 61.5 mt -59.39 -49.06 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -69.13 -52.8 24.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 23.9 mt -47.54 -52.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 75.2 t -57.77 -51.55 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 9.9 mt -56.19 -44.27 79.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.36 -57.53 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.39 -50.38 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -48.49 -33.59 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -97.61 -20.02 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.17 -4.07 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.74 46.7 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -119.83 18.72 12.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 110.919 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.3 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 12.6 mmt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.795 0.331 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -135.05 8.37 3.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 94.4 p -94.12 38.21 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.465 ' N ' ' HD2' ' C' ' 205' ' ' PRO . . . -71.07 -60.52 2.77 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.647 0.736 . . . . 0.0 111.139 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 205' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' C' ' 204' ' ' ALA . 53.8 Cg_endo -69.75 -31.27 20.9 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.684 2.256 . . . . 0.0 112.367 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -68.8 -36.45 78.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -57.56 -51.89 67.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -57.74 -46.47 84.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.938 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -52.08 -45.19 64.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -73.49 -26.02 60.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.3 mtt -72.58 -40.32 66.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 2.6 mp -84.38 -51.5 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -51.57 -58.31 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 98.6 m -50.09 -32.31 15.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.151 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -64.95 -64.1 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 18.9 mt -56.88 -38.62 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.35 -52.14 50.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.4 mt -61.37 -33.84 74.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 21.0 mt -61.32 -57.35 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.24 -46.16 90.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 221' ' ' ILE . . . . . . . . . . . . . 32.0 mt -60.25 -52.67 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -62.39 -56.07 21.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 223' ' ' ILE . . . . . . . . . . . . . 42.8 mt -43.78 -49.17 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.176 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 73.5 t -58.01 -52.38 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 14.0 mt -59.53 -41.88 91.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.12 -56.05 19.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -50.64 77.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -48.89 -33.29 10.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -97.34 -20.07 18.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -70.74 -4.14 22.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.55 46.66 0.21 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.512 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -122.7 18.6 10.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.765 0.317 . . . . 0.0 110.905 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 37.31 4.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 mmt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.82 0.343 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -157.5 119.21 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -97.01 40.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.474 ' N ' ' HD2' ' A' ' 5' ' ' PRO . . . -70.76 -59.83 3.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.594 0.711 . . . . 0.0 111.082 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 53.8 Cg_endo -69.77 -41.64 4.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -56.91 -40.01 75.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.74 -59.08 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.88 -43.99 73.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.907 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -51.49 -41.5 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -73.68 -30.43 62.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.845 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.06 -35.39 64.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.4 mp -84.31 -47.87 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -58.54 -57.81 11.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.4 m -51.76 -32.16 29.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.78 -64.32 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 60.7 mt -51.86 -40.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.49 -57.94 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.5 mt -53.0 -33.62 52.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.0 mt -64.41 -59.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.112 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.51 -38.44 87.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.414 HG12 ' CE2' ' C' ' 220' ' ' PHE . 87.1 mt -63.88 -53.49 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -66.93 -55.14 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.5 mt -45.77 -53.72 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.172 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 43.1 t -55.73 -48.6 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -63.68 -36.06 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.53 -48.04 83.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.4 -49.25 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -51.41 -32.9 28.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.41 -20.01 17.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.1 mm-40 -70.0 -4.06 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.79 50.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.52 19.83 13.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -118.05 36.27 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 28.1 mmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.33 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -158.04 116.24 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -102.19 43.89 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.482 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.83 -59.78 3.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.573 0.701 . . . . 0.0 111.095 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.75 -42.22 3.6 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -56.24 -41.04 75.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.24 -59.24 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.86 -44.54 74.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.04 -40.98 59.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.58 -29.6 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.4 mtm -75.93 -29.09 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 2.7 mt -84.1 -50.65 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.118 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.81 -57.56 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 95.9 m -50.19 -36.51 30.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -61.44 -61.93 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 66.2 mt -50.66 -49.85 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 mt -60.82 -53.35 58.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 22.3 mt -56.39 -33.64 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 19.7 mt -63.89 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.43 ' CZ ' ' HA ' ' C' ' 221' ' ' ILE . 7.1 t80 -62.31 -39.91 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 85.6 mt -64.31 -54.68 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -63.64 -52.28 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 32.9 mt -46.03 -46.09 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 51.7 t -61.92 -52.09 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 18.1 mt -59.92 -36.41 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.957 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.6 tp -59.96 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.563 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.62 -50.14 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.135 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -51.02 -32.4 21.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.59 -20.87 17.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . 0.563 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.7 mm-40 -70.62 -3.88 20.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.9 50.87 0.16 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 20.36 8.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -110.69 38.65 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 27.6 mmt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.755 0.312 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -158.76 120.49 3.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 15.1 m -95.12 37.25 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.837 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.482 ' N ' ' HD2' ' C' ' 205' ' ' PRO . . . -71.21 -60.08 2.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.597 0.713 . . . . 0.0 111.133 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 205' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' C' ' 204' ' ' ALA . 53.9 Cg_endo -69.77 -39.97 5.86 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -58.15 -40.42 81.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.12 -59.2 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -54.05 -45.24 71.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -51.47 -40.34 59.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.37 -29.05 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 1.2 mtm -76.28 -34.92 59.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 2.2 mp -84.35 -28.84 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -49.92 -56.5 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 89.9 m -47.73 -38.34 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -64.78 -63.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 48.9 mt -52.95 -33.87 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.06 -59.94 2.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 31.3 mt -55.88 -32.57 63.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 35.0 mt -63.55 -59.38 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . 0.414 ' CE2' HG12 ' A' ' 21' ' ' ILE . 6.8 t80 -61.89 -41.1 97.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 221' ' ' ILE . . . . . 0.43 ' HA ' ' CZ ' ' B' ' 120' ' ' PHE . 87.9 mt -64.83 -55.55 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.77 -52.26 64.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 223' ' ' ILE . . . . . . . . . . . . . 24.8 mt -45.71 -49.7 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 62.0 t -58.82 -50.38 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 20.3 mt -62.21 -35.33 78.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 22.4 tp -59.98 -47.26 86.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . 0.541 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.6 OUTLIER -68.84 -50.26 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -50.91 -32.69 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -96.89 -21.43 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 230' ' ' GLU . . . . . 0.541 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 11.3 mm-40 -70.78 -3.51 19.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.67 50.39 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -128.74 23.4 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -108.57 36.93 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.755 0.312 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -120.38 4.3 10.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -109.17 37.16 2.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.46 ' N ' ' HD2' ' A' ' 5' ' ' PRO . . . -70.6 -60.32 3.23 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.633 0.73 . . . . 0.0 111.122 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 53.7 Cg_endo -69.83 -34.11 15.01 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.663 2.242 . . . . 0.0 112.334 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -66.13 -35.64 81.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.66 -53.39 58.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -56.44 -47.81 78.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -51.2 -43.15 61.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -75.17 -26.15 58.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.8 mtt -70.21 -32.64 70.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -85.61 -41.88 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -63.65 -40.3 96.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.0 t -50.2 -29.04 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -63.75 -64.8 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 4.4 mt -53.14 -36.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.83 -59.78 2.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.7 mt -52.15 -29.71 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.8 mt -68.14 -60.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.02 -35.79 79.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.447 HG12 ' CZ ' ' C' ' 220' ' ' PHE . 51.7 mt -67.42 -53.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -66.45 -55.68 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 29.2 mt -46.08 -56.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.3 t -52.73 -48.12 49.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.05 -36.81 85.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -48.08 82.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.587 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -65.94 -51.19 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -49.66 -33.79 16.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.14 -20.44 17.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.2 mt-10 -71.32 -2.84 17.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 49.19 0.19 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.454 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -124.94 20.21 8.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.792 0.33 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -101.4 38.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.5 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 7.4 ttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.49 3.19 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 15.0 m -112.64 37.79 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.48 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.05 -60.21 3.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.573 0.701 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.48 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.74 -32.98 17.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -67.59 -35.75 79.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.9 -52.69 64.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -53.97 -51.61 63.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -50.17 -44.51 52.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -73.83 -25.57 60.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.8 mtt -75.41 -32.63 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 3.1 mt -77.27 -48.52 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.67 -55.7 27.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -50.88 -31.58 17.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.48 -62.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.891 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 3.4 mt -50.12 -45.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.147 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.48 -55.71 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.6 mt -57.44 -22.07 40.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 16.2 mt -73.76 -60.71 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' C' ' 221' ' ' ILE . 10.9 t80 -68.63 -37.23 79.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 82.1 mt -63.35 -48.94 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -72.1 -54.95 8.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 48.1 mt -47.69 -48.19 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 32.0 t -61.44 -51.47 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.96 -39.72 78.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.88 -48.3 81.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.593 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -68.59 -48.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -50.78 -32.74 20.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.58 -20.59 16.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . 0.593 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 9.4 mt-10 -70.51 -2.97 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.899 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.84 49.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.467 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -121.77 21.66 10.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -104.37 41.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -119.93 3.99 10.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 14.1 m -111.28 36.67 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.478 ' N ' ' HD2' ' C' ' 205' ' ' PRO . . . -70.52 -60.19 3.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.547 0.689 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 205' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' C' ' 204' ' ' ALA . 53.1 Cg_endo -69.82 -33.54 16.16 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -66.93 -34.94 78.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.01 -54.13 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -54.43 -48.92 71.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -51.08 -45.22 61.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -73.15 -26.16 61.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.1 mtt -74.19 -37.58 63.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 2.7 mp -84.32 -38.03 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -54.09 -62.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.2 t -55.8 -31.06 62.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.92 -63.86 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 7.0 mt -53.33 -33.54 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 1.3 mt -70.84 -60.13 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -54.35 -32.8 57.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 28.3 mt -64.96 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . 0.447 ' CZ ' HG12 ' A' ' 21' ' ' ILE . 4.5 t80 -61.41 -39.27 90.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 221' ' ' ILE . . . . . 0.452 ' HA ' ' CE2' ' B' ' 120' ' ' PHE . 64.2 mt -65.54 -55.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -62.72 -53.89 47.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 223' ' ' ILE . . . . . . . . . . . . . 31.1 mt -43.85 -56.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 16.4 t -54.48 -48.16 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.2 mt -61.45 -37.41 83.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -47.2 86.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . 0.528 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.8 OUTLIER -69.44 -51.86 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.141 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -49.31 -32.36 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -96.19 -23.1 16.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 230' ' ' GLU . . . . . 0.528 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 12.7 mt-10 -71.54 -2.01 15.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 125.74 45.79 0.24 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.522 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.36 18.24 4.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.77 0.319 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -99.65 41.08 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.155 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.808 0.337 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -126.38 3.28 6.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -106.24 37.11 2.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 5' ' ' PRO . . . -70.94 -60.39 2.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.567 0.698 . . . . 0.0 111.077 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 53.4 Cg_endo -69.74 -33.21 17.13 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 0.0 112.325 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.32 -34.83 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.62 -53.21 60.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.74 -46.85 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.939 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -53.02 -46.98 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -71.6 -27.39 63.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.4 mtt -71.09 -28.6 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.34 -36.78 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.099 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -74.51 -29.85 61.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.6 t -50.7 -28.34 8.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.7 mt -53.87 -37.25 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.33 -58.0 4.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -53.33 -28.17 27.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 23.6 mt -70.28 -60.12 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.84 -35.02 78.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.405 HG12 ' CZ ' ' C' ' 220' ' ' PHE . 80.6 mt -65.99 -52.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -70.0 -55.67 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mt -44.27 -51.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.176 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.3 t -59.45 -54.66 31.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.141 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 11.6 mt -54.94 -44.41 74.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.95 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 30' ' ' GLU . 14.0 tp -53.32 -57.2 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.52 -50.22 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.077 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -48.79 -33.43 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -99.12 -17.75 18.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -68.24 -7.25 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.23 48.53 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -100.84 19.34 17.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.915 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -167.51 89.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.132 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.753 0.311 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.75 3.35 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 2.4 m -105.68 37.24 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -71.16 -60.57 2.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 0.0 111.11 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.7 -32.74 18.21 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.755 2.303 . . . . 0.0 112.354 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.01 -34.19 76.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.02 -52.97 63.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.89 -49.13 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -51.63 -47.84 63.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.2 -26.93 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -73.79 -28.0 61.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 54.2 mt -81.65 -42.94 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -69.75 -51.98 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -52.96 -30.94 37.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.145 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.53 -62.57 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 5.0 mt -50.48 -44.85 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.159 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.4 mt -66.37 -55.72 14.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.4 mt -57.81 -22.65 48.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 16.5 mt -72.87 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.455 ' CE2' ' HA ' ' C' ' 221' ' ' ILE . 12.5 t80 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 80.0 mt -61.97 -49.58 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -71.93 -54.17 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 37.7 mt -47.34 -45.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 32.4 t -63.37 -54.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.18 -44.68 75.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.91 -56.05 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -49.86 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.158 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -48.97 -32.74 9.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.32 -19.32 17.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.1 -7.01 25.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 127.33 48.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.46 19.57 20.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.817 0.341 . . . . 0.0 110.964 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -170.4 86.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.121 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 17.5 mtt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.699 0.285 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.79 3.32 7.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 2.5 m -106.16 37.55 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' C' ' 205' ' ' PRO . . . -71.21 -60.48 2.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 205' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' C' ' 204' ' ' ALA . 53.6 Cg_endo -69.79 -32.87 17.6 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.27 . . . . 0.0 112.313 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -67.93 -34.37 76.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.9 -52.21 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -54.52 -48.54 71.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -52.13 -48.64 64.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -68.37 -27.52 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 8.8 mtt -76.43 -32.12 58.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.82 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 62.6 mt -84.53 -30.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -62.35 -55.7 25.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.5 t -58.48 -29.97 66.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.91 -64.25 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 13.4 mt -55.03 -32.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.102 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 1.4 mt -70.57 -58.89 3.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -55.37 -32.8 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 26.8 mt -64.87 -61.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . 0.405 ' CZ ' HG12 ' A' ' 21' ' ' ILE . 4.9 t80 -62.06 -39.41 92.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 221' ' ' ILE . . . . . 0.455 ' HA ' ' CE2' ' B' ' 120' ' ' PHE . 83.9 mt -64.35 -53.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -66.09 -54.0 31.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 223' ' ' ILE . . . . . . . . . . . . . 23.4 mt -42.79 -51.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.104 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 8.9 t -60.08 -54.63 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 12.2 mt -53.61 -44.17 69.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 12.0 tp -54.11 -55.48 27.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.51 -49.95 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.121 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -49.43 -31.77 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -97.97 -20.64 17.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -6.25 25.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.865 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 127.65 45.13 0.21 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -117.76 18.23 14.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.929 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -165.86 87.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 23.6 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mtt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.78 0.324 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.99 127.07 0.85 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -103.41 36.27 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 5' ' ' PRO . . . -71.27 -60.24 2.83 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.59 0.71 . . . . 0.0 111.116 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 53.6 Cg_endo -69.8 -37.2 9.39 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.634 2.223 . . . . 0.0 112.347 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.34 -38.52 87.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.18 -58.36 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -57.95 -43.25 86.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -51.52 -41.05 60.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -76.81 -28.26 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mtt -70.67 -32.65 69.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 2.6 mp -79.84 -52.27 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -51.87 -33.83 38.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -51.18 -32.4 23.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -64.75 -65.27 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.1 mt -53.82 -34.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -70.85 -59.05 3.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.0 mt -53.28 -27.47 22.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 25.6 mt -71.07 -60.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.18 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.09 -34.34 77.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 81.3 mt -67.44 -52.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.139 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -68.56 -55.6 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 36.0 mt -45.62 -54.16 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 33.3 t -56.5 -49.28 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.122 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.37 -38.79 84.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.91 -48.36 81.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.612 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -67.17 -48.05 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.2 t60 -51.54 -33.63 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -98.53 -19.35 17.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.612 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.6 mm-40 -70.47 -3.43 17.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.92 50.06 0.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -114.23 24.21 12.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.737 0.303 . . . . 0.0 110.927 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.12 36.97 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 21.1 mtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.97 126.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -105.47 38.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -70.2 -59.77 3.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 53.6 Cg_endo -69.77 -37.55 8.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.58 -38.41 87.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.52 -57.76 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -55.65 -47.55 76.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.18 -42.03 38.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -73.57 -32.01 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 2.3 mtm -74.82 -25.72 59.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mt -81.89 -62.77 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -52.04 -53.29 43.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 89.9 m -52.3 -31.08 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.9 -64.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 3.5 mt -49.75 -43.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 4.8 mt -66.36 -56.08 12.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 19.8 mt -58.26 -22.17 51.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 19.5 mt -72.81 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . 0.428 ' CE2' ' HA ' ' C' ' 221' ' ' ILE . 15.9 t80 -68.74 -38.85 80.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 79.7 mt -61.29 -49.29 85.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.07 -54.25 10.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 45.1 mt -48.33 -45.53 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 25.4 t -62.94 -52.19 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.86 -38.72 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.88 -48.1 82.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.6 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -67.75 -49.35 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' HIS . . . . . 0.408 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 29.1 t60 -50.46 -33.37 20.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -97.93 -20.4 17.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . 0.6 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 1.7 mm-40 -70.59 -3.07 16.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.19 50.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.533 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.408 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.5 OUTLIER -119.44 24.75 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -92.57 41.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 20.7 mtt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.728 0.299 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.14 127.27 0.84 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 67.9 m -102.16 36.62 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.483 ' N ' ' HD2' ' C' ' 205' ' ' PRO . . . -70.91 -59.89 3.26 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.57 0.7 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 205' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' C' ' 204' ' ' ALA . 53.8 Cg_endo -69.8 -36.76 10.11 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.7 2.266 . . . . 0.0 112.311 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -62.0 -38.81 90.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.86 -58.04 9.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -56.33 -42.39 77.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -52.7 -44.42 66.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -72.08 -29.38 64.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 2.5 mtm -73.79 -36.31 65.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 2.8 mt -84.62 -39.79 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -49.19 -51.67 31.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 98.3 m -56.67 -33.25 66.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -63.87 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 5.8 mt -51.22 -36.42 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.126 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.29 -59.71 2.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.38 -32.59 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 27.9 mt -63.78 -61.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -61.15 -40.47 93.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 221' ' ' ILE . . . . . 0.428 ' HA ' ' CE2' ' B' ' 120' ' ' PHE . 88.8 mt -64.14 -55.03 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.42 -54.78 31.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 223' ' ' ILE . . . . . . . . . . . . . 24.3 mt -42.39 -53.3 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.67 -50.29 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 15.9 mt -57.72 -39.2 76.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.34 -47.95 83.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . 0.54 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.8 OUTLIER -68.92 -51.23 46.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -49.73 -32.54 13.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -97.03 -21.77 17.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 230' ' ' GLU . . . . . 0.54 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 1.7 mm-40 -71.52 -2.51 17.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.05 47.57 0.2 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.64 22.67 5.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.752 0.311 . . . . 0.0 110.925 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -92.6 39.86 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.36 126.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.4 p -94.32 39.35 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.484 ' N ' ' HD2' ' A' ' 5' ' ' PRO . . . -70.84 -59.68 3.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.559 0.695 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD2' ' N ' ' A' ' 4' ' ' ALA . 54.0 Cg_endo -69.72 -41.51 4.26 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.372 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -56.41 -41.86 77.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.5 -59.88 3.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -54.98 -43.03 73.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -53.13 -37.41 61.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -78.32 -28.83 47.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 mtm -77.59 -30.98 52.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.2 mt -80.19 -51.75 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -52.49 -34.84 51.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 m -48.26 -33.18 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.57 -64.37 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 66.0 mt -56.9 -36.2 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.4 mt -69.11 -51.91 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.96 -35.25 72.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 19.0 mt -63.64 -57.95 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.46 -43.88 92.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.9 mt -58.08 -51.98 64.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -68.43 -51.74 40.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.4 mt -48.08 -49.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.135 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.8 t -58.91 -51.21 75.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.5 mt -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.19 -47.67 62.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.609 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -67.3 -46.89 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.112 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -52.36 -34.03 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -98.39 -19.01 17.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.609 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.3 mm-40 -70.56 -3.79 19.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 51.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -115.87 20.26 14.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.07 38.72 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.89 126.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 58.5 p -93.18 41.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ALA . . . . . 0.498 ' N ' ' HD2' ' B' ' 105' ' ' PRO . . . -69.5 -59.22 5.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' B' ' 104' ' ' ALA . 53.4 Cg_endo -69.77 -39.85 6.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.695 2.263 . . . . 0.0 112.322 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -58.05 -42.62 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.31 -58.65 6.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -56.44 -43.78 79.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -52.73 -36.75 58.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -79.88 -27.0 40.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.5 mtm -79.71 -27.98 40.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 3.2 mt -84.29 -57.33 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -50.99 -51.18 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 94.1 m -56.5 -39.26 72.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -62.3 -62.5 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' ILE . . . . . . . . . . . . . 62.8 mt -50.17 -47.59 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.14 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 1.3 mt -63.18 -57.22 11.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 26.3 mt -52.75 -32.46 43.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 19.8 mt -64.17 -57.36 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.137 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -63.77 -43.05 97.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' ILE . . . . . . . . . . . . . 22.4 mt -61.76 -52.75 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.172 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -65.6 -47.99 73.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 13.0 mt -49.77 -44.61 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.71 -52.03 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 16.8 mt -59.77 -47.3 86.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -47.5 63.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ILE . . . . . 0.57 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.9 OUTLIER -66.83 -48.94 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' HIS . . . . . 0.403 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 4.0 t60 -51.5 -33.52 31.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.826 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -97.81 -19.67 18.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.86 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' GLU . . . . . 0.57 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.8 mm-40 -70.8 -3.9 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.37 50.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' TRP . . . . . 0.403 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.6 OUTLIER -119.32 20.32 12.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.27 39.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.823 0.344 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.18 125.95 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 59.7 p -94.7 39.71 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 204' ' ' ALA . . . . . 0.481 ' N ' ' HD2' ' C' ' 205' ' ' PRO . . . -69.32 -59.55 4.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.592 0.71 . . . . 0.0 111.118 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 205' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' C' ' 204' ' ' ALA . 54.0 Cg_endo -69.75 -40.32 5.48 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.736 2.291 . . . . 0.0 112.363 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -57.89 -40.82 81.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -53.69 -58.87 5.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -55.34 -44.72 76.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.935 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -51.71 -38.88 57.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.847 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -76.84 -28.41 55.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 1.4 mtm -77.55 -28.79 51.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 3.3 mt -80.06 -45.08 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.118 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -50.41 -62.19 1.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m -53.31 -38.84 63.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -63.03 -63.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 216' ' ' ILE . . . . . . . . . . . . . 69.7 mt -51.46 -39.54 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 217' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -67.99 -59.22 3.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 25.3 mt -51.26 -30.59 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 219' ' ' ILE . . . . . . . . . . . . . 24.2 mt -68.15 -59.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.52 -37.87 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 221' ' ' ILE . . . . . . . . . . . . . 96.0 mt -63.62 -53.89 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -67.62 -52.11 42.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 223' ' ' ILE . . . . . . . . . . . . . 16.0 mt -46.8 -53.2 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.19 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 55.8 t -57.12 -49.64 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.58 -54.34 47.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -45.95 59.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 227' ' ' ILE . . . . . 0.515 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.9 OUTLIER -68.4 -52.71 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -49.69 -31.49 11.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -96.66 -23.03 16.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 230' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 12.5 mm-40 -71.38 -2.5 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.16 46.67 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -131.98 19.52 4.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.887 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.89 38.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.825 0.26 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.04 -32.28 73.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.12 -55.68 29.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.75 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -52.36 -50.92 61.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.35 -46.46 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -71.47 -26.34 62.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.2 mtt -74.09 -58.99 2.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -58.04 -37.95 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -46.68 -33.94 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.24 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.531 ' HA ' HD12 ' A' ' 19' ' ' ILE . 56.5 mt -57.58 -36.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.581 HD22 HD11 ' A' ' 21' ' ' ILE . 1.3 mt -67.32 -51.87 47.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.43 -38.18 83.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.594 HG22 HD12 ' A' ' 23' ' ' ILE . 22.0 mt -60.03 -56.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -65.76 -47.53 74.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.581 HD11 HD22 ' A' ' 17' ' ' LEU . 34.8 mt -56.65 -48.32 80.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -70.74 -52.45 20.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.594 HD12 HG22 ' A' ' 19' ' ' ILE . 21.7 mt -48.39 -52.86 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' PHE . 87.6 t -57.41 -51.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 25' ' ' LEU . 9.6 mt -55.86 -45.65 78.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 30' ' ' GLU . 2.6 mp -54.51 -59.07 5.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -56.63 -49.69 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -48.03 -36.16 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -97.74 -18.21 18.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.5 tm-20 -71.61 -2.18 16.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.92 49.81 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.58 18.63 14.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.73 0.3 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.68 36.82 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -154.46 116.0 4.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -113.98 37.03 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.56 -60.28 3.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 111.105 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.7 Cg_endo -69.71 -34.93 13.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.69 -34.42 78.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.09 -54.64 44.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.747 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.9 mm? -52.6 -49.58 64.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -51.09 -47.05 61.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -70.97 -26.16 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.4 mtt -74.46 -59.92 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.747 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.6 mp -56.27 -40.54 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.78 -59.69 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 87.8 m -54.34 -36.44 63.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -60.94 -63.14 1.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' B' ' 119' ' ' ILE . 61.6 mt -50.26 -46.1 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.928 HD22 HD11 ' B' ' 121' ' ' ILE . 0.6 OUTLIER -62.71 -57.03 12.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 23.9 mt -53.32 -32.74 50.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' B' ' 116' ' ' ILE . 22.7 mt -63.64 -55.58 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.631 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.1 t80 -62.67 -42.71 99.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.928 HD11 HD22 ' B' ' 117' ' ' LEU . 27.0 mt -62.87 -53.6 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.64 -52.21 61.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.522 HD12 HG22 ' B' ' 119' ' ' ILE . 13.4 mt -46.26 -48.44 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 120' ' ' PHE . 70.4 t -59.37 -52.25 63.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' B' ' 125' ' ' LEU . 10.9 mt -58.3 -42.02 85.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -56.73 15.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.424 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.7 OUTLIER -57.02 -51.95 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -47.5 -35.05 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -95.01 -22.02 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 1.5 tm-20 -72.57 -0.96 14.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.96 45.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -133.02 18.73 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.85 36.68 1.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.146 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.814 0.34 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -63.89 -63.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.633 ' HA ' HD12 ' C' ' 219' ' ' ILE . 58.8 mt -51.83 -39.56 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 217' ' ' LEU . . . . . 0.967 HD22 HD11 ' C' ' 221' ' ' ILE . 0.6 OUTLIER -67.2 -58.86 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 218' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' C' ' 218' ' ' LEU . 19.0 mt -51.56 -33.68 33.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 219' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' C' ' 216' ' ' ILE . 23.3 mt -64.47 -59.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -42.66 99.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 221' ' ' ILE . . . . . 0.967 HD11 HD22 ' C' ' 217' ' ' LEU . 94.4 mt -55.12 -52.25 46.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.838 0.266 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -63.39 -34.67 78.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.48 -57.97 10.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.725 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.5 mm? -52.63 -47.16 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -51.11 -46.32 61.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -72.83 -25.74 61.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.824 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.5 mtt -71.17 -30.47 66.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.9 mp -84.35 -55.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -53.06 -47.83 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -54.79 -27.3 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -64.6 -64.21 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HA ' HD12 ' A' ' 19' ' ' ILE . 2.1 mp -54.14 -40.85 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.883 HD22 HD11 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -66.44 -55.85 13.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 18' ' ' LEU . 24.7 mt -54.84 -31.58 59.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 16' ' ' ILE . 20.7 mt -66.05 -56.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.555 ' O ' HG23 ' A' ' 24' ' ' VAL . 14.7 t80 -62.95 -39.05 93.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.883 HD11 HD22 ' A' ' 17' ' ' LEU . 60.1 mt -63.88 -52.52 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.03 -53.75 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.559 HD12 HG22 ' A' ' 19' ' ' ILE . 22.8 mt -45.5 -44.2 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 20' ' ' PHE . 42.6 t -63.91 -55.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.4 mt -55.65 -43.4 76.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.7 tp -53.87 -56.52 16.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -51.94 66.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -48.16 -32.09 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -96.5 -22.91 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.14 -2.5 15.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 44.98 0.24 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.44 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.6 18.13 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -105.3 35.87 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.088 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -155.29 117.22 4.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 74.9 p -125.68 36.54 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -71.54 -60.46 2.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 111.094 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.72 -36.83 10.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.752 2.302 . . . . 0.0 112.302 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.32 -34.21 77.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.93 -57.96 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.728 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.5 mm? -52.81 -47.08 67.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.5 -46.25 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -72.7 -25.96 61.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 7.5 mtt -70.98 -30.38 66.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.728 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.9 mt -84.39 -55.15 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -53.25 -47.88 68.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -54.8 -27.18 39.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.79 -64.22 0.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.591 ' HA ' HD12 ' B' ' 119' ' ' ILE . 2.1 mp -54.24 -40.63 48.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.898 HD22 HD11 ' B' ' 121' ' ' ILE . 0.7 OUTLIER -66.52 -55.95 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' B' ' 118' ' ' LEU . 25.2 mt -54.99 -31.35 60.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' B' ' 116' ' ' ILE . 20.6 mt -66.19 -56.37 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.53 ' O ' HG23 ' B' ' 124' ' ' VAL . 15.3 t80 -63.13 -38.86 92.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.898 HD11 HD22 ' B' ' 117' ' ' LEU . 61.8 mt -64.04 -52.45 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.115 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.29 -53.52 35.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.534 HD12 HG22 ' B' ' 119' ' ' ILE . 22.6 mt -45.55 -44.32 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 120' ' ' PHE . 42.1 t -64.01 -55.43 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.1 mt -55.21 -43.52 74.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.92 -56.77 14.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -51.5 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -48.42 -32.17 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.835 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -96.66 -22.63 16.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.02 -2.76 16.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.852 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.08 45.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.14 18.17 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.775 0.321 . . . . 0.0 110.953 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -105.92 35.82 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.794 0.331 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -64.8 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.613 ' HA ' HD12 ' C' ' 219' ' ' ILE . 2.0 mp -54.25 -40.47 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.144 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 217' ' ' LEU . . . . . 0.919 HD22 HD11 ' C' ' 221' ' ' ILE . 0.7 OUTLIER -66.67 -56.03 12.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 24.3 mt -54.57 -31.91 57.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 219' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' C' ' 216' ' ' ILE . 20.9 mt -65.84 -56.69 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.84 -39.13 93.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 221' ' ' ILE . . . . . 0.919 HD11 HD22 ' C' ' 217' ' ' LEU . 64.0 mt -63.91 -52.16 60.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.818 0.258 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.92 -34.84 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.51 -50.79 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.4 -48.43 79.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.41 -41.62 63.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -77.09 -26.98 53.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.96 -29.67 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mt -83.78 -45.99 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -60.64 -55.61 31.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.0 m -51.12 -36.25 39.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.172 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.44 -64.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.593 ' HA ' HD12 ' A' ' 19' ' ' ILE . 45.0 mt -52.07 -39.18 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.001 HD22 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -68.36 -58.94 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 18' ' ' LEU . 22.7 mt -51.16 -30.98 18.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 16' ' ' ILE . 22.7 mt -68.13 -60.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -61.64 -34.09 75.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.001 HD11 HD22 ' A' ' 17' ' ' LEU . 87.7 mt -67.42 -55.24 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -65.68 -54.58 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.549 HD12 HG22 ' A' ' 19' ' ' ILE . 30.3 mt -46.21 -56.76 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.506 HG23 ' HD1' ' A' ' 20' ' ' PHE . 40.0 t -52.77 -48.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.2 mt -63.36 -36.19 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.24 -47.76 84.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.12 -50.19 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -50.43 -33.45 20.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -97.56 -20.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 11.1 mt-10 -70.48 -3.67 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 50.06 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.476 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.7 20.51 10.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -98.91 35.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.16 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -147.18 114.64 6.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -114.45 39.56 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.03 -60.29 3.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 111.145 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.0 Cg_endo -69.81 -32.72 17.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -68.44 -34.66 76.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.13 -49.69 76.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.08 -49.49 75.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -51.92 -43.11 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -75.02 -27.16 59.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -72.9 -29.61 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 49.6 mt -81.66 -46.73 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.62 -54.73 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.492 HG22 ' CD1' ' B' ' 118' ' ' LEU . 86.4 m -52.97 -37.68 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.96 -61.91 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.678 ' HA ' HD12 ' B' ' 119' ' ' ILE . 66.1 mt -51.34 -50.27 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.927 HD22 HD11 ' B' ' 121' ' ' ILE . 1.5 mt -60.04 -51.94 67.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.492 ' CD1' HG22 ' B' ' 114' ' ' THR . 25.9 mt -57.16 -33.55 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' B' ' 116' ' ' ILE . 18.5 mt -64.13 -60.69 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.134 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.577 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.8 t80 -62.7 -40.07 96.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.927 HD11 HD22 ' B' ' 117' ' ' LEU . 86.8 mt -64.44 -54.86 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -63.42 -52.52 61.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.486 HD12 HG22 ' B' ' 119' ' ' ILE . 31.1 mt -46.38 -45.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 120' ' ' PHE . 42.3 t -62.26 -52.92 54.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.79 -36.74 77.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' B' ' 126' ' ' LEU . 1.1 tp -59.22 -48.3 82.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.612 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.0 -50.94 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -49.74 -32.86 14.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.86 -20.73 17.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.612 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.9 mt-10 -71.09 -2.86 17.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.47 49.19 0.19 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -123.54 20.47 9.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -102.08 36.69 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.798 0.333 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -60.58 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.672 ' HA ' HD12 ' C' ' 219' ' ' ILE . 46.8 mt -52.31 -35.56 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 217' ' ' LEU . . . . . 0.896 HD22 HD11 ' C' ' 221' ' ' ILE . 0.9 OUTLIER -67.86 -59.65 3.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 35.8 mt -53.77 -32.37 52.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 219' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' C' ' 216' ' ' ILE . 30.9 mt -64.08 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -61.1 -39.85 91.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 221' ' ' ILE . . . . . 0.896 HD11 HD22 ' C' ' 217' ' ' LEU . 88.7 mt -65.37 -57.16 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.808 0.254 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -72.64 -38.31 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.38 -46.42 76.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.28 -50.03 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -51.76 -40.58 60.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -78.2 -26.5 47.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.1 mtt -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 52.5 mt -84.72 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -51.46 -55.42 18.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -52.1 -32.81 36.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 t -65.63 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.827 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mt -52.56 -39.27 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.76 -56.62 7.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 18' ' ' LEU . 26.4 mt -55.87 -35.47 66.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 23' ' ' ILE . 33.2 mt -62.38 -57.01 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.709 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.61 -41.53 98.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.816 HD11 HD22 ' A' ' 17' ' ' LEU . 71.5 mt -59.3 -52.53 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.104 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -68.49 -48.21 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.612 HD12 HG22 ' A' ' 19' ' ' ILE . 11.2 mt -49.55 -47.01 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 20' ' ' PHE . 74.0 t -63.07 -52.84 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.21 -39.14 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.07 -49.23 77.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -66.51 -51.09 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -49.29 -33.12 12.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.44 -20.91 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 3.7 mt-10 -71.49 -2.33 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.31 48.16 0.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 19.24 8.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.961 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -114.08 41.6 2.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.2 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 34.9 ttm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -154.52 117.66 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 30.5 p -101.56 36.96 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -69.2 -60.05 4.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.582 0.706 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.74 -28.59 25.14 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.82 -37.86 70.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.44 -47.25 76.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.08 -48.87 79.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -52.28 -40.69 62.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -78.64 -26.03 45.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -77.13 -28.88 54.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 56.4 mt -83.94 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -52.12 -55.47 20.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.424 HG22 HD12 ' B' ' 118' ' ' LEU . 97.7 m -52.2 -30.26 26.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.657 ' HA ' HD12 ' B' ' 119' ' ' ILE . 3.6 mt -54.84 -41.11 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.922 HD22 HD11 ' B' ' 121' ' ' ILE . 0.4 OUTLIER -64.66 -54.74 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.424 HD12 HG22 ' B' ' 114' ' ' THR . 24.1 mt -56.61 -34.02 66.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' B' ' 116' ' ' ILE . 22.5 mt -62.54 -56.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.602 ' O ' HG23 ' B' ' 124' ' ' VAL . 57.7 t80 -63.49 -46.86 84.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.922 HD11 HD22 ' B' ' 117' ' ' LEU . 80.7 mt -53.94 -52.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.72 -49.97 54.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.625 HD12 HG22 ' B' ' 119' ' ' ILE . 9.2 mt -49.64 -42.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 120' ' ' PHE . 73.5 t -65.61 -53.39 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 125' ' ' LEU . 18.0 mt -58.85 -41.02 85.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.23 -49.03 77.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.632 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -67.0 -49.01 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.135 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 128' ' ' HIS . . . . . 0.41 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 37.7 t-80 -51.25 -32.45 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.827 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -99.22 -19.78 16.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 3.8 mt-10 -70.1 -3.75 18.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.13 50.18 0.19 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.41 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.6 OUTLIER -113.98 21.07 15.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.755 0.312 . . . . 0.0 110.892 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -117.96 41.38 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.781 0.324 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -63.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.62 ' HA ' HD12 ' C' ' 219' ' ' ILE . 5.6 mt -52.93 -42.68 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.082 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 217' ' ' LEU . . . . . 0.885 HD22 HD11 ' C' ' 221' ' ' ILE . 0.6 OUTLIER -65.37 -56.55 11.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 218' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' C' ' 218' ' ' LEU . 17.8 mt -52.88 -34.45 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 219' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' C' ' 216' ' ' ILE . 21.0 mt -63.88 -57.34 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.132 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 220' ' ' PHE . . . . . 0.768 ' CZ ' HG23 ' A' ' 21' ' ' ILE . 50.0 t80 -62.75 -42.48 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 221' ' ' ILE . . . . . 0.885 HD11 HD22 ' C' ' 217' ' ' LEU . 89.7 mt -57.9 -52.92 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.787 0.245 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -51.69 65.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.8 mm? -58.4 -46.14 86.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -51.85 -43.91 63.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -74.16 -26.16 60.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.0 mtt -70.3 -36.17 74.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.5 mp -82.53 -44.39 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.54 HD21 HG21 ' C' ' 216' ' ' ILE . 8.3 t-20 -51.82 -50.88 59.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -51.32 -30.22 17.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.29 -63.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.59 ' HA ' HD12 ' A' ' 19' ' ' ILE . 17.3 mt -54.93 -38.7 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.865 HD22 HD11 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -67.14 -55.14 15.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.24 -35.4 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 16' ' ' ILE . 22.0 mt -62.2 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.614 ' CE1' HG21 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.21 -45.18 92.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.865 HD11 HD22 ' A' ' 17' ' ' LEU . 51.5 mt -58.37 -51.88 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -66.79 -53.99 27.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.578 HD12 HG22 ' A' ' 19' ' ' ILE . 22.0 mt -46.77 -50.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 20' ' ' PHE . 65.6 t -57.56 -52.21 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 25' ' ' LEU . 13.0 mt -58.91 -42.35 89.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -53.2 -56.65 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -51.11 72.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -48.65 -33.5 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -97.55 -19.41 18.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 26' ' ' LEU . 2.6 pt-20 -71.06 -3.99 22.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 46.05 0.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.35 17.61 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.49 35.93 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 12.8 mmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -135.12 8.54 3.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.1 p -93.94 39.1 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.62 -60.49 3.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.554 0.692 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 52.8 Cg_endo -69.77 -31.22 20.88 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.655 2.236 . . . . 0.0 112.307 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.26 -35.5 76.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.74 -52.1 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.72 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.7 mm? -56.1 -48.07 76.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.964 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.05 -45.4 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -73.13 -25.42 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -73.25 -40.45 64.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.72 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.6 mp -84.33 -52.12 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -51.4 -59.11 4.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.438 HG22 HD12 ' B' ' 118' ' ' LEU . 99.9 m -49.35 -30.97 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.441 ' HA ' HD12 ' B' ' 119' ' ' ILE . 15.5 mt -58.91 -35.1 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.128 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.828 HD22 HD11 ' B' ' 121' ' ' ILE . 1.4 mt -68.79 -50.92 46.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.438 HD12 HG22 ' B' ' 114' ' ' THR . 28.2 mt -61.41 -37.37 83.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.604 HG22 HD12 ' B' ' 123' ' ' ILE . 23.1 mt -62.22 -55.72 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.556 ' O ' HG23 ' B' ' 124' ' ' VAL . 0.1 OUTLIER -65.43 -45.09 85.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.828 HD11 HD22 ' B' ' 117' ' ' LEU . 61.5 mt -59.39 -49.06 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -69.13 -52.8 24.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.604 HD12 HG22 ' B' ' 119' ' ' ILE . 23.9 mt -47.54 -52.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.556 HG23 ' O ' ' B' ' 120' ' ' PHE . 75.2 t -57.77 -51.55 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.574 HD11 HG13 ' A' ' 24' ' ' VAL . 9.9 mt -56.19 -44.27 79.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.36 -57.53 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.39 -50.38 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -48.49 -33.59 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -97.61 -20.02 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.17 -4.07 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.74 46.7 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -119.83 18.72 12.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 110.919 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.3 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 214' ' ' THR . . . . . 0.424 HG22 HD12 ' C' ' 218' ' ' LEU . 98.6 m . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.825 0.345 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -64.95 -64.1 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.679 HG23 HD11 ' A' ' 17' ' ' LEU . 18.9 mt -56.88 -38.62 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 217' ' ' LEU . . . . . 0.648 HD22 HD11 ' C' ' 221' ' ' ILE . 0.5 OUTLIER -66.35 -52.14 50.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 218' ' ' LEU . . . . . 0.424 HD12 HG22 ' C' ' 214' ' ' THR . 28.4 mt -61.37 -33.84 74.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 219' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' C' ' 216' ' ' ILE . 21.0 mt -61.32 -57.35 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 220' ' ' PHE . . . . . 0.659 ' HB2' HD21 ' A' ' 17' ' ' LEU . 1.5 t80 -60.24 -46.16 90.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 221' ' ' ILE . . . . . 0.648 HD11 HD22 ' C' ' 217' ' ' LEU . 32.0 mt -60.25 -52.67 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.872 0.28 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -56.91 -40.01 75.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.74 -59.08 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.0 mm? -54.88 -43.99 73.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -51.49 -41.5 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -73.68 -30.43 62.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.845 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.06 -35.39 64.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.4 mp -84.31 -47.87 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -58.54 -57.81 11.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.4 m -51.76 -32.16 29.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.78 -64.32 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.551 ' HA ' HD12 ' A' ' 19' ' ' ILE . 60.7 mt -51.86 -40.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.888 HD22 HD11 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -67.49 -57.94 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 18' ' ' LEU . 23.5 mt -53.0 -33.62 52.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 16' ' ' ILE . 23.0 mt -64.41 -59.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.112 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.58 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -61.51 -38.44 87.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.888 HD11 HD22 ' A' ' 17' ' ' LEU . 87.1 mt -63.88 -53.49 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -66.93 -55.14 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 19' ' ' ILE . 24.5 mt -45.77 -53.72 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 20' ' ' PHE . 43.1 t -55.73 -48.6 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.4 mt -63.68 -36.06 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.53 -48.04 83.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.4 -49.25 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -51.41 -32.9 28.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.41 -20.01 17.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.1 mm-40 -70.0 -4.06 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.79 50.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.52 19.83 13.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -118.05 36.27 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 28.1 mmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.33 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -158.04 116.24 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -102.19 43.89 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.734 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.83 -59.78 3.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.573 0.701 . . . . 0.0 111.095 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.734 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.75 -42.22 3.6 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -56.24 -41.04 75.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.24 -59.24 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.754 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.0 mm? -54.86 -44.54 74.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.04 -40.98 59.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.58 -29.6 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.4 mtm -75.93 -29.09 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.754 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.7 mt -84.1 -50.65 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.118 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.81 -57.56 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.445 HG22 ' CD1' ' B' ' 118' ' ' LEU . 95.9 m -50.19 -36.51 30.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -61.44 -61.93 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.624 ' HA ' HD12 ' B' ' 119' ' ' ILE . 66.2 mt -50.66 -49.85 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.933 HD22 HD11 ' B' ' 121' ' ' ILE . 1.5 mt -60.82 -53.35 58.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' B' ' 114' ' ' THR . 22.3 mt -56.39 -33.64 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.7 mt -63.89 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.575 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.1 t80 -62.31 -39.91 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.933 HD11 HD22 ' B' ' 117' ' ' LEU . 85.6 mt -64.31 -54.68 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -63.64 -52.28 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.475 HD12 HG22 ' B' ' 119' ' ' ILE . 32.9 mt -46.03 -46.09 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 120' ' ' PHE . 51.7 t -61.92 -52.09 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' B' ' 125' ' ' LEU . 18.1 mt -59.92 -36.41 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.957 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.6 tp -59.96 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.591 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.62 -50.14 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.135 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -51.02 -32.4 21.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.59 -20.87 17.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.591 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.7 mm-40 -70.62 -3.88 20.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.9 50.87 0.16 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 20.36 8.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -110.69 38.65 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 89.9 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.786 0.327 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -64.78 -63.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.583 ' HA ' HD12 ' C' ' 219' ' ' ILE . 48.9 mt -52.95 -33.87 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 217' ' ' LEU . . . . . 0.772 HD22 HD11 ' C' ' 221' ' ' ILE . 0.7 OUTLIER -68.06 -59.94 2.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 31.3 mt -55.88 -32.57 63.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 219' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' C' ' 216' ' ' ILE . 35.0 mt -63.55 -59.38 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 220' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' A' ' 21' ' ' ILE . 6.8 t80 -61.89 -41.1 97.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 221' ' ' ILE . . . . . 0.772 HD11 HD22 ' C' ' 217' ' ' LEU . 87.9 mt -64.83 -55.55 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.21 0 CA-C-O 120.791 0.246 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -66.13 -35.64 81.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.66 -53.39 58.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.767 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -56.44 -47.81 78.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -51.2 -43.15 61.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -75.17 -26.15 58.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.605 ' O ' HG22 ' A' ' 14' ' ' THR . 8.8 mtt -70.21 -32.64 70.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.767 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -85.61 -41.88 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -63.65 -40.3 96.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 11' ' ' MET . 7.0 t -50.2 -29.04 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -63.75 -64.8 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HA ' HD12 ' A' ' 19' ' ' ILE . 4.4 mt -53.14 -36.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.687 HD22 HD11 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -68.83 -59.78 2.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.7 mt -52.15 -29.71 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 16' ' ' ILE . 25.8 mt -68.14 -60.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.557 ' CB ' HD13 ' B' ' 117' ' ' LEU . 0.2 OUTLIER -62.02 -35.79 79.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.687 HD11 HD22 ' A' ' 17' ' ' LEU . 51.7 mt -67.42 -53.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -66.45 -55.68 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 19' ' ' ILE . 29.2 mt -46.08 -56.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.468 HG23 ' HD1' ' A' ' 20' ' ' PHE . 38.3 t -52.73 -48.12 49.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.05 -36.81 85.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -48.08 82.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -65.94 -51.19 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -49.66 -33.79 16.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.14 -20.44 17.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.2 mt-10 -71.32 -2.84 17.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 49.19 0.19 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.454 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -124.94 20.21 8.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.792 0.33 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -101.4 38.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.5 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 7.4 ttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.49 3.19 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 15.0 m -112.64 37.79 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.05 -60.21 3.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.573 0.701 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.74 -32.98 17.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -67.59 -35.75 79.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.9 -52.69 64.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.718 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.7 mm? -53.97 -51.61 63.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -50.17 -44.51 52.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -73.83 -25.57 60.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.8 mtt -75.41 -32.63 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.718 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.1 mt -77.27 -48.52 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -61.67 -55.7 27.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -50.88 -31.58 17.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.48 -62.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.891 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.634 HG23 ' HG ' ' C' ' 217' ' ' LEU . 3.4 mt -50.12 -45.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.991 HD22 HD11 ' B' ' 121' ' ' ILE . 4.7 mt -66.48 -55.71 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.6 mt -57.44 -22.07 40.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 116' ' ' ILE . 16.2 mt -73.76 -60.71 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' C' ' 221' ' ' ILE . 10.9 t80 -68.63 -37.23 79.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.991 HD11 HD22 ' B' ' 117' ' ' LEU . 82.1 mt -63.35 -48.94 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -72.1 -54.95 8.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 48.1 mt -47.69 -48.19 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 120' ' ' PHE . 32.0 t -61.44 -51.47 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.96 -39.72 78.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.88 -48.3 81.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.613 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -68.59 -48.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 128' ' ' HIS . . . . . 0.42 ' HA ' ' HB2' ' B' ' 132' ' ' TRP . 16.4 t-80 -50.78 -32.74 20.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.58 -20.59 16.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.613 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 9.4 mt-10 -70.51 -2.97 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.899 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.84 49.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.467 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.42 ' HB2' ' HA ' ' B' ' 128' ' ' HIS . 0.2 OUTLIER -121.77 21.66 10.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -104.37 41.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.83 0.348 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.92 -63.86 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.512 HG22 HG21 ' B' ' 116' ' ' ILE . 7.0 mt -53.33 -33.54 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 217' ' ' LEU . . . . . 0.817 HD22 HD11 ' C' ' 221' ' ' ILE . 1.3 mt -70.84 -60.13 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -54.35 -32.8 57.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 219' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' C' ' 216' ' ' ILE . 28.3 mt -64.96 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 220' ' ' PHE . . . . . 0.564 ' CE2' HD23 ' B' ' 117' ' ' LEU . 4.5 t80 -61.41 -39.27 90.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 221' ' ' ILE . . . . . 0.817 HD11 HD22 ' C' ' 217' ' ' LEU . 64.2 mt -65.54 -55.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.815 0.256 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.32 -34.83 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.62 -53.21 60.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.74 -46.85 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.939 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -53.02 -46.98 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -71.6 -27.39 63.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.643 ' O ' HG22 ' A' ' 14' ' ' THR . 9.4 mtt -71.09 -28.6 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.34 -36.78 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.099 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -74.51 -29.85 61.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 11' ' ' MET . 5.6 t -50.7 -28.34 8.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.588 ' HA ' HD12 ' A' ' 19' ' ' ILE . 7.7 mt -53.87 -37.25 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.907 HD22 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -69.33 -58.0 4.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -53.33 -28.17 27.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 16' ' ' ILE . 23.6 mt -70.28 -60.12 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -62.84 -35.02 78.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.907 HD11 HD22 ' A' ' 17' ' ' LEU . 80.6 mt -65.99 -52.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -70.0 -55.67 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 19' ' ' ILE . 22.3 mt -44.27 -51.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.176 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.463 HG23 ' HD1' ' A' ' 20' ' ' PHE . 40.3 t -59.45 -54.66 31.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.141 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 25' ' ' LEU . 11.6 mt -54.94 -44.41 74.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 30' ' ' GLU . 14.0 tp -53.32 -57.2 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -57.52 -50.22 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.077 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 32' ' ' TRP . 6.8 t60 -48.79 -33.43 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -99.12 -17.75 18.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -68.24 -7.25 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.23 48.53 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 28' ' ' HIS . 0.1 OUTLIER -100.84 19.34 17.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.915 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -167.51 89.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.132 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.753 0.311 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.75 3.35 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 2.4 m -105.68 37.24 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -71.16 -60.57 2.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 0.0 111.11 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.7 -32.74 18.21 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.755 2.303 . . . . 0.0 112.354 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.01 -34.19 76.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.02 -52.97 63.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.89 -49.13 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -51.63 -47.84 63.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.2 -26.93 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -73.79 -28.0 61.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 54.2 mt -81.65 -42.94 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -69.75 -51.98 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -52.96 -30.94 37.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.145 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.53 -62.57 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.684 HG23 ' HG ' ' C' ' 217' ' ' LEU . 5.0 mt -50.48 -44.85 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.159 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 1.0 HD22 HD11 ' B' ' 121' ' ' ILE . 4.4 mt -66.37 -55.72 14.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.4 mt -57.81 -22.65 48.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' B' ' 116' ' ' ILE . 16.5 mt -72.87 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.472 ' O ' HG23 ' B' ' 124' ' ' VAL . 12.5 t80 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 1.0 HD11 HD22 ' B' ' 117' ' ' LEU . 80.0 mt -61.97 -49.58 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -71.93 -54.17 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 37.7 mt -47.34 -45.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 120' ' ' PHE . 32.4 t -63.37 -54.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.18 -44.68 75.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.91 -56.05 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.404 ' HA ' ' HG2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -59.76 -49.86 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.158 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -48.97 -32.74 9.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.32 -19.32 17.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' B' ' 127' ' ' ILE . 0.2 OUTLIER -68.1 -7.01 25.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 127.33 48.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.46 19.57 20.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.817 0.341 . . . . 0.0 110.964 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -170.4 86.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.121 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.807 0.337 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.91 -64.25 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.605 HG22 HG21 ' B' ' 116' ' ' ILE . 13.4 mt -55.03 -32.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.102 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 217' ' ' LEU . . . . . 0.961 HD22 HD11 ' C' ' 221' ' ' ILE . 1.4 mt -70.57 -58.89 3.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -55.37 -32.8 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 219' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' C' ' 216' ' ' ILE . 26.8 mt -64.87 -61.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 220' ' ' PHE . . . . . 0.563 ' CE2' HD23 ' B' ' 117' ' ' LEU . 4.9 t80 -62.06 -39.41 92.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 221' ' ' ILE . . . . . 0.961 HD11 HD22 ' C' ' 217' ' ' LEU . 83.9 mt -64.35 -53.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.931 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.79 0.246 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.34 -38.52 87.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.18 -58.36 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -57.95 -43.25 86.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -51.52 -41.05 60.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -76.81 -28.26 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mtt -70.67 -32.65 69.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -79.84 -52.27 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -51.87 -33.83 38.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -51.18 -32.4 23.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -64.75 -65.27 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.607 ' HA ' HD12 ' A' ' 19' ' ' ILE . 5.1 mt -53.82 -34.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.014 HD22 HD11 ' A' ' 21' ' ' ILE . 1.4 mt -70.85 -59.05 3.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.0 mt -53.28 -27.47 22.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 16' ' ' ILE . 25.6 mt -71.07 -60.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.18 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.09 -34.34 77.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.014 HD11 HD22 ' A' ' 17' ' ' LEU . 81.3 mt -67.44 -52.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.139 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -68.56 -55.6 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 19' ' ' ILE . 36.0 mt -45.62 -54.16 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.501 HG23 ' HD1' ' A' ' 20' ' ' PHE . 33.3 t -56.5 -49.28 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.122 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 25' ' ' LEU . 13.4 mt -60.37 -38.79 84.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.91 -48.36 81.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.632 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -67.17 -48.05 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 32' ' ' TRP . 22.2 t60 -51.54 -33.63 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -98.53 -19.35 17.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.6 mm-40 -70.47 -3.43 17.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.92 50.06 0.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.403 ' CB ' ' HA ' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -114.23 24.21 12.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.737 0.303 . . . . 0.0 110.927 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.12 36.97 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 21.1 mtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.97 126.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -105.47 38.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.2 -59.77 3.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.6 Cg_endo -69.77 -37.55 8.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.58 -38.41 87.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.52 -57.76 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.719 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.5 mm? -55.65 -47.55 76.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.18 -42.03 38.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -73.57 -32.01 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 2.3 mtm -74.82 -25.72 59.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.719 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.2 mt -81.89 -62.77 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -52.04 -53.29 43.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.417 HG22 HD12 ' B' ' 118' ' ' LEU . 89.9 m -52.3 -31.08 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.9 -64.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.653 HG23 ' HG ' ' C' ' 217' ' ' LEU . 3.5 mt -49.75 -43.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 1.008 HD22 HD11 ' B' ' 121' ' ' ILE . 4.8 mt -66.36 -56.08 12.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.417 HD12 HG22 ' B' ' 114' ' ' THR . 19.8 mt -58.26 -22.17 51.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.5 mt -72.81 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.46 ' O ' HG23 ' B' ' 124' ' ' VAL . 15.9 t80 -68.74 -38.85 80.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 1.008 HD11 HD22 ' B' ' 117' ' ' LEU . 79.7 mt -61.29 -49.29 85.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.07 -54.25 10.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 45.1 mt -48.33 -45.53 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 120' ' ' PHE . 25.4 t -62.94 -52.19 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.86 -38.72 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.88 -48.1 82.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.618 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -67.75 -49.35 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 128' ' ' HIS . . . . . 0.418 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 29.1 t60 -50.46 -33.37 20.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -97.93 -20.4 17.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.618 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 1.7 mm-40 -70.59 -3.07 16.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.19 50.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.533 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.418 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.5 OUTLIER -119.44 24.75 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -92.57 41.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 98.3 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.789 0.328 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -63.87 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.472 ' HA ' HD12 ' C' ' 219' ' ' ILE . 5.8 mt -51.22 -36.42 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 217' ' ' LEU . . . . . 0.892 HD22 HD11 ' C' ' 221' ' ' ILE . 0.9 OUTLIER -69.29 -59.71 2.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.38 -32.59 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 219' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' C' ' 216' ' ' ILE . 27.9 mt -63.78 -61.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 220' ' ' PHE . . . . . 0.623 ' CE2' HD23 ' B' ' 117' ' ' LEU . 5.2 t80 -61.15 -40.47 93.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 221' ' ' ILE . . . . . 0.892 HD11 HD22 ' C' ' 217' ' ' LEU . 88.8 mt -64.14 -55.03 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.8 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.849 0.27 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -56.41 -41.86 77.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.5 -59.88 3.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.722 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.1 mm? -54.98 -43.03 73.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -53.13 -37.41 61.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -78.32 -28.83 47.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 mtm -77.59 -30.98 52.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 8' ' ' LEU . 3.2 mt -80.19 -51.75 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.57 ' OD1' HD12 ' A' ' 17' ' ' LEU . 6.9 t-20 -52.49 -34.84 51.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 m -48.26 -33.18 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.57 -64.37 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.586 ' HA ' HD12 ' A' ' 19' ' ' ILE . 66.0 mt -56.9 -36.2 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.95 HD22 HD11 ' A' ' 21' ' ' ILE . 1.4 mt -69.11 -51.91 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.96 -35.25 72.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.638 HG22 HD12 ' A' ' 23' ' ' ILE . 19.0 mt -63.64 -57.95 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.592 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -64.46 -43.88 92.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.95 HD11 HD22 ' A' ' 17' ' ' LEU . 73.9 mt -58.08 -51.98 64.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -68.43 -51.74 40.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 HG22 ' A' ' 19' ' ' ILE . 24.4 mt -48.08 -49.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 20' ' ' PHE . 70.8 t -58.91 -51.21 75.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 10.5 mt -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.19 -47.67 62.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.624 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -67.3 -46.89 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.112 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -52.36 -34.03 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -98.39 -19.01 17.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.624 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.3 mm-40 -70.56 -3.79 19.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 51.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -115.87 20.26 14.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.07 38.72 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.89 126.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 58.5 p -93.18 41.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -69.5 -59.22 5.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.4 Cg_endo -69.77 -39.85 6.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.695 2.263 . . . . 0.0 112.322 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -58.05 -42.62 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.31 -58.65 6.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' LEU . . . . . 0.724 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.1 mm? -56.44 -43.78 79.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -52.73 -36.75 58.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -79.88 -27.0 40.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.5 mtm -79.71 -27.98 40.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' ILE . . . . . 0.724 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.2 mt -84.29 -57.33 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.12 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -50.99 -51.18 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 114' ' ' THR . . . . . 0.476 HG22 HD12 ' B' ' 118' ' ' LEU . 94.1 m -56.5 -39.26 72.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -62.3 -62.5 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' B' ' 119' ' ' ILE . 62.8 mt -50.17 -47.59 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.14 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' LEU . . . . . 0.995 HD22 HD11 ' B' ' 121' ' ' ILE . 1.3 mt -63.18 -57.22 11.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' LEU . . . . . 0.476 HD12 HG22 ' B' ' 114' ' ' THR . 26.3 mt -52.75 -32.46 43.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.8 mt -64.17 -57.36 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.137 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 120' ' ' PHE . . . . . 0.645 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.4 t80 -63.77 -43.05 97.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' ILE . . . . . 0.995 HD11 HD22 ' B' ' 117' ' ' LEU . 22.4 mt -61.76 -52.75 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.172 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -65.6 -47.99 73.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' ILE . . . . . 0.506 HD12 HG22 ' B' ' 119' ' ' ILE . 13.0 mt -49.77 -44.61 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 120' ' ' PHE . 70.6 t -63.71 -52.03 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 125' ' ' LEU . 16.8 mt -59.77 -47.3 86.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -47.5 63.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ILE . . . . . 0.595 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.9 OUTLIER -66.83 -48.94 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 128' ' ' HIS . . . . . 0.412 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 4.0 t60 -51.5 -33.52 31.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.826 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -97.81 -19.67 18.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.86 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.8 mm-40 -70.8 -3.9 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.37 50.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' TRP . . . . . 0.412 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.6 OUTLIER -119.32 20.32 12.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.27 39.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.766 0.317 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -63.03 -63.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 216' ' ' ILE . . . . . 0.6 ' HA ' HD12 ' C' ' 219' ' ' ILE . 69.7 mt -51.46 -39.54 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 217' ' ' LEU . . . . . 0.997 HD22 HD11 ' C' ' 221' ' ' ILE . 1.0 OUTLIER -67.99 -59.22 3.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 25.3 mt -51.26 -30.59 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 219' ' ' ILE . . . . . 0.6 HD12 ' HA ' ' C' ' 216' ' ' ILE . 24.2 mt -68.15 -59.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 220' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -62.52 -37.87 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 221' ' ' ILE . . . . . 0.997 HD11 HD22 ' C' ' 217' ' ' LEU . 96.0 mt -63.62 -53.89 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.2 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.836 0.351 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -154.3 114.68 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.6 p -115.04 36.95 3.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -71.09 -60.54 2.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 0.0 111.109 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 54.1 Cg_endo -69.76 -35.93 11.74 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.38 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.04 -32.28 73.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.12 -55.68 29.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.75 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -52.36 -50.92 61.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.35 -46.46 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -71.47 -26.34 62.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.2 mtt -74.09 -58.99 2.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -58.04 -37.95 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -46.68 -33.94 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.24 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.531 ' HA ' HD12 ' A' ' 19' ' ' ILE . 56.5 mt -57.58 -36.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.581 HD22 HD11 ' A' ' 21' ' ' ILE . 1.3 mt -67.32 -51.87 47.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.43 -38.18 83.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.594 HG22 HD12 ' A' ' 23' ' ' ILE . 22.0 mt -60.03 -56.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -65.76 -47.53 74.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.778 HG21 HG11 ' C' ' 224' ' ' VAL . 34.8 mt -56.65 -48.32 80.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -70.74 -52.45 20.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.594 HD12 HG22 ' A' ' 19' ' ' ILE . 21.7 mt -48.39 -52.86 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' PHE . 87.6 t -57.41 -51.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD11 HD23 ' C' ' 225' ' ' LEU . 9.6 mt -55.86 -45.65 78.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 30' ' ' GLU . 2.6 mp -54.51 -59.07 5.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -56.63 -49.69 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -48.03 -36.16 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -97.74 -18.21 18.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.5 tm-20 -71.61 -2.18 16.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.92 49.81 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.58 18.63 14.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.73 0.3 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.68 36.82 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -154.46 116.0 4.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -113.98 37.03 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.56 -60.28 3.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 111.105 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.7 Cg_endo -69.71 -34.93 13.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.69 -34.42 78.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.09 -54.64 44.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.747 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.9 mm? -52.6 -49.58 64.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -51.09 -47.05 61.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -70.97 -26.16 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.4 mtt -74.46 -59.92 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.747 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.6 mp -56.27 -40.54 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.78 -59.69 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 87.8 m -54.34 -36.44 63.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -60.94 -63.14 1.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' B' ' 119' ' ' ILE . 61.6 mt -50.26 -46.1 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.928 HD22 HD11 ' B' ' 121' ' ' ILE . 0.6 OUTLIER -62.71 -57.03 12.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 23.9 mt -53.32 -32.74 50.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' B' ' 116' ' ' ILE . 22.7 mt -63.64 -55.58 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.631 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.1 t80 -62.67 -42.71 99.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.928 HD11 HD22 ' B' ' 117' ' ' LEU . 27.0 mt -62.87 -53.6 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.64 -52.21 61.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.522 HD12 HG22 ' B' ' 119' ' ' ILE . 13.4 mt -46.26 -48.44 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 120' ' ' PHE . 70.4 t -59.37 -52.25 63.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' B' ' 125' ' ' LEU . 10.9 mt -58.3 -42.02 85.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -56.73 15.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.424 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.7 OUTLIER -57.02 -51.95 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -47.5 -35.05 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -95.01 -22.02 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 1.5 tm-20 -72.57 -0.96 14.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.96 45.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -133.02 18.73 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.85 36.68 1.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.146 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.745 0.307 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -153.53 115.3 4.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 96.1 p -114.69 37.57 3.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -70.88 -60.52 2.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.611 0.72 . . . . 0.0 111.073 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 205' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.9 Cg_endo -69.74 -34.67 14.17 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.665 2.243 . . . . 0.0 112.367 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.98 -33.97 77.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -59.55 -54.39 47.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.756 ' O ' HD12 ' C' ' 212' ' ' ILE . 4.0 mm? -52.79 -49.66 65.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -51.37 -46.88 62.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -71.05 -26.1 62.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.3 mtt -74.27 -58.65 3.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 212' ' ' ILE . . . . . 0.756 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.7 mp -58.74 -36.7 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -63.52 -63.0 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 92.2 m -51.53 -37.49 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.168 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -63.89 -63.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.633 ' HA ' HD12 ' C' ' 219' ' ' ILE . 58.8 mt -51.83 -39.56 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 217' ' ' LEU . . . . . 0.967 HD22 HD11 ' C' ' 221' ' ' ILE . 0.6 OUTLIER -67.2 -58.86 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 218' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' C' ' 218' ' ' LEU . 19.0 mt -51.56 -33.68 33.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' C' ' 216' ' ' ILE . 23.3 mt -64.47 -59.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 220' ' ' PHE . . . . . 0.489 ' O ' HG23 ' C' ' 224' ' ' VAL . 0.1 OUTLIER -62.69 -42.66 99.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 221' ' ' ILE . . . . . 0.967 HD11 HD22 ' C' ' 217' ' ' LEU . 94.4 mt -55.12 -52.25 46.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -71.95 -54.7 9.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 223' ' ' ILE . . . . . 0.573 HD12 ' CG2' ' C' ' 219' ' ' ILE . 26.7 mt -50.28 -58.48 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.084 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 224' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 21' ' ' ILE . 92.5 t -54.74 -44.68 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 225' ' ' LEU . . . . . 0.464 HD23 HD11 ' A' ' 25' ' ' LEU . 9.7 mt -61.28 -45.29 95.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.91 -55.34 31.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.4 HG22 ' N ' ' C' ' 228' ' ' HIS . 0.7 OUTLIER -59.19 -52.22 63.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 228' ' ' HIS . . . . . 0.4 ' N ' HG22 ' C' ' 227' ' ' ILE . 44.1 t-80 -47.93 -33.25 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.818 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -94.83 -24.16 17.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -72.45 -0.54 12.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 125.42 44.04 0.27 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -136.87 19.36 3.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.342 . . . . 0.0 110.926 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.35 38.45 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 179.95 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -155.91 118.53 4.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 p -124.86 36.79 4.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -71.37 -60.34 2.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 0.0 111.119 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 54.1 Cg_endo -69.76 -36.71 10.32 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.615 2.21 . . . . 0.0 112.38 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -63.39 -34.67 78.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.48 -57.97 10.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.725 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.5 mm? -52.63 -47.16 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -51.11 -46.32 61.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -72.83 -25.74 61.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.824 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.5 mtt -71.17 -30.47 66.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.9 mp -84.35 -55.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 59.2 m-80 -53.06 -47.83 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -54.79 -27.3 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -64.6 -64.21 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HA ' HD12 ' A' ' 19' ' ' ILE . 2.1 mp -54.14 -40.85 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.883 HD22 HD11 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -66.44 -55.85 13.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 18' ' ' LEU . 24.7 mt -54.84 -31.58 59.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 16' ' ' ILE . 20.7 mt -66.05 -56.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.555 ' O ' HG23 ' A' ' 24' ' ' VAL . 14.7 t80 -62.95 -39.05 93.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.883 HD11 HD22 ' A' ' 17' ' ' LEU . 60.1 mt -63.88 -52.52 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.03 -53.75 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.559 HD12 HG22 ' A' ' 19' ' ' ILE . 22.8 mt -45.5 -44.2 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 20' ' ' PHE . 42.6 t -63.91 -55.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.4 mt -55.65 -43.4 76.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.7 tp -53.87 -56.52 16.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -51.94 66.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -48.16 -32.09 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -96.5 -22.91 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.14 -2.5 15.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 44.98 0.24 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.44 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.6 18.13 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -105.3 35.87 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.088 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -155.29 117.22 4.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 74.9 p -125.68 36.54 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -71.54 -60.46 2.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 111.094 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.72 -36.83 10.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.752 2.302 . . . . 0.0 112.302 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.32 -34.21 77.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.93 -57.96 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.728 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.5 mm? -52.81 -47.08 67.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.5 -46.25 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -72.7 -25.96 61.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 7.5 mtt -70.98 -30.38 66.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.728 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.9 mt -84.39 -55.15 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -53.25 -47.88 68.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -54.8 -27.18 39.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.79 -64.22 0.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.591 ' HA ' HD12 ' B' ' 119' ' ' ILE . 2.1 mp -54.24 -40.63 48.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.898 HD22 HD11 ' B' ' 121' ' ' ILE . 0.7 OUTLIER -66.52 -55.95 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' B' ' 118' ' ' LEU . 25.2 mt -54.99 -31.35 60.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' B' ' 116' ' ' ILE . 20.6 mt -66.19 -56.37 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.53 ' O ' HG23 ' B' ' 124' ' ' VAL . 15.3 t80 -63.13 -38.86 92.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.898 HD11 HD22 ' B' ' 117' ' ' LEU . 61.8 mt -64.04 -52.45 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.115 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.29 -53.52 35.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.534 HD12 HG22 ' B' ' 119' ' ' ILE . 22.6 mt -45.55 -44.32 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 120' ' ' PHE . 42.1 t -64.01 -55.43 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.1 mt -55.21 -43.52 74.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.92 -56.77 14.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -51.5 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -48.42 -32.17 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.835 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -96.66 -22.63 16.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.02 -2.76 16.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.852 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.08 45.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.14 18.17 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.775 0.321 . . . . 0.0 110.953 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -105.92 35.82 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.797 0.332 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -155.9 118.03 4.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 78.0 p -124.88 36.34 4.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.763 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -71.28 -60.25 2.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.708 . . . . 0.0 111.128 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 205' ' ' PRO . . . . . 0.763 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.8 Cg_endo -69.76 -37.42 9.19 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.713 2.276 . . . . 0.0 112.366 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.7 -34.65 77.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.21 -58.0 10.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.738 ' O ' HD12 ' C' ' 212' ' ' ILE . 3.4 mm? -52.77 -47.08 67.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 209' ' ' PHE . . . . . 0.403 ' CE1' ' ND2' ' C' ' 213' ' ' ASN . 37.6 t80 -51.36 -45.72 62.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.44 -25.94 60.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 7.6 mtt -70.89 -30.47 66.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 212' ' ' ILE . . . . . 0.738 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.9 mt -84.23 -54.94 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.157 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 213' ' ' ASN . . . . . 0.403 ' ND2' ' CE1' ' C' ' 209' ' ' PHE . 59.2 m-80 -53.56 -48.19 69.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 8.3 t -54.31 -26.95 32.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.126 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -64.8 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.613 ' HA ' HD12 ' C' ' 219' ' ' ILE . 2.0 mp -54.25 -40.47 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.144 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 217' ' ' LEU . . . . . 0.919 HD22 HD11 ' C' ' 221' ' ' ILE . 0.7 OUTLIER -66.67 -56.03 12.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 24.3 mt -54.57 -31.91 57.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' C' ' 216' ' ' ILE . 20.9 mt -65.84 -56.69 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 220' ' ' PHE . . . . . 0.56 ' O ' HG23 ' C' ' 224' ' ' VAL . 14.8 t80 -62.84 -39.13 93.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 221' ' ' ILE . . . . . 0.919 HD11 HD22 ' C' ' 217' ' ' LEU . 64.0 mt -63.91 -52.16 60.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -66.25 -53.74 33.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 223' ' ' ILE . . . . . 0.541 HD12 HG22 ' C' ' 219' ' ' ILE . 25.1 mt -45.43 -44.38 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 224' ' ' VAL . . . . . 0.56 HG23 ' O ' ' C' ' 220' ' ' PHE . 44.3 t -63.87 -55.15 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 225' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' C' ' 225' ' ' LEU . 14.5 mt -55.67 -43.5 76.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 15.6 tp -53.7 -56.15 19.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -51.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.099 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -48.23 -31.77 6.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -96.37 -23.48 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -71.47 -2.07 15.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.14 43.92 0.26 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.547 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.34 18.49 4.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -105.05 37.54 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.758 0.313 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -146.1 114.49 6.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.3 m -119.09 39.52 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.787 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.22 -60.33 3.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.583 0.706 . . . . 0.0 111.133 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.8 Cg_endo -69.77 -32.26 18.89 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.337 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.92 -34.84 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.51 -50.79 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.4 -48.43 79.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.41 -41.62 63.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -77.09 -26.98 53.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.96 -29.67 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mt -83.78 -45.99 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -60.64 -55.61 31.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.0 m -51.12 -36.25 39.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.172 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.44 -64.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.593 ' HA ' HD12 ' A' ' 19' ' ' ILE . 45.0 mt -52.07 -39.18 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.001 HD22 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -68.36 -58.94 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 18' ' ' LEU . 22.7 mt -51.16 -30.98 18.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 16' ' ' ILE . 22.7 mt -68.13 -60.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -61.64 -34.09 75.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.001 HD11 HD22 ' A' ' 17' ' ' LEU . 87.7 mt -67.42 -55.24 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -65.68 -54.58 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.549 HD12 HG22 ' A' ' 19' ' ' ILE . 30.3 mt -46.21 -56.76 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.506 HG23 ' HD1' ' A' ' 20' ' ' PHE . 40.0 t -52.77 -48.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.2 mt -63.36 -36.19 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.24 -47.76 84.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.12 -50.19 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -50.43 -33.45 20.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -97.56 -20.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 11.1 mt-10 -70.48 -3.67 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 50.06 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.476 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.7 20.51 10.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -98.91 35.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.16 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -147.18 114.64 6.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -114.45 39.56 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.03 -60.29 3.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 111.145 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.0 Cg_endo -69.81 -32.72 17.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -68.44 -34.66 76.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.13 -49.69 76.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.08 -49.49 75.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -51.92 -43.11 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -75.02 -27.16 59.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -72.9 -29.61 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 49.6 mt -81.66 -46.73 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.62 -54.73 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.492 HG22 ' CD1' ' B' ' 118' ' ' LEU . 86.4 m -52.97 -37.68 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.96 -61.91 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.678 ' HA ' HD12 ' B' ' 119' ' ' ILE . 66.1 mt -51.34 -50.27 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.927 HD22 HD11 ' B' ' 121' ' ' ILE . 1.5 mt -60.04 -51.94 67.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.492 ' CD1' HG22 ' B' ' 114' ' ' THR . 25.9 mt -57.16 -33.55 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' B' ' 116' ' ' ILE . 18.5 mt -64.13 -60.69 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.134 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.577 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.8 t80 -62.7 -40.07 96.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.927 HD11 HD22 ' B' ' 117' ' ' LEU . 86.8 mt -64.44 -54.86 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -63.42 -52.52 61.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.486 HD12 HG22 ' B' ' 119' ' ' ILE . 31.1 mt -46.38 -45.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 120' ' ' PHE . 42.3 t -62.26 -52.92 54.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.79 -36.74 77.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' B' ' 126' ' ' LEU . 1.1 tp -59.22 -48.3 82.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.612 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.0 -50.94 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -49.74 -32.86 14.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.86 -20.73 17.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.612 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.9 mt-10 -71.09 -2.86 17.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.47 49.19 0.19 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -123.54 20.47 9.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -102.08 36.69 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.777 0.322 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -146.21 109.18 4.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 69.4 m -136.48 40.94 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -70.31 -60.65 3.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.613 0.721 . . . . 0.0 111.073 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 205' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.6 Cg_endo -69.71 -33.54 16.55 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.711 2.274 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -68.19 -32.92 73.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -62.35 -54.34 41.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.51 -50.39 73.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -51.79 -39.75 59.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -79.06 -27.38 43.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.1 mtt -74.65 -30.23 61.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 56.2 mt -84.03 -44.43 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.128 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.76 -53.55 56.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 84.8 m -48.55 -42.61 33.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -60.58 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.672 ' HA ' HD12 ' C' ' 219' ' ' ILE . 46.8 mt -52.31 -35.56 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 217' ' ' LEU . . . . . 0.896 HD22 HD11 ' C' ' 221' ' ' ILE . 0.9 OUTLIER -67.86 -59.65 3.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 35.8 mt -53.77 -32.37 52.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' C' ' 216' ' ' ILE . 30.9 mt -64.08 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 220' ' ' PHE . . . . . 0.58 ' O ' HG23 ' C' ' 224' ' ' VAL . 6.9 t80 -61.1 -39.85 91.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 221' ' ' ILE . . . . . 0.896 HD11 HD22 ' C' ' 217' ' ' LEU . 88.7 mt -65.37 -57.16 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -60.61 -52.12 66.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 223' ' ' ILE . . . . . 0.523 HD12 HG22 ' C' ' 219' ' ' ILE . 29.4 mt -46.94 -47.65 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.087 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 224' ' ' VAL . . . . . 0.58 HG23 ' O ' ' C' ' 220' ' ' PHE . 41.6 t -59.18 -51.0 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 19.7 mt -62.26 -36.37 81.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.42 -47.2 84.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.527 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.6 OUTLIER -67.58 -52.09 44.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -49.12 -32.74 10.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -96.01 -22.81 17.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 230' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 12.4 mt-10 -72.5 -1.3 15.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 125.93 46.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.463 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.87 20.01 3.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.0 110.957 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -100.59 39.38 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 ttm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.78 0.324 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -154.1 117.56 4.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.8 p -102.83 37.48 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.12 -60.26 3.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 54.0 Cg_endo -69.72 -27.65 26.41 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.694 2.263 . . . . 0.0 112.33 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -72.64 -38.31 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.38 -46.42 76.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.28 -50.03 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -51.76 -40.58 60.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -78.2 -26.5 47.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.1 mtt -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 52.5 mt -84.72 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -51.46 -55.42 18.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -52.1 -32.81 36.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 t -65.63 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.827 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mt -52.56 -39.27 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.76 -56.62 7.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 18' ' ' LEU . 26.4 mt -55.87 -35.47 66.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 23' ' ' ILE . 33.2 mt -62.38 -57.01 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.709 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.61 -41.53 98.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.816 HD11 HD22 ' A' ' 17' ' ' LEU . 71.5 mt -59.3 -52.53 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.104 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -68.49 -48.21 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.612 HD12 HG22 ' A' ' 19' ' ' ILE . 11.2 mt -49.55 -47.01 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 20' ' ' PHE . 74.0 t -63.07 -52.84 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.21 -39.14 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.07 -49.23 77.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -66.51 -51.09 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -49.29 -33.12 12.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.44 -20.91 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 3.7 mt-10 -71.49 -2.33 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.31 48.16 0.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 19.24 8.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.961 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -114.08 41.6 2.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.2 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 34.9 ttm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -154.52 117.66 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 30.5 p -101.56 36.96 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -69.2 -60.05 4.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.582 0.706 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.74 -28.59 25.14 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.82 -37.86 70.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.44 -47.25 76.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.08 -48.87 79.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -52.28 -40.69 62.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -78.64 -26.03 45.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -77.13 -28.88 54.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 56.4 mt -83.94 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -52.12 -55.47 20.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.424 HG22 HD12 ' B' ' 118' ' ' LEU . 97.7 m -52.2 -30.26 26.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.657 ' HA ' HD12 ' B' ' 119' ' ' ILE . 3.6 mt -54.84 -41.11 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.922 HD22 HD11 ' B' ' 121' ' ' ILE . 0.4 OUTLIER -64.66 -54.74 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.424 HD12 HG22 ' B' ' 114' ' ' THR . 24.1 mt -56.61 -34.02 66.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' B' ' 116' ' ' ILE . 22.5 mt -62.54 -56.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.602 ' O ' HG23 ' B' ' 124' ' ' VAL . 57.7 t80 -63.49 -46.86 84.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.922 HD11 HD22 ' B' ' 117' ' ' LEU . 80.7 mt -53.94 -52.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.72 -49.97 54.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.625 HD12 HG22 ' B' ' 119' ' ' ILE . 9.2 mt -49.64 -42.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 120' ' ' PHE . 73.5 t -65.61 -53.39 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 125' ' ' LEU . 18.0 mt -58.85 -41.02 85.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.23 -49.03 77.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.632 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -67.0 -49.01 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.135 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 128' ' ' HIS . . . . . 0.41 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 37.7 t-80 -51.25 -32.45 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.827 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -99.22 -19.78 16.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 3.8 mt-10 -70.1 -3.75 18.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.13 50.18 0.19 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.41 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.6 OUTLIER -113.98 21.07 15.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.755 0.312 . . . . 0.0 110.892 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -117.96 41.38 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 35.7 ttm . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.778 0.323 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -153.45 116.54 4.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 31.7 p -103.23 38.19 1.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -70.41 -60.53 3.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.585 0.707 . . . . 0.0 111.062 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 205' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 54.0 Cg_endo -69.8 -28.64 24.79 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.665 2.243 . . . . 0.0 112.321 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -71.92 -36.67 70.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.47 -47.15 79.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.6 -51.14 71.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -51.73 -40.4 60.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -77.93 -25.22 48.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.0 mtt -78.66 -28.23 45.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 51.8 mt -84.65 -60.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.155 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -51.59 -56.52 13.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m -51.36 -30.05 17.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -63.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.62 ' HA ' HD12 ' C' ' 219' ' ' ILE . 5.6 mt -52.93 -42.68 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.082 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 217' ' ' LEU . . . . . 0.885 HD22 HD11 ' C' ' 221' ' ' ILE . 0.6 OUTLIER -65.37 -56.55 11.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 218' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' C' ' 218' ' ' LEU . 17.8 mt -52.88 -34.45 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.629 HG22 HD12 ' C' ' 223' ' ' ILE . 21.0 mt -63.88 -57.34 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.132 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 220' ' ' PHE . . . . . 0.768 ' CZ ' HG23 ' A' ' 21' ' ' ILE . 50.0 t80 -62.75 -42.48 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 221' ' ' ILE . . . . . 0.885 HD11 HD22 ' C' ' 217' ' ' LEU . 89.7 mt -57.9 -52.92 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -67.48 -49.86 61.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 223' ' ' ILE . . . . . 0.629 HD12 HG22 ' C' ' 219' ' ' ILE . 14.1 mt -49.19 -45.16 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 224' ' ' VAL . . . . . 0.603 HG23 ' O ' ' C' ' 220' ' ' PHE . 59.9 t -63.14 -52.75 54.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.5 mt -59.25 -37.6 78.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.937 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.89 -49.06 79.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.578 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.6 OUTLIER -66.76 -51.0 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -49.66 -33.09 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -96.84 -21.48 17.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 230' ' ' GLU . . . . . 0.578 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 4.2 mt-10 -71.56 -2.37 16.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.916 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.01 49.71 0.18 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.95 21.03 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -108.32 43.27 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mmt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.774 0.321 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -135.07 51.04 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.4 p -88.57 41.28 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -72.68 -60.71 1.89 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.562 0.696 . . . . 0.0 111.113 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.8 Cg_endo -69.75 -31.66 20.15 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.674 2.25 . . . . 0.0 112.329 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -51.69 65.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.8 mm? -58.4 -46.14 86.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -51.85 -43.91 63.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -74.16 -26.16 60.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.0 mtt -70.3 -36.17 74.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.5 mp -82.53 -44.39 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.54 HD21 HG21 ' C' ' 216' ' ' ILE . 8.3 t-20 -51.82 -50.88 59.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -51.32 -30.22 17.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.29 -63.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.59 ' HA ' HD12 ' A' ' 19' ' ' ILE . 17.3 mt -54.93 -38.7 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.865 HD22 HD11 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -67.14 -55.14 15.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.24 -35.4 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 16' ' ' ILE . 22.0 mt -62.2 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.614 ' CE1' HG21 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.21 -45.18 92.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.865 HD11 HD22 ' A' ' 17' ' ' LEU . 51.5 mt -58.37 -51.88 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -66.79 -53.99 27.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.578 HD12 HG22 ' A' ' 19' ' ' ILE . 22.0 mt -46.77 -50.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 20' ' ' PHE . 65.6 t -57.56 -52.21 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 25' ' ' LEU . 13.0 mt -58.91 -42.35 89.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -53.2 -56.65 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -51.11 72.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -48.65 -33.5 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -97.55 -19.41 18.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 26' ' ' LEU . 2.6 pt-20 -71.06 -3.99 22.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 46.05 0.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.35 17.61 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.49 35.93 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 12.8 mmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -135.12 8.54 3.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.1 p -93.94 39.1 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.62 -60.49 3.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.554 0.692 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 52.8 Cg_endo -69.77 -31.22 20.88 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.655 2.236 . . . . 0.0 112.307 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.26 -35.5 76.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.74 -52.1 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.72 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.7 mm? -56.1 -48.07 76.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.964 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.05 -45.4 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -73.13 -25.42 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -73.25 -40.45 64.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.72 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.6 mp -84.33 -52.12 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 24.0 t30 -51.4 -59.11 4.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.438 HG22 HD12 ' B' ' 118' ' ' LEU . 99.9 m -49.35 -30.97 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.441 ' HA ' HD12 ' B' ' 119' ' ' ILE . 15.5 mt -58.91 -35.1 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.128 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.828 HD22 HD11 ' B' ' 121' ' ' ILE . 1.4 mt -68.79 -50.92 46.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.438 HD12 HG22 ' B' ' 114' ' ' THR . 28.2 mt -61.41 -37.37 83.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.604 HG22 HD12 ' B' ' 123' ' ' ILE . 23.1 mt -62.22 -55.72 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.556 ' O ' HG23 ' B' ' 124' ' ' VAL . 0.1 OUTLIER -65.43 -45.09 85.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.828 HD11 HD22 ' B' ' 117' ' ' LEU . 61.5 mt -59.39 -49.06 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -69.13 -52.8 24.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.604 HD12 HG22 ' B' ' 119' ' ' ILE . 23.9 mt -47.54 -52.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.556 HG23 ' O ' ' B' ' 120' ' ' PHE . 75.2 t -57.77 -51.55 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.574 HD11 HG13 ' A' ' 24' ' ' VAL . 9.9 mt -56.19 -44.27 79.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.36 -57.53 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.39 -50.38 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -48.49 -33.59 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -97.61 -20.02 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.17 -4.07 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.74 46.7 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -119.83 18.72 12.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 110.919 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.3 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 12.6 mmt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.795 0.331 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -135.05 8.37 3.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 94.4 p -94.12 38.21 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.764 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -71.07 -60.52 2.77 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.647 0.736 . . . . 0.0 111.139 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 205' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.8 Cg_endo -69.75 -31.27 20.9 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.684 2.256 . . . . 0.0 112.367 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -68.8 -36.45 78.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -57.56 -51.89 67.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.745 ' O ' HD12 ' C' ' 212' ' ' ILE . 3.8 mm? -57.74 -46.47 84.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -52.08 -45.19 64.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -73.49 -26.02 60.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.3 mtt -72.58 -40.32 66.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 212' ' ' ILE . . . . . 0.745 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.6 mp -84.38 -51.5 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -51.57 -58.31 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 214' ' ' THR . . . . . 0.424 HG22 HD12 ' C' ' 218' ' ' LEU . 98.6 m -50.09 -32.31 15.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.151 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -64.95 -64.1 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.679 HG23 HD11 ' A' ' 17' ' ' LEU . 18.9 mt -56.88 -38.62 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 217' ' ' LEU . . . . . 0.648 HD22 HD11 ' C' ' 221' ' ' ILE . 0.5 OUTLIER -66.35 -52.14 50.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 218' ' ' LEU . . . . . 0.424 HD12 HG22 ' C' ' 214' ' ' THR . 28.4 mt -61.37 -33.84 74.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' C' ' 216' ' ' ILE . 21.0 mt -61.32 -57.35 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 220' ' ' PHE . . . . . 0.659 ' HB2' HD21 ' A' ' 17' ' ' LEU . 1.5 t80 -60.24 -46.16 90.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 221' ' ' ILE . . . . . 0.648 HD11 HD22 ' C' ' 217' ' ' LEU . 32.0 mt -60.25 -52.67 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -62.39 -56.07 21.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 223' ' ' ILE . . . . . 0.463 HD12 HG22 ' C' ' 219' ' ' ILE . 42.8 mt -43.78 -49.17 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.176 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 224' ' ' VAL . . . . . 0.645 HG23 ' O ' ' C' ' 220' ' ' PHE . 73.5 t -58.01 -52.38 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 225' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' C' ' 225' ' ' LEU . 14.0 mt -59.53 -41.88 91.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.12 -56.05 19.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -50.64 77.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -48.89 -33.29 10.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -97.34 -20.07 18.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -70.74 -4.14 22.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.55 46.66 0.21 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.512 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -122.7 18.6 10.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.765 0.317 . . . . 0.0 110.905 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 37.31 4.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 mmt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.82 0.343 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -157.5 119.21 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -97.01 40.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.76 -59.83 3.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.594 0.711 . . . . 0.0 111.082 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.8 Cg_endo -69.77 -41.64 4.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -56.91 -40.01 75.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.74 -59.08 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.0 mm? -54.88 -43.99 73.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -51.49 -41.5 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -73.68 -30.43 62.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.845 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.06 -35.39 64.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.4 mp -84.31 -47.87 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -58.54 -57.81 11.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.4 m -51.76 -32.16 29.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.78 -64.32 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.551 ' HA ' HD12 ' A' ' 19' ' ' ILE . 60.7 mt -51.86 -40.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.888 HD22 HD11 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -67.49 -57.94 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 18' ' ' LEU . 23.5 mt -53.0 -33.62 52.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 16' ' ' ILE . 23.0 mt -64.41 -59.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.112 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.58 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -61.51 -38.44 87.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.888 HD11 HD22 ' A' ' 17' ' ' LEU . 87.1 mt -63.88 -53.49 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -66.93 -55.14 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 19' ' ' ILE . 24.5 mt -45.77 -53.72 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 20' ' ' PHE . 43.1 t -55.73 -48.6 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.4 mt -63.68 -36.06 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.53 -48.04 83.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.4 -49.25 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -51.41 -32.9 28.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.41 -20.01 17.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.1 mm-40 -70.0 -4.06 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.79 50.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.52 19.83 13.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -118.05 36.27 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 28.1 mmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.33 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -158.04 116.24 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -102.19 43.89 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.734 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.83 -59.78 3.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.573 0.701 . . . . 0.0 111.095 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.734 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.75 -42.22 3.6 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -56.24 -41.04 75.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.24 -59.24 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.754 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.0 mm? -54.86 -44.54 74.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.04 -40.98 59.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.58 -29.6 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.4 mtm -75.93 -29.09 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.754 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.7 mt -84.1 -50.65 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.118 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.81 -57.56 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.445 HG22 ' CD1' ' B' ' 118' ' ' LEU . 95.9 m -50.19 -36.51 30.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -61.44 -61.93 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.624 ' HA ' HD12 ' B' ' 119' ' ' ILE . 66.2 mt -50.66 -49.85 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.933 HD22 HD11 ' B' ' 121' ' ' ILE . 1.5 mt -60.82 -53.35 58.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' B' ' 114' ' ' THR . 22.3 mt -56.39 -33.64 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.7 mt -63.89 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.575 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.1 t80 -62.31 -39.91 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.933 HD11 HD22 ' B' ' 117' ' ' LEU . 85.6 mt -64.31 -54.68 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -63.64 -52.28 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.475 HD12 HG22 ' B' ' 119' ' ' ILE . 32.9 mt -46.03 -46.09 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 120' ' ' PHE . 51.7 t -61.92 -52.09 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' B' ' 125' ' ' LEU . 18.1 mt -59.92 -36.41 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.957 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.6 tp -59.96 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.591 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.62 -50.14 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.135 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -51.02 -32.4 21.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.59 -20.87 17.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.591 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.7 mm-40 -70.62 -3.88 20.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.9 50.87 0.16 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 20.36 8.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -110.69 38.65 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 27.6 mmt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.755 0.312 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -158.76 120.49 3.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 15.1 m -95.12 37.25 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.837 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -71.21 -60.08 2.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.597 0.713 . . . . 0.0 111.133 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 205' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.9 Cg_endo -69.77 -39.97 5.86 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -58.15 -40.42 81.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.12 -59.2 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.734 ' O ' HD12 ' C' ' 212' ' ' ILE . 4.0 mm? -54.05 -45.24 71.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -51.47 -40.34 59.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.37 -29.05 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 1.2 mtm -76.28 -34.92 59.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 212' ' ' ILE . . . . . 0.734 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.2 mp -84.35 -28.84 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -49.92 -56.5 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 89.9 m -47.73 -38.34 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -64.78 -63.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.583 ' HA ' HD12 ' C' ' 219' ' ' ILE . 48.9 mt -52.95 -33.87 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 217' ' ' LEU . . . . . 0.772 HD22 HD11 ' C' ' 221' ' ' ILE . 0.7 OUTLIER -68.06 -59.94 2.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 31.3 mt -55.88 -32.57 63.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' C' ' 216' ' ' ILE . 35.0 mt -63.55 -59.38 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 220' ' ' PHE . . . . . 0.604 ' O ' HG23 ' C' ' 224' ' ' VAL . 6.8 t80 -61.89 -41.1 97.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 221' ' ' ILE . . . . . 0.772 HD11 HD22 ' C' ' 217' ' ' LEU . 87.9 mt -64.83 -55.55 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.77 -52.26 64.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 223' ' ' ILE . . . . . 0.533 HD12 HG22 ' C' ' 219' ' ' ILE . 24.8 mt -45.71 -49.7 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 224' ' ' VAL . . . . . 0.604 HG23 ' O ' ' C' ' 220' ' ' PHE . 62.0 t -58.82 -50.38 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 20.3 mt -62.21 -35.33 78.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 22.4 tp -59.98 -47.26 86.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.571 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.6 OUTLIER -68.84 -50.26 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -50.91 -32.69 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -96.89 -21.43 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 230' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 11.3 mm-40 -70.78 -3.51 19.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.67 50.39 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -128.74 23.4 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -108.57 36.93 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.755 0.312 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -120.38 4.3 10.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -109.17 37.16 2.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.6 -60.32 3.23 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.633 0.73 . . . . 0.0 111.122 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.7 Cg_endo -69.83 -34.11 15.01 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.663 2.242 . . . . 0.0 112.334 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -66.13 -35.64 81.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.66 -53.39 58.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.767 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -56.44 -47.81 78.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -51.2 -43.15 61.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -75.17 -26.15 58.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.605 ' O ' HG22 ' A' ' 14' ' ' THR . 8.8 mtt -70.21 -32.64 70.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.767 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -85.61 -41.88 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -63.65 -40.3 96.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 11' ' ' MET . 7.0 t -50.2 -29.04 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -63.75 -64.8 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HA ' HD12 ' A' ' 19' ' ' ILE . 4.4 mt -53.14 -36.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.687 HD22 HD11 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -68.83 -59.78 2.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.7 mt -52.15 -29.71 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 16' ' ' ILE . 25.8 mt -68.14 -60.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.557 ' CB ' HD13 ' B' ' 117' ' ' LEU . 0.2 OUTLIER -62.02 -35.79 79.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.687 HD11 HD22 ' A' ' 17' ' ' LEU . 51.7 mt -67.42 -53.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -66.45 -55.68 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 19' ' ' ILE . 29.2 mt -46.08 -56.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.468 HG23 ' HD1' ' A' ' 20' ' ' PHE . 38.3 t -52.73 -48.12 49.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.05 -36.81 85.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -48.08 82.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -65.94 -51.19 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -49.66 -33.79 16.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.14 -20.44 17.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.2 mt-10 -71.32 -2.84 17.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 49.19 0.19 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.454 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -124.94 20.21 8.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.792 0.33 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -101.4 38.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.5 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 7.4 ttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.49 3.19 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 15.0 m -112.64 37.79 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.05 -60.21 3.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.573 0.701 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.74 -32.98 17.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -67.59 -35.75 79.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.9 -52.69 64.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.718 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.7 mm? -53.97 -51.61 63.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -50.17 -44.51 52.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -73.83 -25.57 60.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.8 mtt -75.41 -32.63 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.718 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.1 mt -77.27 -48.52 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -61.67 -55.7 27.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -50.88 -31.58 17.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.48 -62.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.891 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.634 HG23 ' HG ' ' C' ' 217' ' ' LEU . 3.4 mt -50.12 -45.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.991 HD22 HD11 ' B' ' 121' ' ' ILE . 4.7 mt -66.48 -55.71 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.6 mt -57.44 -22.07 40.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 116' ' ' ILE . 16.2 mt -73.76 -60.71 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' C' ' 221' ' ' ILE . 10.9 t80 -68.63 -37.23 79.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.991 HD11 HD22 ' B' ' 117' ' ' LEU . 82.1 mt -63.35 -48.94 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -72.1 -54.95 8.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 48.1 mt -47.69 -48.19 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 120' ' ' PHE . 32.0 t -61.44 -51.47 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.96 -39.72 78.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.88 -48.3 81.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.613 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -68.59 -48.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 128' ' ' HIS . . . . . 0.42 ' HA ' ' HB2' ' B' ' 132' ' ' TRP . 16.4 t-80 -50.78 -32.74 20.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.58 -20.59 16.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.613 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 9.4 mt-10 -70.51 -2.97 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.899 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.84 49.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.467 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.42 ' HB2' ' HA ' ' B' ' 128' ' ' HIS . 0.2 OUTLIER -121.77 21.66 10.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -104.37 41.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -119.93 3.99 10.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 14.1 m -111.28 36.67 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -70.52 -60.19 3.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.547 0.689 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 205' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.1 Cg_endo -69.82 -33.54 16.16 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -66.93 -34.94 78.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.01 -54.13 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.758 ' O ' HD12 ' C' ' 212' ' ' ILE . 3.7 mm? -54.43 -48.92 71.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -51.08 -45.22 61.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -73.15 -26.16 61.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.1 mtt -74.19 -37.58 63.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 212' ' ' ILE . . . . . 0.758 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.7 mp -84.32 -38.03 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -54.09 -62.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.2 t -55.8 -31.06 62.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.92 -63.86 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.512 HG22 HG21 ' B' ' 116' ' ' ILE . 7.0 mt -53.33 -33.54 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 217' ' ' LEU . . . . . 0.817 HD22 HD11 ' C' ' 221' ' ' ILE . 1.3 mt -70.84 -60.13 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -54.35 -32.8 57.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.476 HG22 HD12 ' C' ' 223' ' ' ILE . 28.3 mt -64.96 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 220' ' ' PHE . . . . . 0.564 ' CE2' HD23 ' B' ' 117' ' ' LEU . 4.5 t80 -61.41 -39.27 90.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 221' ' ' ILE . . . . . 0.817 HD11 HD22 ' C' ' 217' ' ' LEU . 64.2 mt -65.54 -55.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -62.72 -53.89 47.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 223' ' ' ILE . . . . . 0.476 HD12 HG22 ' C' ' 219' ' ' ILE . 31.1 mt -43.85 -56.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 16.4 t -54.48 -48.16 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.2 mt -61.45 -37.41 83.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -47.2 86.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.55 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.8 OUTLIER -69.44 -51.86 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.141 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -49.31 -32.36 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -96.19 -23.1 16.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 230' ' ' GLU . . . . . 0.55 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 12.7 mt-10 -71.54 -2.01 15.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 125.74 45.79 0.24 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.522 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.36 18.24 4.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.77 0.319 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -99.65 41.08 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.155 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.808 0.337 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -126.38 3.28 6.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -106.24 37.11 2.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.763 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.94 -60.39 2.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.567 0.698 . . . . 0.0 111.077 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.763 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.4 Cg_endo -69.74 -33.21 17.13 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 0.0 112.325 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.32 -34.83 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.62 -53.21 60.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.74 -46.85 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.939 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -53.02 -46.98 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -71.6 -27.39 63.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.643 ' O ' HG22 ' A' ' 14' ' ' THR . 9.4 mtt -71.09 -28.6 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.34 -36.78 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.099 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -74.51 -29.85 61.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 11' ' ' MET . 5.6 t -50.7 -28.34 8.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.588 ' HA ' HD12 ' A' ' 19' ' ' ILE . 7.7 mt -53.87 -37.25 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.907 HD22 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -69.33 -58.0 4.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -53.33 -28.17 27.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 16' ' ' ILE . 23.6 mt -70.28 -60.12 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -62.84 -35.02 78.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.907 HD11 HD22 ' A' ' 17' ' ' LEU . 80.6 mt -65.99 -52.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -70.0 -55.67 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 19' ' ' ILE . 22.3 mt -44.27 -51.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.176 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.463 HG23 ' HD1' ' A' ' 20' ' ' PHE . 40.3 t -59.45 -54.66 31.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.141 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 25' ' ' LEU . 11.6 mt -54.94 -44.41 74.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 30' ' ' GLU . 14.0 tp -53.32 -57.2 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -57.52 -50.22 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.077 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 32' ' ' TRP . 6.8 t60 -48.79 -33.43 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -99.12 -17.75 18.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -68.24 -7.25 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.23 48.53 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 28' ' ' HIS . 0.1 OUTLIER -100.84 19.34 17.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.915 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -167.51 89.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.132 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.753 0.311 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.75 3.35 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 2.4 m -105.68 37.24 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -71.16 -60.57 2.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 0.0 111.11 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.7 -32.74 18.21 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.755 2.303 . . . . 0.0 112.354 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.01 -34.19 76.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.02 -52.97 63.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.89 -49.13 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -51.63 -47.84 63.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.2 -26.93 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -73.79 -28.0 61.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 54.2 mt -81.65 -42.94 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -69.75 -51.98 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -52.96 -30.94 37.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.145 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.53 -62.57 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.684 HG23 ' HG ' ' C' ' 217' ' ' LEU . 5.0 mt -50.48 -44.85 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.159 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 1.0 HD22 HD11 ' B' ' 121' ' ' ILE . 4.4 mt -66.37 -55.72 14.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.4 mt -57.81 -22.65 48.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' B' ' 116' ' ' ILE . 16.5 mt -72.87 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.472 ' O ' HG23 ' B' ' 124' ' ' VAL . 12.5 t80 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 1.0 HD11 HD22 ' B' ' 117' ' ' LEU . 80.0 mt -61.97 -49.58 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -71.93 -54.17 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 37.7 mt -47.34 -45.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 120' ' ' PHE . 32.4 t -63.37 -54.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.18 -44.68 75.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.91 -56.05 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.404 ' HA ' ' HG2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -59.76 -49.86 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.158 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -48.97 -32.74 9.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.32 -19.32 17.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' B' ' 127' ' ' ILE . 0.2 OUTLIER -68.1 -7.01 25.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 127.33 48.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.46 19.57 20.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.817 0.341 . . . . 0.0 110.964 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -170.4 86.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.121 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 17.5 mtt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.699 0.285 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.79 3.32 7.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 2.5 m -106.16 37.55 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -71.21 -60.48 2.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 205' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.6 Cg_endo -69.79 -32.87 17.6 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.27 . . . . 0.0 112.313 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -67.93 -34.37 76.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.9 -52.21 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -54.52 -48.54 71.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -52.13 -48.64 64.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -68.37 -27.52 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 8.8 mtt -76.43 -32.12 58.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.82 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 62.6 mt -84.53 -30.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -62.35 -55.7 25.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.5 t -58.48 -29.97 66.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.91 -64.25 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.605 HG22 HG21 ' B' ' 116' ' ' ILE . 13.4 mt -55.03 -32.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.102 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 217' ' ' LEU . . . . . 0.961 HD22 HD11 ' C' ' 221' ' ' ILE . 1.4 mt -70.57 -58.89 3.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -55.37 -32.8 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' C' ' 216' ' ' ILE . 26.8 mt -64.87 -61.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 220' ' ' PHE . . . . . 0.563 ' CE2' HD23 ' B' ' 117' ' ' LEU . 4.9 t80 -62.06 -39.41 92.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 221' ' ' ILE . . . . . 0.961 HD11 HD22 ' C' ' 217' ' ' LEU . 83.9 mt -64.35 -53.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -66.09 -54.0 31.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 223' ' ' ILE . . . . . 0.503 HD12 HG22 ' C' ' 219' ' ' ILE . 23.4 mt -42.79 -51.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.104 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 8.9 t -60.08 -54.63 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 225' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' C' ' 225' ' ' LEU . 12.2 mt -53.61 -44.17 69.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 12.0 tp -54.11 -55.48 27.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.51 -49.95 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.121 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -49.43 -31.77 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -97.97 -20.64 17.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -6.25 25.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.865 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 127.65 45.13 0.21 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -117.76 18.23 14.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.929 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -165.86 87.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 23.6 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mtt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.78 0.324 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.99 127.07 0.85 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -103.41 36.27 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.791 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -71.27 -60.24 2.83 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.59 0.71 . . . . 0.0 111.116 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.791 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.6 Cg_endo -69.8 -37.2 9.39 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.634 2.223 . . . . 0.0 112.347 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.34 -38.52 87.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.18 -58.36 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -57.95 -43.25 86.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -51.52 -41.05 60.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -76.81 -28.26 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mtt -70.67 -32.65 69.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -79.84 -52.27 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -51.87 -33.83 38.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -51.18 -32.4 23.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -64.75 -65.27 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.607 ' HA ' HD12 ' A' ' 19' ' ' ILE . 5.1 mt -53.82 -34.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.014 HD22 HD11 ' A' ' 21' ' ' ILE . 1.4 mt -70.85 -59.05 3.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.0 mt -53.28 -27.47 22.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 16' ' ' ILE . 25.6 mt -71.07 -60.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.18 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.09 -34.34 77.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.014 HD11 HD22 ' A' ' 17' ' ' LEU . 81.3 mt -67.44 -52.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.139 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -68.56 -55.6 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 19' ' ' ILE . 36.0 mt -45.62 -54.16 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.501 HG23 ' HD1' ' A' ' 20' ' ' PHE . 33.3 t -56.5 -49.28 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.122 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 25' ' ' LEU . 13.4 mt -60.37 -38.79 84.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.91 -48.36 81.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.632 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -67.17 -48.05 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 32' ' ' TRP . 22.2 t60 -51.54 -33.63 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -98.53 -19.35 17.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.6 mm-40 -70.47 -3.43 17.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.92 50.06 0.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.403 ' CB ' ' HA ' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -114.23 24.21 12.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.737 0.303 . . . . 0.0 110.927 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.12 36.97 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 21.1 mtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.97 126.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -105.47 38.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.2 -59.77 3.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.6 Cg_endo -69.77 -37.55 8.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.58 -38.41 87.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.52 -57.76 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.719 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.5 mm? -55.65 -47.55 76.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.18 -42.03 38.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -73.57 -32.01 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 2.3 mtm -74.82 -25.72 59.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.719 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.2 mt -81.89 -62.77 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -52.04 -53.29 43.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.417 HG22 HD12 ' B' ' 118' ' ' LEU . 89.9 m -52.3 -31.08 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.9 -64.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.653 HG23 ' HG ' ' C' ' 217' ' ' LEU . 3.5 mt -49.75 -43.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 1.008 HD22 HD11 ' B' ' 121' ' ' ILE . 4.8 mt -66.36 -56.08 12.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.417 HD12 HG22 ' B' ' 114' ' ' THR . 19.8 mt -58.26 -22.17 51.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.5 mt -72.81 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.46 ' O ' HG23 ' B' ' 124' ' ' VAL . 15.9 t80 -68.74 -38.85 80.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 1.008 HD11 HD22 ' B' ' 117' ' ' LEU . 79.7 mt -61.29 -49.29 85.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.07 -54.25 10.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 45.1 mt -48.33 -45.53 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 120' ' ' PHE . 25.4 t -62.94 -52.19 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.86 -38.72 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.88 -48.1 82.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.618 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -67.75 -49.35 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 128' ' ' HIS . . . . . 0.418 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 29.1 t60 -50.46 -33.37 20.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -97.93 -20.4 17.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.618 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 1.7 mm-40 -70.59 -3.07 16.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.19 50.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.533 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.418 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.5 OUTLIER -119.44 24.75 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -92.57 41.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 20.7 mtt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.728 0.299 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.14 127.27 0.84 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 67.9 m -102.16 36.62 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -70.91 -59.89 3.26 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.57 0.7 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 205' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.8 Cg_endo -69.8 -36.76 10.11 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.7 2.266 . . . . 0.0 112.311 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -62.0 -38.81 90.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.86 -58.04 9.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.704 ' O ' HD12 ' C' ' 212' ' ' ILE . 4.6 mm? -56.33 -42.39 77.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -52.7 -44.42 66.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -72.08 -29.38 64.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 2.5 mtm -73.79 -36.31 65.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 212' ' ' ILE . . . . . 0.704 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.8 mt -84.62 -39.79 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -49.19 -51.67 31.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 98.3 m -56.67 -33.25 66.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -63.87 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.472 ' HA ' HD12 ' C' ' 219' ' ' ILE . 5.8 mt -51.22 -36.42 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 217' ' ' LEU . . . . . 0.892 HD22 HD11 ' C' ' 221' ' ' ILE . 0.9 OUTLIER -69.29 -59.71 2.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.38 -32.59 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.496 HG22 HD12 ' C' ' 223' ' ' ILE . 27.9 mt -63.78 -61.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 220' ' ' PHE . . . . . 0.623 ' CE2' HD23 ' B' ' 117' ' ' LEU . 5.2 t80 -61.15 -40.47 93.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 221' ' ' ILE . . . . . 0.892 HD11 HD22 ' C' ' 217' ' ' LEU . 88.8 mt -64.14 -55.03 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.42 -54.78 31.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 223' ' ' ILE . . . . . 0.496 HD12 HG22 ' C' ' 219' ' ' ILE . 24.3 mt -42.39 -53.3 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.67 -50.29 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 225' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' C' ' 225' ' ' LEU . 15.9 mt -57.72 -39.2 76.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.34 -47.95 83.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.563 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.8 OUTLIER -68.92 -51.23 46.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -49.73 -32.54 13.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -97.03 -21.77 17.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 230' ' ' GLU . . . . . 0.563 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 1.7 mm-40 -71.52 -2.51 17.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.05 47.57 0.2 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.64 22.67 5.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.752 0.311 . . . . 0.0 110.925 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -92.6 39.86 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.36 126.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.4 p -94.32 39.35 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.84 -59.68 3.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.559 0.695 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 54.0 Cg_endo -69.72 -41.51 4.26 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.372 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -56.41 -41.86 77.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.5 -59.88 3.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.722 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.1 mm? -54.98 -43.03 73.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -53.13 -37.41 61.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -78.32 -28.83 47.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 mtm -77.59 -30.98 52.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 8' ' ' LEU . 3.2 mt -80.19 -51.75 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.57 ' OD1' HD12 ' A' ' 17' ' ' LEU . 6.9 t-20 -52.49 -34.84 51.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 m -48.26 -33.18 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.57 -64.37 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.586 ' HA ' HD12 ' A' ' 19' ' ' ILE . 66.0 mt -56.9 -36.2 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.95 HD22 HD11 ' A' ' 21' ' ' ILE . 1.4 mt -69.11 -51.91 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.96 -35.25 72.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.638 HG22 HD12 ' A' ' 23' ' ' ILE . 19.0 mt -63.64 -57.95 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.592 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -64.46 -43.88 92.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.95 HD11 HD22 ' A' ' 17' ' ' LEU . 73.9 mt -58.08 -51.98 64.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -68.43 -51.74 40.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 HG22 ' A' ' 19' ' ' ILE . 24.4 mt -48.08 -49.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 20' ' ' PHE . 70.8 t -58.91 -51.21 75.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 10.5 mt -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.19 -47.67 62.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.624 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -67.3 -46.89 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.112 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -52.36 -34.03 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -98.39 -19.01 17.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.624 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.3 mm-40 -70.56 -3.79 19.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 51.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -115.87 20.26 14.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.07 38.72 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.89 126.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 58.5 p -93.18 41.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -69.5 -59.22 5.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.4 Cg_endo -69.77 -39.85 6.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.695 2.263 . . . . 0.0 112.322 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -58.05 -42.62 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.31 -58.65 6.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' LEU . . . . . 0.724 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.1 mm? -56.44 -43.78 79.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -52.73 -36.75 58.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -79.88 -27.0 40.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.5 mtm -79.71 -27.98 40.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ILE . . . . . 0.724 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.2 mt -84.29 -57.33 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.12 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -50.99 -51.18 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' THR . . . . . 0.476 HG22 HD12 ' B' ' 118' ' ' LEU . 94.1 m -56.5 -39.26 72.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -62.3 -62.5 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' B' ' 119' ' ' ILE . 62.8 mt -50.17 -47.59 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.14 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LEU . . . . . 0.995 HD22 HD11 ' B' ' 121' ' ' ILE . 1.3 mt -63.18 -57.22 11.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.476 HD12 HG22 ' B' ' 114' ' ' THR . 26.3 mt -52.75 -32.46 43.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.8 mt -64.17 -57.36 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.137 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 120' ' ' PHE . . . . . 0.645 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.4 t80 -63.77 -43.05 97.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' ILE . . . . . 0.995 HD11 HD22 ' B' ' 117' ' ' LEU . 22.4 mt -61.76 -52.75 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.172 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -65.6 -47.99 73.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' ILE . . . . . 0.506 HD12 HG22 ' B' ' 119' ' ' ILE . 13.0 mt -49.77 -44.61 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 120' ' ' PHE . 70.6 t -63.71 -52.03 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 125' ' ' LEU . 16.8 mt -59.77 -47.3 86.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -47.5 63.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ILE . . . . . 0.595 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.9 OUTLIER -66.83 -48.94 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 128' ' ' HIS . . . . . 0.412 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 4.0 t60 -51.5 -33.52 31.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.826 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -97.81 -19.67 18.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.86 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.8 mm-40 -70.8 -3.9 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.37 50.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 132' ' ' TRP . . . . . 0.412 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.6 OUTLIER -119.32 20.32 12.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.27 39.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.823 0.344 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.18 125.95 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 59.7 p -94.7 39.71 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 204' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -69.32 -59.55 4.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.592 0.71 . . . . 0.0 111.118 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 205' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 54.0 Cg_endo -69.75 -40.32 5.48 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.736 2.291 . . . . 0.0 112.363 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -57.89 -40.82 81.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -53.69 -58.87 5.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 208' ' ' LEU . . . . . 0.706 ' O ' HD12 ' C' ' 212' ' ' ILE . 4.1 mm? -55.34 -44.72 76.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.935 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -51.71 -38.88 57.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.847 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -76.84 -28.41 55.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 1.4 mtm -77.55 -28.79 51.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 212' ' ' ILE . . . . . 0.706 HD12 ' O ' ' C' ' 208' ' ' LEU . 3.3 mt -80.06 -45.08 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 29.3 t30 -50.41 -62.19 1.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m -53.31 -38.84 63.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -63.03 -63.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 216' ' ' ILE . . . . . 0.6 ' HA ' HD12 ' C' ' 219' ' ' ILE . 69.7 mt -51.46 -39.54 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 217' ' ' LEU . . . . . 0.997 HD22 HD11 ' C' ' 221' ' ' ILE . 1.0 OUTLIER -67.99 -59.22 3.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 25.3 mt -51.26 -30.59 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 219' ' ' ILE . . . . . 0.6 HD12 ' HA ' ' C' ' 216' ' ' ILE . 24.2 mt -68.15 -59.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 220' ' ' PHE . . . . . 0.528 ' O ' HG23 ' C' ' 224' ' ' VAL . 0.1 OUTLIER -62.52 -37.87 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 221' ' ' ILE . . . . . 0.997 HD11 HD22 ' C' ' 217' ' ' LEU . 96.0 mt -63.62 -53.89 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -67.62 -52.11 42.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 223' ' ' ILE . . . . . 0.586 HD12 HG22 ' C' ' 219' ' ' ILE . 16.0 mt -46.8 -53.2 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.19 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 224' ' ' VAL . . . . . 0.891 HG21 HG21 ' A' ' 21' ' ' ILE . 55.8 t -57.12 -49.64 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.58 -54.34 47.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -45.95 59.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 227' ' ' ILE . . . . . 0.542 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.9 OUTLIER -68.4 -52.71 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 228' ' ' HIS . . . . . 0.4 ' HA ' ' HB3' ' C' ' 232' ' ' TRP . 11.7 t60 -49.69 -31.49 11.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -96.66 -23.03 16.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 230' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 12.5 mm-40 -71.38 -2.5 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.16 46.67 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 232' ' ' TRP . . . . . 0.4 ' HB3' ' HA ' ' C' ' 228' ' ' HIS . 0.7 OUTLIER -131.98 19.52 4.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.887 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.89 38.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.825 0.26 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.04 -32.28 73.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.12 -55.68 29.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.75 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -52.36 -50.92 61.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.35 -46.46 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -71.47 -26.34 62.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.2 mtt -74.09 -58.99 2.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -58.04 -37.95 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -46.68 -33.94 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.24 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.531 ' HA ' HD12 ' A' ' 19' ' ' ILE . 56.5 mt -57.58 -36.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.581 HD22 HD11 ' A' ' 21' ' ' ILE . 1.3 mt -67.32 -51.87 47.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.43 -38.18 83.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.594 HG22 HD12 ' A' ' 23' ' ' ILE . 22.0 mt -60.03 -56.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -65.76 -47.53 74.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.581 HD11 HD22 ' A' ' 17' ' ' LEU . 34.8 mt -56.65 -48.32 80.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -70.74 -52.45 20.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.594 HD12 HG22 ' A' ' 19' ' ' ILE . 21.7 mt -48.39 -52.86 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' PHE . 87.6 t -57.41 -51.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 25' ' ' LEU . 9.6 mt -55.86 -45.65 78.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 30' ' ' GLU . 2.6 mp -54.51 -59.07 5.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -56.63 -49.69 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -48.03 -36.16 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -97.74 -18.21 18.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.5 tm-20 -71.61 -2.18 16.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.92 49.81 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.58 18.63 14.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.73 0.3 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.68 36.82 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -154.46 116.0 4.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -113.98 37.03 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.56 -60.28 3.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 111.105 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.7 Cg_endo -69.71 -34.93 13.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.69 -34.42 78.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.09 -54.64 44.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.747 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.9 mm? -52.6 -49.58 64.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -51.09 -47.05 61.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -70.97 -26.16 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.4 mtt -74.46 -59.92 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.747 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.6 mp -56.27 -40.54 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.78 -59.69 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 87.8 m -54.34 -36.44 63.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -60.94 -63.14 1.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' B' ' 119' ' ' ILE . 61.6 mt -50.26 -46.1 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.928 HD22 HD11 ' B' ' 121' ' ' ILE . 0.6 OUTLIER -62.71 -57.03 12.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 23.9 mt -53.32 -32.74 50.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' B' ' 116' ' ' ILE . 22.7 mt -63.64 -55.58 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.631 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.1 t80 -62.67 -42.71 99.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.928 HD11 HD22 ' B' ' 117' ' ' LEU . 27.0 mt -62.87 -53.6 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.64 -52.21 61.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.522 HD12 HG22 ' B' ' 119' ' ' ILE . 13.4 mt -46.26 -48.44 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 120' ' ' PHE . 70.4 t -59.37 -52.25 63.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' B' ' 125' ' ' LEU . 10.9 mt -58.3 -42.02 85.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -56.73 15.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.424 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.7 OUTLIER -57.02 -51.95 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -47.5 -35.05 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -95.01 -22.02 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 1.5 tm-20 -72.57 -0.96 14.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.96 45.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -133.02 18.73 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.85 36.68 1.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.146 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 92.2 m . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.814 0.34 . . . . 0.0 111.168 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -63.89 -63.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.633 ' HA ' HD12 ' C' ' 219' ' ' ILE . 58.8 mt -51.83 -39.56 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 217' ' ' LEU . . . . . 0.967 HD22 HD11 ' C' ' 221' ' ' ILE . 0.6 OUTLIER -67.2 -58.86 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' C' ' 218' ' ' LEU . 19.0 mt -51.56 -33.68 33.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 219' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' C' ' 216' ' ' ILE . 23.3 mt -64.47 -59.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -42.66 99.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 221' ' ' ILE . . . . . 0.967 HD11 HD22 ' C' ' 217' ' ' LEU . 94.4 mt -55.12 -52.25 46.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.937 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo . . . . . 0 C--O 1.23 0.124 0 CA-C-O 120.838 0.266 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -63.39 -34.67 78.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.48 -57.97 10.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.725 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.5 mm? -52.63 -47.16 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -51.11 -46.32 61.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -72.83 -25.74 61.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.824 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.5 mtt -71.17 -30.47 66.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.9 mp -84.35 -55.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -53.06 -47.83 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -54.79 -27.3 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -64.6 -64.21 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HA ' HD12 ' A' ' 19' ' ' ILE . 2.1 mp -54.14 -40.85 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.883 HD22 HD11 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -66.44 -55.85 13.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 18' ' ' LEU . 24.7 mt -54.84 -31.58 59.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 16' ' ' ILE . 20.7 mt -66.05 -56.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.555 ' O ' HG23 ' A' ' 24' ' ' VAL . 14.7 t80 -62.95 -39.05 93.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.883 HD11 HD22 ' A' ' 17' ' ' LEU . 60.1 mt -63.88 -52.52 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.03 -53.75 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.559 HD12 HG22 ' A' ' 19' ' ' ILE . 22.8 mt -45.5 -44.2 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 20' ' ' PHE . 42.6 t -63.91 -55.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.4 mt -55.65 -43.4 76.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.7 tp -53.87 -56.52 16.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -51.94 66.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -48.16 -32.09 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -96.5 -22.91 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.14 -2.5 15.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 44.98 0.24 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.44 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.6 18.13 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -105.3 35.87 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.088 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -155.29 117.22 4.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 74.9 p -125.68 36.54 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -71.54 -60.46 2.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 111.094 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.72 -36.83 10.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.752 2.302 . . . . 0.0 112.302 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.32 -34.21 77.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.93 -57.96 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.728 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.5 mm? -52.81 -47.08 67.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.5 -46.25 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -72.7 -25.96 61.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 7.5 mtt -70.98 -30.38 66.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.728 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.9 mt -84.39 -55.15 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -53.25 -47.88 68.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -54.8 -27.18 39.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.79 -64.22 0.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.591 ' HA ' HD12 ' B' ' 119' ' ' ILE . 2.1 mp -54.24 -40.63 48.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.898 HD22 HD11 ' B' ' 121' ' ' ILE . 0.7 OUTLIER -66.52 -55.95 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' B' ' 118' ' ' LEU . 25.2 mt -54.99 -31.35 60.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' B' ' 116' ' ' ILE . 20.6 mt -66.19 -56.37 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.53 ' O ' HG23 ' B' ' 124' ' ' VAL . 15.3 t80 -63.13 -38.86 92.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.898 HD11 HD22 ' B' ' 117' ' ' LEU . 61.8 mt -64.04 -52.45 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.115 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.29 -53.52 35.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.534 HD12 HG22 ' B' ' 119' ' ' ILE . 22.6 mt -45.55 -44.32 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 120' ' ' PHE . 42.1 t -64.01 -55.43 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.1 mt -55.21 -43.52 74.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.92 -56.77 14.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -51.5 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -48.42 -32.17 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.835 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -96.66 -22.63 16.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.02 -2.76 16.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.852 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.08 45.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.14 18.17 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.775 0.321 . . . . 0.0 110.953 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -105.92 35.82 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.794 0.331 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -64.8 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.613 ' HA ' HD12 ' C' ' 219' ' ' ILE . 2.0 mp -54.25 -40.47 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.144 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 217' ' ' LEU . . . . . 0.919 HD22 HD11 ' C' ' 221' ' ' ILE . 0.7 OUTLIER -66.67 -56.03 12.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 24.3 mt -54.57 -31.91 57.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 219' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' C' ' 216' ' ' ILE . 20.9 mt -65.84 -56.69 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -62.84 -39.13 93.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 221' ' ' ILE . . . . . 0.919 HD11 HD22 ' C' ' 217' ' ' LEU . 64.0 mt -63.91 -52.16 60.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.1 t80 . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.818 0.258 . . . . 0.0 112.337 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.92 -34.84 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.51 -50.79 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.4 -48.43 79.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.41 -41.62 63.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -77.09 -26.98 53.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.96 -29.67 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mt -83.78 -45.99 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -60.64 -55.61 31.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.0 m -51.12 -36.25 39.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.172 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.44 -64.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.593 ' HA ' HD12 ' A' ' 19' ' ' ILE . 45.0 mt -52.07 -39.18 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.001 HD22 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -68.36 -58.94 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 18' ' ' LEU . 22.7 mt -51.16 -30.98 18.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 16' ' ' ILE . 22.7 mt -68.13 -60.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -61.64 -34.09 75.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.001 HD11 HD22 ' A' ' 17' ' ' LEU . 87.7 mt -67.42 -55.24 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -65.68 -54.58 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.549 HD12 HG22 ' A' ' 19' ' ' ILE . 30.3 mt -46.21 -56.76 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.506 HG23 ' HD1' ' A' ' 20' ' ' PHE . 40.0 t -52.77 -48.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.2 mt -63.36 -36.19 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.24 -47.76 84.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.12 -50.19 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -50.43 -33.45 20.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -97.56 -20.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 11.1 mt-10 -70.48 -3.67 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 50.06 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.476 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.7 20.51 10.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -98.91 35.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.16 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -147.18 114.64 6.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -114.45 39.56 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.03 -60.29 3.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 111.145 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.0 Cg_endo -69.81 -32.72 17.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -68.44 -34.66 76.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.13 -49.69 76.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.08 -49.49 75.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -51.92 -43.11 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -75.02 -27.16 59.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -72.9 -29.61 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 49.6 mt -81.66 -46.73 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.62 -54.73 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.492 HG22 ' CD1' ' B' ' 118' ' ' LEU . 86.4 m -52.97 -37.68 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.96 -61.91 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.678 ' HA ' HD12 ' B' ' 119' ' ' ILE . 66.1 mt -51.34 -50.27 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.927 HD22 HD11 ' B' ' 121' ' ' ILE . 1.5 mt -60.04 -51.94 67.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.492 ' CD1' HG22 ' B' ' 114' ' ' THR . 25.9 mt -57.16 -33.55 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' B' ' 116' ' ' ILE . 18.5 mt -64.13 -60.69 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.134 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.577 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.8 t80 -62.7 -40.07 96.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.927 HD11 HD22 ' B' ' 117' ' ' LEU . 86.8 mt -64.44 -54.86 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -63.42 -52.52 61.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.486 HD12 HG22 ' B' ' 119' ' ' ILE . 31.1 mt -46.38 -45.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 120' ' ' PHE . 42.3 t -62.26 -52.92 54.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.79 -36.74 77.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' B' ' 126' ' ' LEU . 1.1 tp -59.22 -48.3 82.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.612 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.0 -50.94 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -49.74 -32.86 14.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.86 -20.73 17.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.612 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.9 mt-10 -71.09 -2.86 17.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.47 49.19 0.19 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -123.54 20.47 9.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -102.08 36.69 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 84.8 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.798 0.333 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -60.58 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.672 ' HA ' HD12 ' C' ' 219' ' ' ILE . 46.8 mt -52.31 -35.56 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 217' ' ' LEU . . . . . 0.896 HD22 HD11 ' C' ' 221' ' ' ILE . 0.9 OUTLIER -67.86 -59.65 3.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 35.8 mt -53.77 -32.37 52.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 219' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' C' ' 216' ' ' ILE . 30.9 mt -64.08 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -61.1 -39.85 91.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 221' ' ' ILE . . . . . 0.896 HD11 HD22 ' C' ' 217' ' ' LEU . 88.7 mt -65.37 -57.16 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.231 0.156 0 CA-C-O 120.808 0.254 . . . . 0.0 112.33 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -72.64 -38.31 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.38 -46.42 76.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.28 -50.03 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -51.76 -40.58 60.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -78.2 -26.5 47.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.1 mtt -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 52.5 mt -84.72 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -51.46 -55.42 18.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -52.1 -32.81 36.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 t -65.63 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.827 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mt -52.56 -39.27 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.76 -56.62 7.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 18' ' ' LEU . 26.4 mt -55.87 -35.47 66.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 23' ' ' ILE . 33.2 mt -62.38 -57.01 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.709 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.61 -41.53 98.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.816 HD11 HD22 ' A' ' 17' ' ' LEU . 71.5 mt -59.3 -52.53 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.104 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -68.49 -48.21 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.612 HD12 HG22 ' A' ' 19' ' ' ILE . 11.2 mt -49.55 -47.01 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 20' ' ' PHE . 74.0 t -63.07 -52.84 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.21 -39.14 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.07 -49.23 77.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -66.51 -51.09 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -49.29 -33.12 12.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.44 -20.91 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 3.7 mt-10 -71.49 -2.33 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.31 48.16 0.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 19.24 8.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.961 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -114.08 41.6 2.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.2 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 34.9 ttm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -154.52 117.66 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 30.5 p -101.56 36.96 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -69.2 -60.05 4.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.582 0.706 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.74 -28.59 25.14 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.82 -37.86 70.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.44 -47.25 76.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.08 -48.87 79.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -52.28 -40.69 62.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -78.64 -26.03 45.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -77.13 -28.88 54.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 56.4 mt -83.94 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -52.12 -55.47 20.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.424 HG22 HD12 ' B' ' 118' ' ' LEU . 97.7 m -52.2 -30.26 26.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.657 ' HA ' HD12 ' B' ' 119' ' ' ILE . 3.6 mt -54.84 -41.11 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.922 HD22 HD11 ' B' ' 121' ' ' ILE . 0.4 OUTLIER -64.66 -54.74 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.424 HD12 HG22 ' B' ' 114' ' ' THR . 24.1 mt -56.61 -34.02 66.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' B' ' 116' ' ' ILE . 22.5 mt -62.54 -56.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.602 ' O ' HG23 ' B' ' 124' ' ' VAL . 57.7 t80 -63.49 -46.86 84.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.922 HD11 HD22 ' B' ' 117' ' ' LEU . 80.7 mt -53.94 -52.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.72 -49.97 54.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.625 HD12 HG22 ' B' ' 119' ' ' ILE . 9.2 mt -49.64 -42.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 120' ' ' PHE . 73.5 t -65.61 -53.39 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 125' ' ' LEU . 18.0 mt -58.85 -41.02 85.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.23 -49.03 77.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.632 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -67.0 -49.01 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.135 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' HIS . . . . . 0.41 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 37.7 t-80 -51.25 -32.45 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.827 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -99.22 -19.78 16.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 3.8 mt-10 -70.1 -3.75 18.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.13 50.18 0.19 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.41 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.6 OUTLIER -113.98 21.07 15.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.755 0.312 . . . . 0.0 110.892 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -117.96 41.38 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.781 0.324 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -63.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.62 ' HA ' HD12 ' C' ' 219' ' ' ILE . 5.6 mt -52.93 -42.68 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.082 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 217' ' ' LEU . . . . . 0.885 HD22 HD11 ' C' ' 221' ' ' ILE . 0.6 OUTLIER -65.37 -56.55 11.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' C' ' 218' ' ' LEU . 17.8 mt -52.88 -34.45 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 219' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' C' ' 216' ' ' ILE . 21.0 mt -63.88 -57.34 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.132 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . 0.768 ' CZ ' HG23 ' A' ' 21' ' ' ILE . 50.0 t80 -62.75 -42.48 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 221' ' ' ILE . . . . . 0.885 HD11 HD22 ' C' ' 217' ' ' LEU . 89.7 mt -57.9 -52.92 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.6 t80 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.162 0 CA-C-O 120.787 0.245 . . . . 0.0 112.329 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -51.69 65.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.8 mm? -58.4 -46.14 86.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -51.85 -43.91 63.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -74.16 -26.16 60.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.0 mtt -70.3 -36.17 74.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.5 mp -82.53 -44.39 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.54 HD21 HG21 ' C' ' 216' ' ' ILE . 8.3 t-20 -51.82 -50.88 59.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -51.32 -30.22 17.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.29 -63.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.59 ' HA ' HD12 ' A' ' 19' ' ' ILE . 17.3 mt -54.93 -38.7 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.865 HD22 HD11 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -67.14 -55.14 15.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.24 -35.4 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 16' ' ' ILE . 22.0 mt -62.2 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.614 ' CE1' HG21 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.21 -45.18 92.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.865 HD11 HD22 ' A' ' 17' ' ' LEU . 51.5 mt -58.37 -51.88 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -66.79 -53.99 27.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.578 HD12 HG22 ' A' ' 19' ' ' ILE . 22.0 mt -46.77 -50.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 20' ' ' PHE . 65.6 t -57.56 -52.21 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 25' ' ' LEU . 13.0 mt -58.91 -42.35 89.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -53.2 -56.65 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -51.11 72.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -48.65 -33.5 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -97.55 -19.41 18.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 26' ' ' LEU . 2.6 pt-20 -71.06 -3.99 22.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 46.05 0.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.35 17.61 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.49 35.93 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 12.8 mmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -135.12 8.54 3.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.1 p -93.94 39.1 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.62 -60.49 3.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.554 0.692 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 52.8 Cg_endo -69.77 -31.22 20.88 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.655 2.236 . . . . 0.0 112.307 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.26 -35.5 76.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.74 -52.1 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.72 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.7 mm? -56.1 -48.07 76.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.964 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.05 -45.4 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -73.13 -25.42 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -73.25 -40.45 64.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.72 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.6 mp -84.33 -52.12 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -51.4 -59.11 4.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.438 HG22 HD12 ' B' ' 118' ' ' LEU . 99.9 m -49.35 -30.97 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.441 ' HA ' HD12 ' B' ' 119' ' ' ILE . 15.5 mt -58.91 -35.1 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.128 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.828 HD22 HD11 ' B' ' 121' ' ' ILE . 1.4 mt -68.79 -50.92 46.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.438 HD12 HG22 ' B' ' 114' ' ' THR . 28.2 mt -61.41 -37.37 83.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.604 HG22 HD12 ' B' ' 123' ' ' ILE . 23.1 mt -62.22 -55.72 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.556 ' O ' HG23 ' B' ' 124' ' ' VAL . 0.1 OUTLIER -65.43 -45.09 85.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.828 HD11 HD22 ' B' ' 117' ' ' LEU . 61.5 mt -59.39 -49.06 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -69.13 -52.8 24.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.604 HD12 HG22 ' B' ' 119' ' ' ILE . 23.9 mt -47.54 -52.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.556 HG23 ' O ' ' B' ' 120' ' ' PHE . 75.2 t -57.77 -51.55 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.574 HD11 HG13 ' A' ' 24' ' ' VAL . 9.9 mt -56.19 -44.27 79.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.36 -57.53 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.39 -50.38 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -48.49 -33.59 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -97.61 -20.02 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.17 -4.07 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.74 46.7 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -119.83 18.72 12.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 110.919 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.3 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . 0.424 HG22 HD12 ' C' ' 218' ' ' LEU . 98.6 m . . . . . 0 N--CA 1.458 -0.075 0 CA-C-O 120.825 0.345 . . . . 0.0 111.151 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -64.95 -64.1 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.679 HG23 HD11 ' A' ' 17' ' ' LEU . 18.9 mt -56.88 -38.62 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 217' ' ' LEU . . . . . 0.648 HD22 HD11 ' C' ' 221' ' ' ILE . 0.5 OUTLIER -66.35 -52.14 50.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . 0.424 HD12 HG22 ' C' ' 214' ' ' THR . 28.4 mt -61.37 -33.84 74.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 219' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' C' ' 216' ' ' ILE . 21.0 mt -61.32 -57.35 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . 0.659 ' HB2' HD21 ' A' ' 17' ' ' LEU . 1.5 t80 -60.24 -46.16 90.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 221' ' ' ILE . . . . . 0.648 HD11 HD22 ' C' ' 217' ' ' LEU . 32.0 mt -60.25 -52.67 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.92 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.872 0.28 . . . . 0.0 112.345 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -56.91 -40.01 75.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.74 -59.08 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.0 mm? -54.88 -43.99 73.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -51.49 -41.5 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -73.68 -30.43 62.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.845 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.06 -35.39 64.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.4 mp -84.31 -47.87 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -58.54 -57.81 11.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.4 m -51.76 -32.16 29.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.78 -64.32 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.551 ' HA ' HD12 ' A' ' 19' ' ' ILE . 60.7 mt -51.86 -40.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.888 HD22 HD11 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -67.49 -57.94 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 18' ' ' LEU . 23.5 mt -53.0 -33.62 52.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 16' ' ' ILE . 23.0 mt -64.41 -59.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.112 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.58 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -61.51 -38.44 87.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.888 HD11 HD22 ' A' ' 17' ' ' LEU . 87.1 mt -63.88 -53.49 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -66.93 -55.14 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 19' ' ' ILE . 24.5 mt -45.77 -53.72 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 20' ' ' PHE . 43.1 t -55.73 -48.6 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.4 mt -63.68 -36.06 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.53 -48.04 83.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.4 -49.25 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -51.41 -32.9 28.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.41 -20.01 17.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.1 mm-40 -70.0 -4.06 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.79 50.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.52 19.83 13.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -118.05 36.27 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 28.1 mmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.33 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -158.04 116.24 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -102.19 43.89 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.734 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.83 -59.78 3.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.573 0.701 . . . . 0.0 111.095 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.734 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.75 -42.22 3.6 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -56.24 -41.04 75.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.24 -59.24 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.754 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.0 mm? -54.86 -44.54 74.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.04 -40.98 59.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.58 -29.6 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.4 mtm -75.93 -29.09 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.754 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.7 mt -84.1 -50.65 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.118 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.81 -57.56 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.445 HG22 ' CD1' ' B' ' 118' ' ' LEU . 95.9 m -50.19 -36.51 30.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -61.44 -61.93 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.624 ' HA ' HD12 ' B' ' 119' ' ' ILE . 66.2 mt -50.66 -49.85 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.933 HD22 HD11 ' B' ' 121' ' ' ILE . 1.5 mt -60.82 -53.35 58.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' B' ' 114' ' ' THR . 22.3 mt -56.39 -33.64 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.7 mt -63.89 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.575 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.1 t80 -62.31 -39.91 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.933 HD11 HD22 ' B' ' 117' ' ' LEU . 85.6 mt -64.31 -54.68 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -63.64 -52.28 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.475 HD12 HG22 ' B' ' 119' ' ' ILE . 32.9 mt -46.03 -46.09 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 120' ' ' PHE . 51.7 t -61.92 -52.09 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' B' ' 125' ' ' LEU . 18.1 mt -59.92 -36.41 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.957 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.6 tp -59.96 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.591 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.62 -50.14 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.135 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -51.02 -32.4 21.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.59 -20.87 17.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.591 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.7 mm-40 -70.62 -3.88 20.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.9 50.87 0.16 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 20.36 8.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -110.69 38.65 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 89.9 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.786 0.327 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -64.78 -63.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.583 ' HA ' HD12 ' C' ' 219' ' ' ILE . 48.9 mt -52.95 -33.87 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 217' ' ' LEU . . . . . 0.772 HD22 HD11 ' C' ' 221' ' ' ILE . 0.7 OUTLIER -68.06 -59.94 2.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 31.3 mt -55.88 -32.57 63.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 219' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' C' ' 216' ' ' ILE . 35.0 mt -63.55 -59.38 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . 0.419 ' CE2' HG12 ' A' ' 21' ' ' ILE . 6.8 t80 -61.89 -41.1 97.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 221' ' ' ILE . . . . . 0.772 HD11 HD22 ' C' ' 217' ' ' LEU . 87.9 mt -64.83 -55.55 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 179.944 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo . . . . . 0 C--O 1.232 0.21 0 CA-C-O 120.791 0.246 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -66.13 -35.64 81.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.66 -53.39 58.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.767 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -56.44 -47.81 78.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -51.2 -43.15 61.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -75.17 -26.15 58.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.605 ' O ' HG22 ' A' ' 14' ' ' THR . 8.8 mtt -70.21 -32.64 70.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.767 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -85.61 -41.88 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -63.65 -40.3 96.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 11' ' ' MET . 7.0 t -50.2 -29.04 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -63.75 -64.8 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HA ' HD12 ' A' ' 19' ' ' ILE . 4.4 mt -53.14 -36.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.687 HD22 HD11 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -68.83 -59.78 2.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.7 mt -52.15 -29.71 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 16' ' ' ILE . 25.8 mt -68.14 -60.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.557 ' CB ' HD13 ' B' ' 117' ' ' LEU . 0.2 OUTLIER -62.02 -35.79 79.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.687 HD11 HD22 ' A' ' 17' ' ' LEU . 51.7 mt -67.42 -53.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -66.45 -55.68 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 19' ' ' ILE . 29.2 mt -46.08 -56.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.468 HG23 ' HD1' ' A' ' 20' ' ' PHE . 38.3 t -52.73 -48.12 49.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.05 -36.81 85.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -48.08 82.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -65.94 -51.19 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -49.66 -33.79 16.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.14 -20.44 17.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.2 mt-10 -71.32 -2.84 17.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 49.19 0.19 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.454 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -124.94 20.21 8.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.792 0.33 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -101.4 38.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.5 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 7.4 ttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.49 3.19 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 15.0 m -112.64 37.79 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.05 -60.21 3.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.573 0.701 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.74 -32.98 17.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -67.59 -35.75 79.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.9 -52.69 64.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.718 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.7 mm? -53.97 -51.61 63.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -50.17 -44.51 52.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -73.83 -25.57 60.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.8 mtt -75.41 -32.63 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.718 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.1 mt -77.27 -48.52 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.67 -55.7 27.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -50.88 -31.58 17.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.48 -62.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.891 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.634 HG23 ' HG ' ' C' ' 217' ' ' LEU . 3.4 mt -50.12 -45.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.991 HD22 HD11 ' B' ' 121' ' ' ILE . 4.7 mt -66.48 -55.71 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.6 mt -57.44 -22.07 40.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 116' ' ' ILE . 16.2 mt -73.76 -60.71 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' C' ' 221' ' ' ILE . 10.9 t80 -68.63 -37.23 79.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.991 HD11 HD22 ' B' ' 117' ' ' LEU . 82.1 mt -63.35 -48.94 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -72.1 -54.95 8.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 48.1 mt -47.69 -48.19 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 120' ' ' PHE . 32.0 t -61.44 -51.47 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.96 -39.72 78.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.88 -48.3 81.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.613 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -68.59 -48.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' HIS . . . . . 0.42 ' HA ' ' HB2' ' B' ' 132' ' ' TRP . 16.4 t-80 -50.78 -32.74 20.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.58 -20.59 16.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.613 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 9.4 mt-10 -70.51 -2.97 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.899 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.84 49.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.467 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.42 ' HB2' ' HA ' ' B' ' 128' ' ' HIS . 0.2 OUTLIER -121.77 21.66 10.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -104.37 41.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.2 t . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.83 0.348 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.92 -63.86 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.512 HG22 HG21 ' B' ' 116' ' ' ILE . 7.0 mt -53.33 -33.54 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 217' ' ' LEU . . . . . 0.817 HD22 HD11 ' C' ' 221' ' ' ILE . 1.3 mt -70.84 -60.13 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -54.35 -32.8 57.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 219' ' ' ILE . . . . . 0.444 HD12 ' HA ' ' C' ' 216' ' ' ILE . 28.3 mt -64.96 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . 0.564 ' CE2' HD23 ' B' ' 117' ' ' LEU . 4.5 t80 -61.41 -39.27 90.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 221' ' ' ILE . . . . . 0.817 HD11 HD22 ' C' ' 217' ' ' LEU . 64.2 mt -65.54 -55.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.965 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo . . . . . 0 C--O 1.231 0.135 0 CA-C-O 120.815 0.256 . . . . 0.0 112.325 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.32 -34.83 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.62 -53.21 60.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.74 -46.85 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.939 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -53.02 -46.98 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -71.6 -27.39 63.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.643 ' O ' HG22 ' A' ' 14' ' ' THR . 9.4 mtt -71.09 -28.6 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.34 -36.78 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.099 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -74.51 -29.85 61.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 11' ' ' MET . 5.6 t -50.7 -28.34 8.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.588 ' HA ' HD12 ' A' ' 19' ' ' ILE . 7.7 mt -53.87 -37.25 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.907 HD22 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -69.33 -58.0 4.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -53.33 -28.17 27.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 16' ' ' ILE . 23.6 mt -70.28 -60.12 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -62.84 -35.02 78.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.907 HD11 HD22 ' A' ' 17' ' ' LEU . 80.6 mt -65.99 -52.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -70.0 -55.67 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 19' ' ' ILE . 22.3 mt -44.27 -51.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.176 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.463 HG23 ' HD1' ' A' ' 20' ' ' PHE . 40.3 t -59.45 -54.66 31.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.141 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 25' ' ' LEU . 11.6 mt -54.94 -44.41 74.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 30' ' ' GLU . 14.0 tp -53.32 -57.2 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -57.52 -50.22 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.077 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 32' ' ' TRP . 10.1 t-160 -48.79 -33.43 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -99.12 -17.75 18.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -68.24 -7.25 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.23 48.53 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 28' ' ' HIS . 0.1 OUTLIER -100.84 19.34 17.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.915 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -167.51 89.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.132 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.753 0.311 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.75 3.35 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 2.4 m -105.68 37.24 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -71.16 -60.57 2.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 0.0 111.11 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.7 -32.74 18.21 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.755 2.303 . . . . 0.0 112.354 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.01 -34.19 76.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.02 -52.97 63.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.89 -49.13 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -51.63 -47.84 63.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.2 -26.93 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -73.79 -28.0 61.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 54.2 mt -81.65 -42.94 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -69.75 -51.98 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -52.96 -30.94 37.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.145 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.53 -62.57 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.684 HG23 ' HG ' ' C' ' 217' ' ' LEU . 5.0 mt -50.48 -44.85 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.159 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 1.0 HD22 HD11 ' B' ' 121' ' ' ILE . 4.4 mt -66.37 -55.72 14.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.4 mt -57.81 -22.65 48.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' B' ' 116' ' ' ILE . 16.5 mt -72.87 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.472 ' O ' HG23 ' B' ' 124' ' ' VAL . 12.5 t80 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 1.0 HD11 HD22 ' B' ' 117' ' ' LEU . 80.0 mt -61.97 -49.58 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -71.93 -54.17 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 37.7 mt -47.34 -45.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 120' ' ' PHE . 32.4 t -63.37 -54.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.18 -44.68 75.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.91 -56.05 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.404 ' HA ' ' HG2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -59.76 -49.86 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.158 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -48.97 -32.74 9.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.32 -19.32 17.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' B' ' 127' ' ' ILE . 0.2 OUTLIER -68.1 -7.01 25.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 127.33 48.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.46 19.57 20.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.817 0.341 . . . . 0.0 110.964 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -170.4 86.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.121 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.807 0.337 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.91 -64.25 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.605 HG22 HG21 ' B' ' 116' ' ' ILE . 13.4 mt -55.03 -32.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.102 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 217' ' ' LEU . . . . . 0.961 HD22 HD11 ' C' ' 221' ' ' ILE . 1.4 mt -70.57 -58.89 3.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -55.37 -32.8 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 219' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' C' ' 216' ' ' ILE . 26.8 mt -64.87 -61.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . 0.563 ' CE2' HD23 ' B' ' 117' ' ' LEU . 4.9 t80 -62.06 -39.41 92.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 221' ' ' ILE . . . . . 0.961 HD11 HD22 ' C' ' 217' ' ' LEU . 83.9 mt -64.35 -53.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.2 t80 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.931 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 C--O 1.231 0.144 0 CA-C-O 120.79 0.246 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.34 -38.52 87.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.18 -58.36 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -57.95 -43.25 86.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -51.52 -41.05 60.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -76.81 -28.26 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mtt -70.67 -32.65 69.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -79.84 -52.27 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -51.87 -33.83 38.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -51.18 -32.4 23.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -64.75 -65.27 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.607 ' HA ' HD12 ' A' ' 19' ' ' ILE . 5.1 mt -53.82 -34.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.014 HD22 HD11 ' A' ' 21' ' ' ILE . 1.4 mt -70.85 -59.05 3.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.0 mt -53.28 -27.47 22.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 16' ' ' ILE . 25.6 mt -71.07 -60.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.18 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.09 -34.34 77.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.014 HD11 HD22 ' A' ' 17' ' ' LEU . 81.3 mt -67.44 -52.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.139 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -68.56 -55.6 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 19' ' ' ILE . 36.0 mt -45.62 -54.16 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.501 HG23 ' HD1' ' A' ' 20' ' ' PHE . 33.3 t -56.5 -49.28 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.122 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 25' ' ' LEU . 13.4 mt -60.37 -38.79 84.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.91 -48.36 81.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.632 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -67.17 -48.05 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 32' ' ' TRP . 22.2 t60 -51.54 -33.63 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -98.53 -19.35 17.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.6 mm-40 -70.47 -3.43 17.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.92 50.06 0.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.403 ' CB ' ' HA ' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -114.23 24.21 12.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.737 0.303 . . . . 0.0 110.927 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.12 36.97 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 21.1 mtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.97 126.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -105.47 38.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.2 -59.77 3.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.6 Cg_endo -69.77 -37.55 8.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.58 -38.41 87.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.52 -57.76 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.719 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.5 mm? -55.65 -47.55 76.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.18 -42.03 38.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -73.57 -32.01 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 2.3 mtm -74.82 -25.72 59.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.719 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.2 mt -81.89 -62.77 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -52.04 -53.29 43.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.417 HG22 HD12 ' B' ' 118' ' ' LEU . 89.9 m -52.3 -31.08 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.9 -64.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.653 HG23 ' HG ' ' C' ' 217' ' ' LEU . 3.5 mt -49.75 -43.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 1.008 HD22 HD11 ' B' ' 121' ' ' ILE . 4.8 mt -66.36 -56.08 12.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.417 HD12 HG22 ' B' ' 114' ' ' THR . 19.8 mt -58.26 -22.17 51.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.5 mt -72.81 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.46 ' O ' HG23 ' B' ' 124' ' ' VAL . 15.9 t80 -68.74 -38.85 80.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 1.008 HD11 HD22 ' B' ' 117' ' ' LEU . 79.7 mt -61.29 -49.29 85.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.07 -54.25 10.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 45.1 mt -48.33 -45.53 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 120' ' ' PHE . 25.4 t -62.94 -52.19 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.86 -38.72 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.88 -48.1 82.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.618 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -67.75 -49.35 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' HIS . . . . . 0.418 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 29.1 t60 -50.46 -33.37 20.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -97.93 -20.4 17.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.618 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 1.7 mm-40 -70.59 -3.07 16.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.19 50.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.533 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.418 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.5 OUTLIER -119.44 24.75 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -92.57 41.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 98.3 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.789 0.328 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -63.87 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.472 ' HA ' HD12 ' C' ' 219' ' ' ILE . 5.8 mt -51.22 -36.42 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 217' ' ' LEU . . . . . 0.892 HD22 HD11 ' C' ' 221' ' ' ILE . 0.9 OUTLIER -69.29 -59.71 2.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.38 -32.59 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 219' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' C' ' 216' ' ' ILE . 27.9 mt -63.78 -61.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . 0.623 ' CE2' HD23 ' B' ' 117' ' ' LEU . 5.2 t80 -61.15 -40.47 93.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 221' ' ' ILE . . . . . 0.892 HD11 HD22 ' C' ' 217' ' ' LEU . 88.8 mt -64.14 -55.03 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.8 t80 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 179.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.849 0.27 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -56.41 -41.86 77.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.5 -59.88 3.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.722 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.1 mm? -54.98 -43.03 73.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -53.13 -37.41 61.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -78.32 -28.83 47.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 mtm -77.59 -30.98 52.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 8' ' ' LEU . 3.2 mt -80.19 -51.75 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.57 ' OD1' HD12 ' A' ' 17' ' ' LEU . 6.9 t-20 -52.49 -34.84 51.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 m -48.26 -33.18 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.57 -64.37 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.586 ' HA ' HD12 ' A' ' 19' ' ' ILE . 66.0 mt -56.9 -36.2 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.95 HD22 HD11 ' A' ' 21' ' ' ILE . 1.4 mt -69.11 -51.91 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.96 -35.25 72.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.638 HG22 HD12 ' A' ' 23' ' ' ILE . 19.0 mt -63.64 -57.95 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.592 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -64.46 -43.88 92.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.95 HD11 HD22 ' A' ' 17' ' ' LEU . 73.9 mt -58.08 -51.98 64.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -68.43 -51.74 40.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 HG22 ' A' ' 19' ' ' ILE . 24.4 mt -48.08 -49.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 20' ' ' PHE . 70.8 t -58.91 -51.21 75.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 10.5 mt -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.19 -47.67 62.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.624 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -67.3 -46.89 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.112 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -52.36 -34.03 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -98.39 -19.01 17.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.624 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.3 mm-40 -70.56 -3.79 19.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 51.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -115.87 20.26 14.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.07 38.72 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.89 126.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 58.5 p -93.18 41.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -69.5 -59.22 5.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.4 Cg_endo -69.77 -39.85 6.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.695 2.263 . . . . 0.0 112.322 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -58.05 -42.62 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.31 -58.65 6.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' LEU . . . . . 0.724 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.1 mm? -56.44 -43.78 79.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -52.73 -36.75 58.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -79.88 -27.0 40.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.5 mtm -79.71 -27.98 40.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' ILE . . . . . 0.724 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.2 mt -84.29 -57.33 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.12 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -50.99 -51.18 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' THR . . . . . 0.476 HG22 HD12 ' B' ' 118' ' ' LEU . 94.1 m -56.5 -39.26 72.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -62.3 -62.5 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' B' ' 119' ' ' ILE . 62.8 mt -50.17 -47.59 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.14 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' LEU . . . . . 0.995 HD22 HD11 ' B' ' 121' ' ' ILE . 1.3 mt -63.18 -57.22 11.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' LEU . . . . . 0.476 HD12 HG22 ' B' ' 114' ' ' THR . 26.3 mt -52.75 -32.46 43.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.8 mt -64.17 -57.36 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.137 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' PHE . . . . . 0.645 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.4 t80 -63.77 -43.05 97.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' ILE . . . . . 0.995 HD11 HD22 ' B' ' 117' ' ' LEU . 22.4 mt -61.76 -52.75 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.172 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -65.6 -47.99 73.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' ILE . . . . . 0.506 HD12 HG22 ' B' ' 119' ' ' ILE . 13.0 mt -49.77 -44.61 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 120' ' ' PHE . 70.6 t -63.71 -52.03 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 125' ' ' LEU . 16.8 mt -59.77 -47.3 86.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -47.5 63.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ILE . . . . . 0.595 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.9 OUTLIER -66.83 -48.94 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' HIS . . . . . 0.412 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 4.0 t60 -51.5 -33.52 31.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.826 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -97.81 -19.67 18.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.86 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.8 mm-40 -70.8 -3.9 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.37 50.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' TRP . . . . . 0.412 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.6 OUTLIER -119.32 20.32 12.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.27 39.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.766 0.317 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -63.03 -63.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 216' ' ' ILE . . . . . 0.6 ' HA ' HD12 ' C' ' 219' ' ' ILE . 69.7 mt -51.46 -39.54 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 217' ' ' LEU . . . . . 0.997 HD22 HD11 ' C' ' 221' ' ' ILE . 1.0 OUTLIER -67.99 -59.22 3.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 25.3 mt -51.26 -30.59 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 219' ' ' ILE . . . . . 0.6 HD12 ' HA ' ' C' ' 216' ' ' ILE . 24.2 mt -68.15 -59.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 220' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -62.52 -37.87 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 221' ' ' ILE . . . . . 0.997 HD11 HD22 ' C' ' 217' ' ' LEU . 96.0 mt -63.62 -53.89 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.2 t80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.982 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.836 0.351 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -154.3 114.68 3.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 97.6 p -115.04 36.95 3.65 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.822 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -71.09 -60.54 2.75 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.589 0.709 . . . . 0.0 111.109 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 54.1 Cg_endo -69.76 -35.93 11.74 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.682 2.255 . . . . 0.0 112.38 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.04 -32.28 73.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -61.12 -55.68 29.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.75 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -52.36 -50.92 61.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.915 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -51.35 -46.46 62.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -71.47 -26.34 62.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.867 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.2 mtt -74.09 -58.99 2.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.75 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -58.04 -37.95 64.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.096 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.55 -49.73 72.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 51.8 m -46.68 -33.94 4.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.163 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.24 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.531 ' HA ' HD12 ' A' ' 19' ' ' ILE . 56.5 mt -57.58 -36.89 55.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.103 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.581 HD22 HD11 ' A' ' 21' ' ' ILE . 1.3 mt -67.32 -51.87 47.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.912 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 22.9 mt -60.43 -38.18 83.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.937 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.594 HG22 HD12 ' A' ' 23' ' ' ILE . 22.0 mt -60.03 -56.53 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.103 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.565 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -65.76 -47.53 74.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.778 HG21 HG11 ' C' ' 224' ' ' VAL . 34.8 mt -56.65 -48.32 80.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.119 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -70.74 -52.45 20.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.861 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.594 HD12 HG22 ' A' ' 19' ' ' ILE . 21.7 mt -48.39 -52.86 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.128 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 20' ' ' PHE . 87.6 t -57.41 -51.09 74.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.134 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.464 HD11 HD23 ' C' ' 225' ' ' LEU . 9.6 mt -55.86 -45.65 78.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.429 ' O ' ' N ' ' A' ' 30' ' ' GLU . 2.6 mp -54.51 -59.07 5.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.481 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -56.63 -49.69 76.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.834 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -48.03 -36.16 12.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.851 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -97.74 -18.21 18.95 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.5 tm-20 -71.61 -2.18 16.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.873 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 123.92 49.81 0.21 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.5 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -117.58 18.63 14.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.73 0.3 . . . . 0.0 110.892 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.68 36.82 2.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.18 179.927 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -154.46 116.0 4.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.6 p -113.98 37.03 3.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.903 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.56 -60.28 3.28 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.585 0.707 . . . . 0.0 111.105 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.7 Cg_endo -69.71 -34.93 13.74 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.692 2.261 . . . . 0.0 112.301 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -65.69 -34.42 78.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -59.09 -54.64 44.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.886 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.747 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.9 mm? -52.6 -49.58 64.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -51.09 -47.05 61.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -70.97 -26.16 63.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.897 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.4 mtt -74.46 -59.92 2.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.905 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.747 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.6 mp -56.27 -40.54 66.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.122 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.78 -59.69 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.949 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 87.8 m -54.34 -36.44 63.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.15 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.4 t -60.94 -63.14 1.4 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.842 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' B' ' 119' ' ' ILE . 61.6 mt -50.26 -46.1 25.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.132 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.928 HD22 HD11 ' B' ' 121' ' ' ILE . 0.6 OUTLIER -62.71 -57.03 12.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.955 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 23.9 mt -53.32 -32.74 50.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' B' ' 116' ' ' ILE . 22.7 mt -63.64 -55.58 21.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.158 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.631 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.1 t80 -62.67 -42.71 99.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.928 HD11 HD22 ' B' ' 117' ' ' LEU . 27.0 mt -62.87 -53.6 44.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.64 -52.21 61.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.877 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.522 HD12 HG22 ' B' ' 119' ' ' ILE . 13.4 mt -46.26 -48.44 6.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.631 HG23 ' O ' ' B' ' 120' ' ' PHE . 70.4 t -59.37 -52.25 63.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' B' ' 125' ' ' LEU . 10.9 mt -58.3 -42.02 85.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.47 -56.73 15.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.424 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.7 OUTLIER -57.02 -51.95 62.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -47.5 -35.05 8.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.833 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -95.01 -22.02 18.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.915 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.424 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 1.5 tm-20 -72.57 -0.96 14.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.911 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.96 45.76 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.481 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -133.02 18.73 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.768 0.318 . . . . 0.0 110.907 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.85 36.68 1.89 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.856 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.146 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 3.4 mpp? . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.745 0.307 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -153.53 115.3 4.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 96.1 p -114.69 37.57 3.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -70.88 -60.52 2.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.611 0.72 . . . . 0.0 111.073 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 205' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.9 Cg_endo -69.74 -34.67 14.17 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.665 2.243 . . . . 0.0 112.367 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -65.98 -33.97 77.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.86 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -59.55 -54.39 47.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.873 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.756 ' O ' HD12 ' C' ' 212' ' ' ILE . 4.0 mm? -52.79 -49.66 65.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -51.37 -46.88 62.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -71.05 -26.1 62.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.3 mtt -74.27 -58.65 3.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' ILE . . . . . 0.756 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.7 mp -58.74 -36.7 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.131 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -63.52 -63.0 1.3 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 92.2 m -51.53 -37.49 49.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.168 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.4 t -63.89 -63.87 1.05 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.633 ' HA ' HD12 ' C' ' 219' ' ' ILE . 58.8 mt -51.83 -39.56 25.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.12 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' LEU . . . . . 0.967 HD22 HD11 ' C' ' 221' ' ' ILE . 0.6 OUTLIER -67.2 -58.86 4.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' C' ' 218' ' ' LEU . 19.0 mt -51.56 -33.68 33.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.896 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' C' ' 216' ' ' ILE . 23.3 mt -64.47 -59.62 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.105 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . 0.489 ' O ' HG23 ' C' ' 224' ' ' VAL . 0.1 OUTLIER -62.69 -42.66 99.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.885 179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' ILE . . . . . 0.967 HD11 HD22 ' C' ' 217' ' ' LEU . 94.4 mt -55.12 -52.25 46.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.082 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -71.95 -54.7 9.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.884 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' ILE . . . . . 0.573 HD12 ' CG2' ' C' ' 219' ' ' ILE . 26.7 mt -50.28 -58.48 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.084 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . 0.778 HG11 HG21 ' A' ' 21' ' ' ILE . 92.5 t -54.74 -44.68 71.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . 0.464 HD23 HD11 ' A' ' 25' ' ' LEU . 9.7 mt -61.28 -45.29 95.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.898 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 2.9 mp -54.91 -55.34 31.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.4 HG22 ' N ' ' C' ' 228' ' ' HIS . 0.7 OUTLIER -59.19 -52.22 63.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.151 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' HIS . . . . . 0.4 ' N ' HG22 ' C' ' 227' ' ' ILE . 44.1 t-80 -47.93 -33.25 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.818 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -94.83 -24.16 17.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.842 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -72.45 -0.54 12.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.863 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 125.42 44.04 0.27 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.473 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -136.87 19.36 3.03 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.817 0.342 . . . . 0.0 110.926 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.35 38.45 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.868 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 37.6 mm . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.159 179.95 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.802 0.334 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -155.91 118.53 4.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.833 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 73.8 p -124.86 36.79 4.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.781 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -71.37 -60.34 2.72 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.629 0.728 . . . . 0.0 111.119 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.781 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 54.1 Cg_endo -69.76 -36.71 10.32 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.615 2.21 . . . . 0.0 112.38 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -63.39 -34.67 78.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.48 -57.97 10.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.885 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.725 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.5 mm? -52.63 -47.16 67.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -51.11 -46.32 61.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -72.83 -25.74 61.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.824 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 7.5 mtt -71.17 -30.47 66.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.725 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.9 mp -84.35 -55.32 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.129 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -53.06 -47.83 68.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.6 t -54.79 -27.3 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.147 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -64.6 -64.21 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.831 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HA ' HD12 ' A' ' 19' ' ' ILE . 2.1 mp -54.14 -40.85 48.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.108 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.883 HD22 HD11 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -66.44 -55.85 13.76 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.897 179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 18' ' ' LEU . 24.7 mt -54.84 -31.58 59.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 16' ' ' ILE . 20.7 mt -66.05 -56.35 15.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.555 ' O ' HG23 ' A' ' 24' ' ' VAL . 14.7 t80 -62.95 -39.05 93.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.904 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.883 HD11 HD22 ' A' ' 17' ' ' LEU . 60.1 mt -63.88 -52.52 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.131 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.03 -53.75 34.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.559 HD12 HG22 ' A' ' 19' ' ' ILE . 22.8 mt -45.5 -44.2 3.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.121 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 20' ' ' PHE . 42.6 t -63.91 -55.25 23.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.113 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.4 mt -55.65 -43.4 76.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.931 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 15.7 tp -53.87 -56.52 16.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.88 -51.94 66.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -48.16 -32.09 6.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -96.5 -22.91 16.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -71.14 -2.5 15.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 44.98 0.24 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.44 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.6 18.13 5.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.771 0.319 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 2.5 ptt180 -105.3 35.87 2.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.917 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 69.5 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.088 -179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 9.5 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.767 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -155.29 117.22 4.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 74.9 p -125.68 36.54 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -71.54 -60.46 2.57 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.602 0.715 . . . . 0.0 111.094 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.72 -36.83 10.19 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.752 2.302 . . . . 0.0 112.302 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -63.32 -34.21 77.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -59.93 -57.96 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.728 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.5 mm? -52.81 -47.08 67.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.901 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -51.5 -46.25 63.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.851 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -72.7 -25.96 61.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.939 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 7.5 mtt -70.98 -30.38 66.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.728 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.9 mt -84.39 -55.15 7.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.147 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -53.25 -47.88 68.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 7.5 t -54.8 -27.18 39.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.086 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.79 -64.22 0.92 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.591 ' HA ' HD12 ' B' ' 119' ' ' ILE . 2.1 mp -54.24 -40.63 48.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.091 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.898 HD22 HD11 ' B' ' 121' ' ' ILE . 0.7 OUTLIER -66.52 -55.95 13.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' B' ' 118' ' ' LEU . 25.2 mt -54.99 -31.35 60.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.907 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.591 HD12 ' HA ' ' B' ' 116' ' ' ILE . 20.6 mt -66.19 -56.37 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.153 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.53 ' O ' HG23 ' B' ' 124' ' ' VAL . 15.3 t80 -63.13 -38.86 92.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.898 HD11 HD22 ' B' ' 117' ' ' LEU . 61.8 mt -64.04 -52.45 56.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.115 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -66.29 -53.52 35.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.534 HD12 HG22 ' B' ' 119' ' ' ILE . 22.6 mt -45.55 -44.32 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.159 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.53 HG23 ' O ' ' B' ' 120' ' ' PHE . 42.1 t -64.01 -55.43 22.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.106 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.1 mt -55.21 -43.52 74.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.92 -56.77 14.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.906 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -51.5 71.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.152 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -48.42 -32.17 7.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.835 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -96.66 -22.63 16.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -71.02 -2.76 16.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.852 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.08 45.93 0.23 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.502 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -129.14 18.17 6.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.775 0.321 . . . . 0.0 110.953 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -105.92 35.82 2.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.875 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.915 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 9.3 mtt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.797 0.332 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -155.9 118.03 4.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.888 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 78.0 p -124.88 36.34 4.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.763 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -71.28 -60.25 2.82 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.586 0.708 . . . . 0.0 111.128 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 205' ' ' PRO . . . . . 0.763 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.8 Cg_endo -69.76 -37.42 9.19 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.713 2.276 . . . . 0.0 112.366 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -62.7 -34.65 77.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -59.21 -58.0 10.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.908 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.738 ' O ' HD12 ' C' ' 212' ' ' ILE . 3.4 mm? -52.77 -47.08 67.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.902 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -51.36 -45.72 62.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -73.44 -25.94 60.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.878 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 7.6 mtt -70.89 -30.47 66.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.844 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 212' ' ' ILE . . . . . 0.738 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.9 mt -84.23 -54.94 7.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.157 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -53.56 -48.19 69.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 8.3 t -54.31 -26.95 32.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.126 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -64.8 -64.18 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.613 ' HA ' HD12 ' C' ' 219' ' ' ILE . 2.0 mp -54.25 -40.47 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.144 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 217' ' ' LEU . . . . . 0.919 HD22 HD11 ' C' ' 221' ' ' ILE . 0.7 OUTLIER -66.67 -56.03 12.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 24.3 mt -54.57 -31.91 57.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.914 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.613 HD12 ' HA ' ' C' ' 216' ' ' ILE . 20.9 mt -65.84 -56.69 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . 0.56 ' O ' HG23 ' C' ' 224' ' ' VAL . 14.8 t80 -62.84 -39.13 93.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.837 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 221' ' ' ILE . . . . . 0.919 HD11 HD22 ' C' ' 217' ' ' LEU . 64.0 mt -63.91 -52.16 60.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.122 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -66.25 -53.74 33.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 223' ' ' ILE . . . . . 0.541 HD12 HG22 ' C' ' 219' ' ' ILE . 25.1 mt -45.43 -44.38 3.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.102 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . 0.56 HG23 ' O ' ' C' ' 220' ' ' PHE . 44.3 t -63.87 -55.15 23.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.113 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' C' ' 225' ' ' LEU . 14.5 mt -55.67 -43.5 76.41 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.92 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 15.6 tp -53.7 -56.15 19.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.869 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -59.32 -51.96 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.099 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -48.23 -31.77 6.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.89 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -96.37 -23.48 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.838 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -71.47 -2.07 15.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.858 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.14 43.92 0.26 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.547 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -131.34 18.49 4.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 0.0 110.944 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -105.05 37.54 2.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.864 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.937 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.758 0.313 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -146.1 114.49 6.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.853 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.3 m -119.09 39.52 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.841 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.787 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.22 -60.33 3.51 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.583 0.706 . . . . 0.0 111.133 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.787 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.8 Cg_endo -69.77 -32.26 18.89 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.72 2.28 . . . . 0.0 112.337 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -68.92 -34.84 76.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -58.51 -50.79 72.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.927 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.4 -48.43 79.12 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.914 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -52.41 -41.62 63.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.88 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -77.09 -26.98 53.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.7 mtt -72.96 -29.67 63.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 50.1 mt -83.78 -45.99 18.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.12 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -60.64 -55.61 31.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.904 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 88.0 m -51.12 -36.25 39.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.172 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.44 -64.18 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.849 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.593 ' HA ' HD12 ' A' ' 19' ' ' ILE . 45.0 mt -52.07 -39.18 25.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.107 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.001 HD22 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -68.36 -58.94 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.945 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 18' ' ' LEU . 22.7 mt -51.16 -30.98 18.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.593 HD12 ' HA ' ' A' ' 16' ' ' ILE . 22.7 mt -68.13 -60.41 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.134 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -61.64 -34.09 75.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.001 HD11 HD22 ' A' ' 17' ' ' LEU . 87.7 mt -67.42 -55.24 18.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.136 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -65.68 -54.58 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.889 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.549 HD12 HG22 ' A' ' 19' ' ' ILE . 30.3 mt -46.21 -56.76 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.147 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.506 HG23 ' HD1' ' A' ' 20' ' ' PHE . 40.0 t -52.77 -48.65 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.152 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.2 mt -63.36 -36.19 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.933 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tp -59.24 -47.76 84.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.917 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.12 -50.19 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.868 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -50.43 -33.45 20.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.891 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -97.56 -20.43 17.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 11.1 mt-10 -70.48 -3.67 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.875 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.98 50.06 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.476 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.7 20.51 10.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.723 0.297 . . . . 0.0 110.894 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -98.91 35.8 1.8 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.16 179.976 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.781 0.324 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -147.18 114.64 6.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.888 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -114.45 39.56 2.77 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.03 -60.29 3.68 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.622 0.725 . . . . 0.0 111.145 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.0 Cg_endo -69.81 -32.72 17.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.675 2.25 . . . . 0.0 112.329 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -68.44 -34.66 76.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.882 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -58.13 -49.69 76.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.961 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -57.08 -49.49 75.7 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.883 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -51.92 -43.11 63.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.877 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -75.02 -27.16 59.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -72.9 -29.61 63.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.886 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 49.6 mt -81.66 -46.73 20.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.62 -54.73 43.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.492 HG22 ' CD1' ' B' ' 118' ' ' LEU . 86.4 m -52.97 -37.68 61.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.117 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -60.96 -61.91 2.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.678 ' HA ' HD12 ' B' ' 119' ' ' ILE . 66.1 mt -51.34 -50.27 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.137 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.927 HD22 HD11 ' B' ' 121' ' ' ILE . 1.5 mt -60.04 -51.94 67.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.492 ' CD1' HG22 ' B' ' 114' ' ' THR . 25.9 mt -57.16 -33.55 67.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.907 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.678 HD12 ' HA ' ' B' ' 116' ' ' ILE . 18.5 mt -64.13 -60.69 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.134 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.577 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.8 t80 -62.7 -40.07 96.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.927 HD11 HD22 ' B' ' 117' ' ' LEU . 86.8 mt -64.44 -54.86 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.108 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -63.42 -52.52 61.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.486 HD12 HG22 ' B' ' 119' ' ' ILE . 31.1 mt -46.38 -45.09 6.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 120' ' ' PHE . 42.3 t -62.26 -52.92 54.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 18.6 mt -59.79 -36.74 77.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.898 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.421 HD12 ' HA ' ' B' ' 126' ' ' LEU . 1.1 tp -59.22 -48.3 82.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.904 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.612 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.0 -50.94 54.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -49.74 -32.86 14.58 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.821 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -97.86 -20.73 17.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.612 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.9 mt-10 -71.09 -2.86 17.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.909 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.47 49.19 0.19 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.516 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -123.54 20.47 9.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.707 0.289 . . . . 0.0 110.881 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -102.08 36.69 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.875 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 79.0 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.138 -179.983 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.777 0.322 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -146.21 109.18 4.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 69.4 m -136.48 40.94 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.885 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -70.31 -60.65 3.21 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.613 0.721 . . . . 0.0 111.073 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 205' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.6 Cg_endo -69.71 -33.54 16.55 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.711 2.274 . . . . 0.0 112.321 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -68.19 -32.92 73.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -62.35 -54.34 41.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.901 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.51 -50.39 73.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.936 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -51.79 -39.75 59.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -79.06 -27.38 43.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.881 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.1 mtt -74.65 -30.23 61.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.851 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 56.2 mt -84.03 -44.43 18.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.128 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -59.76 -53.55 56.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 84.8 m -48.55 -42.61 33.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.144 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -60.58 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.835 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.672 ' HA ' HD12 ' C' ' 219' ' ' ILE . 46.8 mt -52.31 -35.56 19.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 217' ' ' LEU . . . . . 0.896 HD22 HD11 ' C' ' 221' ' ' ILE . 0.9 OUTLIER -67.86 -59.65 3.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.896 179.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 35.8 mt -53.77 -32.37 52.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.672 HD12 ' HA ' ' C' ' 216' ' ' ILE . 30.9 mt -64.08 -61.15 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.162 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . 0.58 ' O ' HG23 ' C' ' 224' ' ' VAL . 6.9 t80 -61.1 -39.85 91.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.866 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 221' ' ' ILE . . . . . 0.896 HD11 HD22 ' C' ' 217' ' ' LEU . 88.7 mt -65.37 -57.16 12.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -60.61 -52.12 66.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.935 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 223' ' ' ILE . . . . . 0.523 HD12 HG22 ' C' ' 219' ' ' ILE . 29.4 mt -46.94 -47.65 8.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.087 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . 0.58 HG23 ' O ' ' C' ' 220' ' ' PHE . 41.6 t -59.18 -51.0 77.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 19.7 mt -62.26 -36.37 81.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.42 -47.2 84.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.943 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.527 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.6 OUTLIER -67.58 -52.09 44.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.153 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -49.12 -32.74 10.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.914 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -96.01 -22.81 17.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.926 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 230' ' ' GLU . . . . . 0.527 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 12.4 mt-10 -72.5 -1.3 15.35 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.914 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 125.93 46.43 0.22 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.463 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -134.87 20.01 3.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.778 0.323 . . . . 0.0 110.957 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 4.8 ttt180 -100.59 39.38 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.162 179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.7 ttm . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.78 0.324 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -154.1 117.56 4.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.895 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.8 p -102.83 37.48 1.94 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.86 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.12 -60.26 3.64 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.594 0.711 . . . . 0.0 111.095 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 54.0 Cg_endo -69.72 -27.65 26.41 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.694 2.263 . . . . 0.0 112.33 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -72.64 -38.31 67.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.38 -46.42 76.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.868 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.28 -50.03 75.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.891 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -51.76 -40.58 60.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.878 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -78.2 -26.5 47.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.1 mtt -76.88 -27.94 55.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.885 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 52.5 mt -84.72 -59.57 2.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.168 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -51.46 -55.42 18.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 97.0 m -52.1 -32.81 36.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.134 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.1 t -65.63 -63.68 1.04 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.827 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 5.7 mt -52.56 -39.27 29.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.133 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.816 HD22 HD11 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -68.76 -56.62 7.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 18' ' ' LEU . 26.4 mt -55.87 -35.47 66.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.612 HG22 HD12 ' A' ' 23' ' ' ILE . 33.2 mt -62.38 -57.01 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.125 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.709 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.61 -41.53 98.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.878 179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.816 HD11 HD22 ' A' ' 17' ' ' LEU . 71.5 mt -59.3 -52.53 59.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.104 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -68.49 -48.21 65.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.87 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.612 HD12 HG22 ' A' ' 19' ' ' ILE . 11.2 mt -49.55 -47.01 20.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.153 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 20' ' ' PHE . 74.0 t -63.07 -52.84 54.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.142 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.1 mt -58.21 -39.14 78.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 19.9 tp -58.07 -49.23 77.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.589 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -66.51 -51.09 61.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.144 179.843 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -49.29 -33.12 12.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -97.44 -20.91 17.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 3.7 mt-10 -71.49 -2.33 16.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.31 48.16 0.21 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -125.62 19.24 8.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.764 0.316 . . . . 0.0 110.961 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -114.08 41.6 2.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 41.2 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.167 179.993 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 34.9 ttm . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -154.52 117.66 4.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.832 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 30.5 p -101.56 36.96 1.9 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.861 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.79 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -69.2 -60.05 4.54 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.582 0.706 . . . . 0.0 111.158 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.79 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.74 -28.59 25.14 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.724 2.283 . . . . 0.0 112.335 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -71.82 -37.86 70.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -55.44 -47.25 76.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -60.08 -48.87 79.92 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.918 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -52.28 -40.69 62.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -78.64 -26.03 45.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -77.13 -28.88 54.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 56.4 mt -83.94 -59.49 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.187 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -52.12 -55.47 20.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.89 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.424 HG22 HD12 ' B' ' 118' ' ' LEU . 97.7 m -52.2 -30.26 26.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.135 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.856 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.657 ' HA ' HD12 ' B' ' 119' ' ' ILE . 3.6 mt -54.84 -41.11 55.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.134 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.922 HD22 HD11 ' B' ' 121' ' ' ILE . 0.4 OUTLIER -64.66 -54.74 26.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.424 HD12 HG22 ' B' ' 114' ' ' THR . 24.1 mt -56.61 -34.02 66.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.935 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.657 HD12 ' HA ' ' B' ' 116' ' ' ILE . 22.5 mt -62.54 -56.08 19.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.141 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.602 ' O ' HG23 ' B' ' 124' ' ' VAL . 57.7 t80 -63.49 -46.86 84.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.885 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.922 HD11 HD22 ' B' ' 117' ' ' LEU . 80.7 mt -53.94 -52.2 38.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.113 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -68.72 -49.97 54.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.855 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.625 HD12 HG22 ' B' ' 119' ' ' ILE . 9.2 mt -49.64 -42.24 17.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.139 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.602 HG23 ' O ' ' B' ' 120' ' ' PHE . 73.5 t -65.61 -53.39 39.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.127 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' B' ' 125' ' ' LEU . 18.0 mt -58.85 -41.02 85.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.93 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.3 tp -57.23 -49.03 77.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.632 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -67.0 -49.01 77.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.135 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' HIS . . . . . 0.41 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 37.7 t-80 -51.25 -32.45 24.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.827 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -99.22 -19.78 16.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.828 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 3.8 mt-10 -70.1 -3.75 18.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.13 50.18 0.19 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.502 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.41 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.6 OUTLIER -113.98 21.07 15.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.755 0.312 . . . . 0.0 110.892 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -117.96 41.38 2.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 40.7 mm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.072 -179.967 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 35.7 ttm . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.778 0.323 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -153.45 116.54 4.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 31.7 p -103.23 38.19 1.82 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.789 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -70.41 -60.53 3.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.585 0.707 . . . . 0.0 111.062 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 205' ' ' PRO . . . . . 0.789 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 54.0 Cg_endo -69.8 -28.64 24.79 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.665 2.243 . . . . 0.0 112.321 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -71.92 -36.67 70.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -56.47 -47.15 79.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -58.6 -51.14 71.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -51.73 -40.4 60.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.862 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 77.5 t80 -77.93 -25.22 48.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.0 mtt -78.66 -28.23 45.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 51.8 mt -84.65 -60.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.155 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -51.59 -56.52 13.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.901 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m -51.36 -30.05 17.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.106 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -64.53 -63.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.62 ' HA ' HD12 ' C' ' 219' ' ' ILE . 5.6 mt -52.93 -42.68 44.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.082 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 217' ' ' LEU . . . . . 0.885 HD22 HD11 ' C' ' 221' ' ' ILE . 0.6 OUTLIER -65.37 -56.55 11.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.892 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' C' ' 218' ' ' LEU . 17.8 mt -52.88 -34.45 54.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.893 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.629 HG22 HD12 ' C' ' 223' ' ' ILE . 21.0 mt -63.88 -57.34 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.132 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . 0.768 ' CZ ' HG23 ' A' ' 21' ' ' ILE . 50.0 t80 -62.75 -42.48 99.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 221' ' ' ILE . . . . . 0.885 HD11 HD22 ' C' ' 217' ' ' LEU . 89.7 mt -57.9 -52.92 52.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -67.48 -49.86 61.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 223' ' ' ILE . . . . . 0.629 HD12 HG22 ' C' ' 219' ' ' ILE . 14.1 mt -49.19 -45.16 17.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . 0.603 HG23 ' O ' ' C' ' 220' ' ' PHE . 59.9 t -63.14 -52.75 54.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.123 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.5 mt -59.25 -37.6 78.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.937 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.89 -49.06 79.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.896 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.578 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.6 OUTLIER -66.76 -51.0 60.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.149 179.825 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -49.66 -33.09 14.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -96.84 -21.48 17.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 230' ' ' GLU . . . . . 0.578 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 4.2 mt-10 -71.56 -2.37 16.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.916 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.01 49.71 0.18 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.498 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.95 21.03 5.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.728 0.299 . . . . 0.0 110.854 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 4.0 tpt180 -108.32 43.27 1.25 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 37.7 mm . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.095 -179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 mmt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.774 0.321 . . . . 0.0 110.901 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -135.07 51.04 2.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 90.4 p -88.57 41.28 1.01 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.757 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -72.68 -60.71 1.89 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.562 0.696 . . . . 0.0 111.113 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.8 Cg_endo -69.75 -31.66 20.15 Favored 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.674 2.25 . . . . 0.0 112.329 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -67.92 -38.24 82.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -54.98 -51.69 65.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.8 mm? -58.4 -46.14 86.99 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.936 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -51.85 -43.91 63.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.869 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -74.16 -26.16 60.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.86 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 9.0 mtt -70.3 -36.17 74.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.858 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.762 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.5 mp -82.53 -44.39 19.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.54 HD21 HG21 ' C' ' 216' ' ' ILE . 8.3 t-20 -51.82 -50.88 59.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.886 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.5 m -51.32 -30.22 17.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.109 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.29 -63.35 1.17 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.59 ' HA ' HD12 ' A' ' 19' ' ' ILE . 17.3 mt -54.93 -38.7 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.168 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.865 HD22 HD11 ' A' ' 21' ' ' ILE . 0.8 OUTLIER -67.14 -55.14 15.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.0 mt -56.24 -35.4 67.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.59 HD12 ' HA ' ' A' ' 16' ' ' ILE . 22.0 mt -62.2 -56.39 17.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.094 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.614 ' CE1' HG21 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.21 -45.18 92.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.865 HD11 HD22 ' A' ' 17' ' ' LEU . 51.5 mt -58.37 -51.88 66.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.114 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -66.79 -53.99 27.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.897 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.578 HD12 HG22 ' A' ' 19' ' ' ILE . 22.0 mt -46.77 -50.27 5.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.135 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.603 HG23 ' O ' ' A' ' 20' ' ' PHE . 65.6 t -57.56 -52.21 60.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.096 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 25' ' ' LEU . 13.0 mt -58.91 -42.35 89.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' O ' ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -53.2 -56.65 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.929 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -56.99 -51.11 72.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.108 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -48.65 -33.5 10.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.868 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -97.55 -19.41 18.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.917 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.404 ' N ' ' O ' ' A' ' 26' ' ' LEU . 2.6 pt-20 -71.06 -3.99 22.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.87 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 126.36 46.05 0.22 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.476 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -121.35 17.61 11.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.49 35.93 4.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.161 179.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 12.8 mmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.751 0.31 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -135.12 8.54 3.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 93.1 p -93.94 39.1 1.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.843 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.62 -60.49 3.1 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.554 0.692 . . . . 0.0 111.098 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 52.8 Cg_endo -69.77 -31.22 20.88 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.655 2.236 . . . . 0.0 112.307 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -69.26 -35.5 76.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -58.74 -52.1 67.13 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.891 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.72 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.7 mm? -56.1 -48.07 76.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.964 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -52.05 -45.4 64.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -73.13 -25.42 60.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.907 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.5 mtt -73.25 -40.45 64.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.864 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.72 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.6 mp -84.33 -52.12 13.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -51.4 -59.11 4.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.894 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.438 HG22 HD12 ' B' ' 118' ' ' LEU . 99.9 m -49.35 -30.97 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -65.39 -64.05 0.95 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.441 ' HA ' HD12 ' B' ' 119' ' ' ILE . 15.5 mt -58.91 -35.1 54.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.128 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.828 HD22 HD11 ' B' ' 121' ' ' ILE . 1.4 mt -68.79 -50.92 46.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.438 HD12 HG22 ' B' ' 114' ' ' THR . 28.2 mt -61.41 -37.37 83.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.903 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.604 HG22 HD12 ' B' ' 123' ' ' ILE . 23.1 mt -62.22 -55.72 22.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.111 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.556 ' O ' HG23 ' B' ' 124' ' ' VAL . 0.1 OUTLIER -65.43 -45.09 85.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.929 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.828 HD11 HD22 ' B' ' 117' ' ' LEU . 61.5 mt -59.39 -49.06 84.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.116 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -69.13 -52.8 24.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.604 HD12 HG22 ' B' ' 119' ' ' ILE . 23.9 mt -47.54 -52.54 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.154 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.556 HG23 ' O ' ' B' ' 120' ' ' PHE . 75.2 t -57.77 -51.55 68.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.141 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.574 HD11 HG13 ' A' ' 24' ' ' VAL . 9.9 mt -56.19 -44.27 79.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.911 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 mp -54.36 -57.53 10.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -58.39 -50.38 78.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.127 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -48.49 -33.59 9.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.87 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 36.1 m-85 -97.61 -20.02 17.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -70.17 -4.07 19.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.74 46.7 0.22 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.492 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -119.83 18.72 12.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 110.919 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.3 36.86 4.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 70.6 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.092 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 12.6 mmt . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.795 0.331 . . . . 0.0 110.914 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -135.05 8.37 3.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.853 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 94.4 p -94.12 38.21 1.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.764 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -71.07 -60.52 2.77 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.647 0.736 . . . . 0.0 111.139 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 205' ' ' PRO . . . . . 0.764 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.8 Cg_endo -69.75 -31.27 20.9 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.684 2.256 . . . . 0.0 112.367 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -68.8 -36.45 78.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.904 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -57.56 -51.89 67.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.887 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.745 ' O ' HD12 ' C' ' 212' ' ' ILE . 3.8 mm? -57.74 -46.47 84.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.938 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -52.08 -45.19 64.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.858 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 76.0 t80 -73.49 -26.02 60.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.897 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.3 mtt -72.58 -40.32 66.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 212' ' ' ILE . . . . . 0.745 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.6 mp -84.38 -51.5 13.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.143 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -51.57 -58.31 6.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.898 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . 0.424 HG22 HD12 ' C' ' 218' ' ' LEU . 98.6 m -50.09 -32.31 15.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.151 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -64.95 -64.1 0.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.679 HG23 HD11 ' A' ' 17' ' ' LEU . 18.9 mt -56.88 -38.62 60.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.1 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 217' ' ' LEU . . . . . 0.648 HD22 HD11 ' C' ' 221' ' ' ILE . 0.5 OUTLIER -66.35 -52.14 50.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.858 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . 0.424 HD12 HG22 ' C' ' 214' ' ' THR . 28.4 mt -61.37 -33.84 74.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' C' ' 216' ' ' ILE . 21.0 mt -61.32 -57.35 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.162 179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . 0.659 ' HB2' HD21 ' A' ' 17' ' ' LEU . 1.5 t80 -60.24 -46.16 90.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.898 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 221' ' ' ILE . . . . . 0.648 HD11 HD22 ' C' ' 217' ' ' LEU . 32.0 mt -60.25 -52.67 58.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.154 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -62.39 -56.07 21.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 223' ' ' ILE . . . . . 0.463 HD12 HG22 ' C' ' 219' ' ' ILE . 42.8 mt -43.78 -49.17 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.176 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . 0.645 HG23 ' O ' ' C' ' 220' ' ' PHE . 73.5 t -58.01 -52.38 59.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' C' ' 225' ' ' LEU . 14.0 mt -59.53 -41.88 91.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -53.12 -56.05 19.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -57.87 -50.64 77.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.137 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -48.89 -33.29 10.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -97.34 -20.07 18.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -70.74 -4.14 22.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.55 46.66 0.21 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.512 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -122.7 18.6 10.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.765 0.317 . . . . 0.0 110.905 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.7 37.31 4.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 63.1 mt . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.134 179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.9 mmt . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.82 0.343 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -157.5 119.21 3.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -97.01 40.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.76 -59.83 3.42 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.594 0.711 . . . . 0.0 111.082 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.8 Cg_endo -69.77 -41.64 4.09 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.255 . . . . 0.0 112.345 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -56.91 -40.01 75.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.74 -59.08 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.0 mm? -54.88 -43.99 73.66 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.907 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -51.49 -41.5 60.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -73.68 -30.43 62.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.845 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.2 mtm -74.06 -35.39 64.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.4 mp -84.31 -47.87 17.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -58.54 -57.81 11.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.891 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 87.4 m -51.76 -32.16 29.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -64.78 -64.32 0.9 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.551 ' HA ' HD12 ' A' ' 19' ' ' ILE . 60.7 mt -51.86 -40.29 27.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.163 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.888 HD22 HD11 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -67.49 -57.94 5.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.939 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 18' ' ' LEU . 23.5 mt -53.0 -33.62 52.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.551 HD12 ' HA ' ' A' ' 16' ' ' ILE . 23.0 mt -64.41 -59.51 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.112 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.58 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -61.51 -38.44 87.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.888 HD11 HD22 ' A' ' 17' ' ' LEU . 87.1 mt -63.88 -53.49 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -66.93 -55.14 15.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.829 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.53 HD12 HG22 ' A' ' 19' ' ' ILE . 24.5 mt -45.77 -53.72 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 20' ' ' PHE . 43.1 t -55.73 -48.6 77.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.124 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 25' ' ' LEU . 16.4 mt -63.68 -36.06 82.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.53 -48.04 83.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.931 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.604 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -67.4 -49.25 73.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.107 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 34.4 t-80 -51.41 -32.9 28.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -98.41 -20.01 17.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.857 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.604 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.1 mm-40 -70.0 -4.06 19.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.932 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.79 50.57 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -118.52 19.83 13.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.753 0.311 . . . . 0.0 110.918 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -118.05 36.27 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 70.8 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 28.1 mmt . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.792 0.33 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -158.04 116.24 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 14.5 m -102.19 43.89 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.734 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.83 -59.78 3.4 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.573 0.701 . . . . 0.0 111.095 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.734 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.1 Cg_endo -69.75 -42.22 3.6 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.364 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -56.24 -41.04 75.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.865 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -53.24 -59.24 4.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.754 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.0 mm? -54.86 -44.54 74.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.902 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.04 -40.98 59.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -74.58 -29.6 61.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.899 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.4 mtm -75.93 -29.09 58.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.754 HD12 ' O ' ' B' ' 108' ' ' LEU . 2.7 mt -84.1 -50.65 14.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.118 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -57.81 -57.56 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.904 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.445 HG22 ' CD1' ' B' ' 118' ' ' LEU . 95.9 m -50.19 -36.51 30.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.117 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.2 t -61.44 -61.93 2.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.624 ' HA ' HD12 ' B' ' 119' ' ' ILE . 66.2 mt -50.66 -49.85 24.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.168 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.933 HD22 HD11 ' B' ' 121' ' ' ILE . 1.5 mt -60.82 -53.35 58.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.885 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.445 ' CD1' HG22 ' B' ' 114' ' ' THR . 22.3 mt -56.39 -33.64 65.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.624 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.7 mt -63.89 -61.24 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.165 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.575 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.1 t80 -62.31 -39.91 94.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.896 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.933 HD11 HD22 ' B' ' 117' ' ' LEU . 85.6 mt -64.31 -54.68 28.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -63.64 -52.28 61.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.475 HD12 HG22 ' B' ' 119' ' ' ILE . 32.9 mt -46.03 -46.09 5.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.18 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.575 HG23 ' O ' ' B' ' 120' ' ' PHE . 51.7 t -61.92 -52.09 64.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.124 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' B' ' 125' ' ' LEU . 18.1 mt -59.92 -36.41 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.957 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 20.6 tp -59.96 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.92 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.591 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -68.62 -50.14 58.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.135 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -51.02 -32.4 21.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -97.59 -20.87 17.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.909 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.591 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.7 mm-40 -70.62 -3.88 20.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.9 50.87 0.16 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.478 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.1 20.36 8.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.934 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 60.9 mtm180 -110.69 38.65 2.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.878 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 69.4 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 27.6 mmt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.755 0.312 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -158.76 120.49 3.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.902 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 15.1 m -95.12 37.25 1.17 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.837 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.779 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -71.21 -60.08 2.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.597 0.713 . . . . 0.0 111.133 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 205' ' ' PRO . . . . . 0.779 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.9 Cg_endo -69.77 -39.97 5.86 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -58.15 -40.42 81.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -54.12 -59.2 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.864 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.734 ' O ' HD12 ' C' ' 212' ' ' ILE . 4.0 mm? -54.05 -45.24 71.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.921 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -51.47 -40.34 59.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -74.37 -29.05 61.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.896 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 1.2 mtm -76.28 -34.92 59.1 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.86 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 212' ' ' ILE . . . . . 0.734 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.2 mp -84.35 -28.84 7.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.148 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -49.92 -56.5 10.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 89.9 m -47.73 -38.34 15.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.134 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -64.78 -63.69 1.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.831 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.583 ' HA ' HD12 ' C' ' 219' ' ' ILE . 48.9 mt -52.95 -33.87 19.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.095 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 217' ' ' LEU . . . . . 0.772 HD22 HD11 ' C' ' 221' ' ' ILE . 0.7 OUTLIER -68.06 -59.94 2.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 31.3 mt -55.88 -32.57 63.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.583 HD12 ' HA ' ' C' ' 216' ' ' ILE . 35.0 mt -63.55 -59.38 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . 0.604 ' O ' HG23 ' C' ' 224' ' ' VAL . 6.8 t80 -61.89 -41.1 97.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.874 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 221' ' ' ILE . . . . . 0.772 HD11 HD22 ' C' ' 217' ' ' LEU . 87.9 mt -64.83 -55.55 20.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.14 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -61.77 -52.26 64.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 223' ' ' ILE . . . . . 0.533 HD12 HG22 ' C' ' 219' ' ' ILE . 24.8 mt -45.71 -49.7 4.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.142 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . 0.604 HG23 ' O ' ' C' ' 220' ' ' PHE . 62.0 t -58.82 -50.38 79.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 20.3 mt -62.21 -35.33 78.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.912 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 22.4 tp -59.98 -47.26 86.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.571 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.6 OUTLIER -68.84 -50.26 56.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 -50.91 -32.69 21.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -96.89 -21.43 17.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.869 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 230' ' ' GLU . . . . . 0.571 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 11.3 mm-40 -70.78 -3.51 19.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.67 50.39 0.17 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.51 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -128.74 23.4 5.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.794 0.33 . . . . 0.0 110.914 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -108.57 36.93 2.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.85 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 64.0 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.133 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.8 ttt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.755 0.312 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -120.38 4.3 10.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.7 m -109.17 37.16 2.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.773 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.6 -60.32 3.23 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.633 0.73 . . . . 0.0 111.122 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.773 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.7 Cg_endo -69.83 -34.11 15.01 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.663 2.242 . . . . 0.0 112.334 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -66.13 -35.64 81.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -57.66 -53.39 58.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.767 ' O ' HD12 ' A' ' 12' ' ' ILE . 3.7 mm? -56.44 -47.81 78.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -51.2 -43.15 61.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -75.17 -26.15 58.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.605 ' O ' HG22 ' A' ' 14' ' ' THR . 8.8 mtt -70.21 -32.64 70.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.767 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -85.61 -41.88 15.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.107 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -63.65 -40.3 96.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 11' ' ' MET . 7.0 t -50.2 -29.04 8.53 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.109 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -63.75 -64.8 0.8 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.85 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.612 ' HA ' HD12 ' A' ' 19' ' ' ILE . 4.4 mt -53.14 -36.81 25.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.103 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.687 HD22 HD11 ' A' ' 21' ' ' ILE . 0.7 OUTLIER -68.83 -59.78 2.84 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.917 179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 26.7 mt -52.15 -29.71 23.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.943 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.612 HD12 ' HA ' ' A' ' 16' ' ' ILE . 25.8 mt -68.14 -60.33 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.092 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.557 ' CB ' HD13 ' B' ' 117' ' ' LEU . 0.2 OUTLIER -62.02 -35.79 79.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.687 HD11 HD22 ' A' ' 17' ' ' LEU . 51.7 mt -67.42 -53.46 32.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -66.45 -55.68 14.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 19' ' ' ILE . 29.2 mt -46.08 -56.94 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.097 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.468 HG23 ' HD1' ' A' ' 20' ' ' PHE . 38.3 t -52.73 -48.12 49.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.139 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 14.8 mt -64.05 -36.81 85.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.52 -48.08 82.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.869 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.611 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -65.94 -51.19 63.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -49.66 -33.79 16.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.848 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -97.14 -20.44 17.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.2 mt-10 -71.32 -2.84 17.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.893 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.59 49.19 0.19 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.454 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -124.94 20.21 8.37 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.792 0.33 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.4 ttp85 -101.4 38.68 1.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 35.5 mm . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.105 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 7.4 ttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.827 0.346 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -119.49 3.19 11.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.851 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 15.0 m -112.64 37.79 2.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.767 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.05 -60.21 3.73 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.573 0.701 . . . . 0.0 111.078 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.767 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.74 -32.98 17.6 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.652 2.235 . . . . 0.0 112.377 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -67.59 -35.75 79.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -57.9 -52.69 64.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.718 ' O ' HD12 ' B' ' 112' ' ' ILE . 3.7 mm? -53.97 -51.61 63.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.914 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -50.17 -44.51 52.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 74.0 t80 -73.83 -25.57 60.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.8 mtt -75.41 -32.63 60.81 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.911 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.718 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.1 mt -77.27 -48.52 24.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.083 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -61.67 -55.7 27.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.916 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -50.88 -31.58 17.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.156 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.48 -62.16 1.76 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.891 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.634 HG23 ' HG ' ' C' ' 217' ' ' LEU . 3.4 mt -50.12 -45.43 23.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.991 HD22 HD11 ' B' ' 121' ' ' ILE . 4.7 mt -66.48 -55.71 14.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.6 mt -57.44 -22.07 40.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.893 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.505 HD12 ' HA ' ' B' ' 116' ' ' ILE . 16.2 mt -73.76 -60.71 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.136 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' C' ' 221' ' ' ILE . 10.9 t80 -68.63 -37.23 79.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.881 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.991 HD11 HD22 ' B' ' 117' ' ' LEU . 82.1 mt -63.35 -48.94 84.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -72.1 -54.95 8.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 48.1 mt -47.69 -48.19 11.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.123 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.439 HG23 ' O ' ' B' ' 120' ' ' PHE . 32.0 t -61.44 -51.47 72.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.087 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.96 -39.72 78.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.88 -48.3 81.88 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.613 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -68.59 -48.88 69.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' HIS . . . . . 0.42 ' HA ' ' HB2' ' B' ' 132' ' ' TRP . 16.4 t-80 -50.78 -32.74 20.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -98.58 -20.59 16.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.613 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 9.4 mt-10 -70.51 -2.97 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.899 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 124.84 49.18 0.2 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.467 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.42 ' HB2' ' HA ' ' B' ' 128' ' ' HIS . 0.2 OUTLIER -121.77 21.66 10.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.745 0.307 . . . . 0.0 110.888 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 51.8 ttp85 -104.37 41.4 1.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.889 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 36.0 mm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.09 -179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.83 0.348 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -119.93 3.99 10.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.866 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 14.1 m -111.28 36.67 3.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.848 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.788 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -70.52 -60.19 3.37 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.547 0.689 . . . . 0.0 111.121 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 205' ' ' PRO . . . . . 0.788 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.1 Cg_endo -69.82 -33.54 16.16 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.644 2.229 . . . . 0.0 112.331 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -66.93 -34.94 78.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -59.01 -54.13 50.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.849 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.758 ' O ' HD12 ' C' ' 212' ' ' ILE . 3.7 mm? -54.43 -48.92 71.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -51.08 -45.22 61.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.877 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -73.15 -26.16 61.1 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 9.1 mtt -74.19 -37.58 63.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 212' ' ' ILE . . . . . 0.758 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.7 mp -84.32 -38.03 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 213' ' ' ASN . . . . . 0.49 ' ND2' HD11 ' B' ' 116' ' ' ILE . 13.9 t-20 -54.09 -62.66 1.51 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.2 t -55.8 -31.06 62.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.186 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.92 -63.86 1.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.887 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.512 HG22 HG21 ' B' ' 116' ' ' ILE . 7.0 mt -53.33 -33.54 21.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.102 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 217' ' ' LEU . . . . . 0.817 HD22 HD11 ' C' ' 221' ' ' ILE . 1.3 mt -70.84 -60.13 2.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.907 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -54.35 -32.8 57.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.909 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.476 HG22 HD12 ' C' ' 223' ' ' ILE . 28.3 mt -64.96 -61.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . 0.564 ' CE2' HD23 ' B' ' 117' ' ' LEU . 4.5 t80 -61.41 -39.27 90.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 221' ' ' ILE . . . . . 0.817 HD11 HD22 ' C' ' 217' ' ' LEU . 64.2 mt -65.54 -55.46 19.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -62.72 -53.89 47.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 223' ' ' ILE . . . . . 0.476 HD12 HG22 ' C' ' 219' ' ' ILE . 31.1 mt -43.85 -56.34 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.153 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 16.4 t -54.48 -48.16 69.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.126 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 17.2 mt -61.45 -37.41 83.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.927 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.53 -47.2 86.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.55 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.8 OUTLIER -69.44 -51.86 38.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.141 179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 32.2 t-80 -49.31 -32.36 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.901 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -96.19 -23.1 16.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 230' ' ' GLU . . . . . 0.55 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 12.7 mt-10 -71.54 -2.01 15.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.885 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 125.74 45.79 0.24 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.522 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -131.36 18.24 4.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.77 0.319 . . . . 0.0 110.923 -179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 51.0 ttp85 -99.65 41.08 1.18 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.87 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 36.6 mm . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.155 179.981 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.5 mtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.808 0.337 . . . . 0.0 110.877 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -126.38 3.28 6.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.4 m -106.24 37.11 2.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.763 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.94 -60.39 2.94 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.567 0.698 . . . . 0.0 111.077 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.763 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.4 Cg_endo -69.74 -33.21 17.13 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.694 2.263 . . . . 0.0 112.325 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -67.32 -34.83 78.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -58.62 -53.21 60.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.876 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -54.74 -46.85 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.939 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -53.02 -46.98 68.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -71.6 -27.39 63.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.643 ' O ' HG22 ' A' ' 14' ' ' THR . 9.4 mtt -71.09 -28.6 64.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.858 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.3 mt -85.34 -36.78 11.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.099 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -74.51 -29.85 61.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 11' ' ' MET . 5.6 t -50.7 -28.34 8.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.3 t -65.91 -65.37 0.69 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.879 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.588 ' HA ' HD12 ' A' ' 19' ' ' ILE . 7.7 mt -53.87 -37.25 32.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.127 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.907 HD22 HD11 ' A' ' 21' ' ' ILE . 0.9 OUTLIER -69.33 -58.0 4.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.934 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.4 mt -53.33 -28.17 27.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.934 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.588 HD12 ' HA ' ' A' ' 16' ' ' ILE . 23.6 mt -70.28 -60.12 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.1 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.573 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.2 OUTLIER -62.84 -35.02 78.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.893 179.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.907 HD11 HD22 ' A' ' 17' ' ' LEU . 80.6 mt -65.99 -52.06 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.137 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -70.0 -55.67 8.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.94 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.47 HD12 HG22 ' A' ' 19' ' ' ILE . 22.3 mt -44.27 -51.4 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.176 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.463 HG23 ' HD1' ' A' ' 20' ' ' PHE . 40.3 t -59.45 -54.66 31.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.141 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 25' ' ' LEU . 11.6 mt -54.94 -44.41 74.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 30' ' ' GLU . 14.0 tp -53.32 -57.2 11.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.406 ' HA ' ' HG2' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -57.52 -50.22 77.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.077 179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.401 ' HA ' ' HB2' ' A' ' 32' ' ' TRP . 10.1 t-160 -48.79 -33.43 10.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.92 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -99.12 -17.75 18.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.836 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -68.24 -7.25 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.89 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 127.23 48.53 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.401 ' HB2' ' HA ' ' A' ' 28' ' ' HIS . 0.1 OUTLIER -100.84 19.34 17.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.715 0.293 . . . . 0.0 110.915 -179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -167.51 89.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.885 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 22.4 mt . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.132 179.957 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 17.2 mtt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.753 0.311 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.75 3.35 7.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 2.4 m -105.68 37.24 2.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.76 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -71.16 -60.57 2.7 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.584 0.707 . . . . 0.0 111.11 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.76 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 54.0 Cg_endo -69.7 -32.74 18.21 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.755 2.303 . . . . 0.0 112.354 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.01 -34.19 76.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.896 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.02 -52.97 63.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -53.89 -49.13 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -51.63 -47.84 63.55 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -70.2 -26.93 64.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 9.2 mtt -73.79 -28.0 61.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.895 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . . . . . . . . . 54.2 mt -81.65 -42.94 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -69.75 -51.98 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . . . . . . . . . 6.1 t -52.96 -30.94 37.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.145 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.1 t -64.53 -62.57 1.51 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.684 HG23 ' HG ' ' C' ' 217' ' ' LEU . 5.0 mt -50.48 -44.85 25.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.159 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 1.0 HD22 HD11 ' B' ' 121' ' ' ILE . 4.4 mt -66.37 -55.72 14.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.942 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 31.4 mt -57.81 -22.65 48.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' B' ' 116' ' ' ILE . 16.5 mt -72.87 -61.53 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.143 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.472 ' O ' HG23 ' B' ' 124' ' ' VAL . 12.5 t80 -67.88 -38.27 82.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 1.0 HD11 HD22 ' B' ' 117' ' ' LEU . 80.0 mt -61.97 -49.58 83.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.102 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -71.93 -54.17 10.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.875 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 37.7 mt -47.34 -45.67 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.133 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.472 HG23 ' O ' ' B' ' 120' ' ' PHE . 32.4 t -63.37 -54.1 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.143 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 12.1 mt -55.18 -44.68 75.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 13.1 tp -53.91 -56.05 21.28 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.947 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.404 ' HA ' ' HG2' ' B' ' 130' ' ' GLU . 0.6 OUTLIER -59.76 -49.86 82.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.158 179.82 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -48.97 -32.74 9.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.833 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.32 -19.32 17.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.922 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' B' ' 127' ' ' ILE . 0.2 OUTLIER -68.1 -7.01 25.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.902 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 127.33 48.24 0.18 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.497 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -107.46 19.57 20.07 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.817 0.341 . . . . 0.0 110.964 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 17.1 tpp180 -170.4 86.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 23.8 mt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.121 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 17.5 mtt . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.699 0.285 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -125.79 3.32 7.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.833 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 2.5 m -106.16 37.55 2.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.782 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -71.21 -60.48 2.73 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 111.12 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 205' ' ' PRO . . . . . 0.782 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.6 Cg_endo -69.79 -32.87 17.6 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.704 2.27 . . . . 0.0 112.313 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -67.93 -34.37 76.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -58.9 -52.21 66.74 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -54.52 -48.54 71.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.897 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -52.13 -48.64 64.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -68.37 -27.52 66.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.902 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 8.8 mtt -76.43 -32.12 58.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.82 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 212' ' ' ILE . . . . . . . . . . . . . 62.6 mt -84.53 -30.63 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.149 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 213' ' ' ASN . . . . . 0.469 ' ND2' HD11 ' B' ' 116' ' ' ILE . 11.8 t-20 -62.35 -55.7 25.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.866 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 7.5 t -58.48 -29.97 66.63 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.3 t -62.91 -64.25 0.97 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.878 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.605 HG22 HG21 ' B' ' 116' ' ' ILE . 13.4 mt -55.03 -32.53 27.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.102 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 217' ' ' LEU . . . . . 0.961 HD22 HD11 ' C' ' 221' ' ' ILE . 1.4 mt -70.57 -58.89 3.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.914 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 30.6 mt -55.37 -32.8 62.89 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.922 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' C' ' 216' ' ' ILE . 26.8 mt -64.87 -61.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.125 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . 0.563 ' CE2' HD23 ' B' ' 117' ' ' LEU . 4.9 t80 -62.06 -39.41 92.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 221' ' ' ILE . . . . . 0.961 HD11 HD22 ' C' ' 217' ' ' LEU . 83.9 mt -64.35 -53.61 40.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.136 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -66.09 -54.0 31.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 223' ' ' ILE . . . . . 0.503 HD12 HG22 ' C' ' 219' ' ' ILE . 23.4 mt -42.79 -51.67 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.104 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 8.9 t -60.08 -54.63 32.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.125 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . 0.434 HD23 ' HA ' ' C' ' 225' ' ' LEU . 12.2 mt -53.61 -44.17 69.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.913 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 12.0 tp -54.11 -55.48 27.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -60.51 -49.95 82.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.121 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -49.43 -31.77 10.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.85 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -97.97 -20.64 17.3 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.85 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 230' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.8 -6.25 25.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.865 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 127.65 45.13 0.21 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.496 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -117.76 18.23 14.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.929 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 16.7 tpp180 -165.86 87.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 23.6 mt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.144 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mtt . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.78 0.324 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.99 127.07 0.85 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -103.41 36.27 2.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.791 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -71.27 -60.24 2.83 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.59 0.71 . . . . 0.0 111.116 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.791 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 53.6 Cg_endo -69.8 -37.2 9.39 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.634 2.223 . . . . 0.0 112.347 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -61.34 -38.52 87.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.896 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -57.18 -58.36 8.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.768 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.5 mm? -57.95 -43.25 86.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.944 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -51.52 -41.05 60.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -76.81 -28.26 55.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.4 mtt -70.67 -32.65 69.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.835 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.768 HD12 ' O ' ' A' ' 8' ' ' LEU . 2.6 mp -79.84 -52.27 15.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -51.87 -33.83 38.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 53.7 m -51.18 -32.4 23.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.163 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.4 t -64.75 -65.27 0.7 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.607 ' HA ' HD12 ' A' ' 19' ' ' ILE . 5.1 mt -53.82 -34.21 24.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.131 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.014 HD22 HD11 ' A' ' 21' ' ' ILE . 1.4 mt -70.85 -59.05 3.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.89 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.0 mt -53.28 -27.47 22.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.607 HD12 ' HA ' ' A' ' 16' ' ' ILE . 25.6 mt -71.07 -60.97 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.18 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.558 ' CD1' HD13 ' B' ' 121' ' ' ILE . 0.1 OUTLIER -63.09 -34.34 77.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.014 HD11 HD22 ' A' ' 17' ' ' LEU . 81.3 mt -67.44 -52.46 41.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.139 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -68.56 -55.6 11.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.862 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.51 HD12 HG22 ' A' ' 19' ' ' ILE . 36.0 mt -45.62 -54.16 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.134 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.501 HG23 ' HD1' ' A' ' 20' ' ' PHE . 33.3 t -56.5 -49.28 78.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.122 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 25' ' ' LEU . 13.4 mt -60.37 -38.79 84.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 mp -58.91 -48.36 81.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.856 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.632 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.7 OUTLIER -67.17 -48.05 79.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 32' ' ' TRP . 22.2 t60 -51.54 -33.63 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.894 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -98.53 -19.35 17.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.632 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 1.6 mm-40 -70.47 -3.43 17.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.869 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 124.92 50.06 0.2 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.466 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.403 ' CB ' ' HA ' ' A' ' 28' ' ' HIS . 0.2 OUTLIER -114.23 24.21 12.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.737 0.303 . . . . 0.0 110.927 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 56.4 mtp180 -94.12 36.97 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.848 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 21.1 mtt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.786 0.327 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -169.97 126.89 0.85 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.897 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 67.4 m -105.47 38.41 1.98 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.832 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.749 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -70.2 -59.77 3.94 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.664 0.745 . . . . 0.0 111.118 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.749 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.6 Cg_endo -69.77 -37.55 8.99 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.707 2.271 . . . . 0.0 112.352 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.58 -38.41 87.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.932 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -56.52 -57.76 10.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.882 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.719 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.5 mm? -55.65 -47.55 76.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.941 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -49.18 -42.03 38.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.873 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -73.57 -32.01 63.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 2.3 mtm -74.82 -25.72 59.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.856 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.719 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.2 mt -81.89 -62.77 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.133 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 5.4 t-20 -52.04 -53.29 43.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.417 HG22 HD12 ' B' ' 118' ' ' LEU . 89.9 m -52.3 -31.08 31.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.179 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -64.9 -64.05 0.96 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.653 HG23 ' HG ' ' C' ' 217' ' ' LEU . 3.5 mt -49.75 -43.85 19.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.153 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 1.008 HD22 HD11 ' B' ' 121' ' ' ILE . 4.8 mt -66.36 -56.08 12.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.417 HD12 HG22 ' B' ' 114' ' ' THR . 19.8 mt -58.26 -22.17 51.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.5 mt -72.81 -61.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.46 ' O ' HG23 ' B' ' 124' ' ' VAL . 15.9 t80 -68.74 -38.85 80.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.864 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 1.008 HD11 HD22 ' B' ' 117' ' ' LEU . 79.7 mt -61.29 -49.29 85.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.164 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.0 t80 -72.07 -54.25 10.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.901 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . . . . . . . . . 45.1 mt -48.33 -45.53 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.148 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.46 HG23 ' O ' ' B' ' 120' ' ' PHE . 25.4 t -62.94 -52.19 62.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.105 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . . . . . . . . . 14.5 mt -58.86 -38.72 79.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.916 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.2 mp -58.88 -48.1 82.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.618 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.8 OUTLIER -67.75 -49.35 70.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.159 179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' HIS . . . . . 0.418 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 29.1 t60 -50.46 -33.37 20.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.871 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -97.93 -20.4 17.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.618 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 1.7 mm-40 -70.59 -3.07 16.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.842 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 125.19 50.22 0.19 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.533 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.418 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.5 OUTLIER -119.44 24.75 10.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.778 0.323 . . . . 0.0 110.943 -179.912 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -92.57 41.65 1.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 66.9 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.154 -179.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 20.7 mtt . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.728 0.299 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -170.14 127.27 0.84 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.862 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 67.9 m -102.16 36.62 2.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.86 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.772 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -70.91 -59.89 3.26 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.57 0.7 . . . . 0.0 111.088 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 205' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 53.8 Cg_endo -69.8 -36.76 10.11 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.7 2.266 . . . . 0.0 112.311 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -62.0 -38.81 90.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.9 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -56.86 -58.04 9.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.704 ' O ' HD12 ' C' ' 212' ' ' ILE . 4.6 mm? -56.33 -42.39 77.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -52.7 -44.42 66.29 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -72.08 -29.38 64.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.867 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 2.5 mtm -73.79 -36.31 65.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.902 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 212' ' ' ILE . . . . . 0.704 HD12 ' O ' ' C' ' 208' ' ' LEU . 2.8 mt -84.62 -39.79 14.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 213' ' ' ASN . . . . . 0.521 HD22 HD11 ' B' ' 116' ' ' ILE . 7.1 t-20 -49.19 -51.67 31.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 98.3 m -56.67 -33.25 66.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.2 t -63.87 -64.36 0.91 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.892 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.472 ' HA ' HD12 ' C' ' 219' ' ' ILE . 5.8 mt -51.22 -36.42 16.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.126 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 217' ' ' LEU . . . . . 0.892 HD22 HD11 ' C' ' 221' ' ' ILE . 0.9 OUTLIER -69.29 -59.71 2.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.857 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 28.7 mt -55.38 -32.59 62.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.496 HG22 HD12 ' C' ' 223' ' ' ILE . 27.9 mt -63.78 -61.11 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.124 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . 0.623 ' CE2' HD23 ' B' ' 117' ' ' LEU . 5.2 t80 -61.15 -40.47 93.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 221' ' ' ILE . . . . . 0.892 HD11 HD22 ' C' ' 217' ' ' LEU . 88.8 mt -64.14 -55.03 24.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.126 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 7.8 t80 -63.42 -54.78 31.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 223' ' ' ILE . . . . . 0.496 HD12 HG22 ' C' ' 219' ' ' ILE . 24.3 mt -42.39 -53.3 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.076 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . . . . . . . . . 21.4 t -57.67 -50.29 77.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' C' ' 225' ' ' LEU . 15.9 mt -57.72 -39.2 76.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.34 -47.95 83.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.563 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.8 OUTLIER -68.92 -51.23 46.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 228' ' ' HIS . . . . . . . . . . . . . 60.9 t60 -49.73 -32.54 13.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -97.03 -21.77 17.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.853 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 230' ' ' GLU . . . . . 0.563 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 1.7 mm-40 -71.52 -2.51 17.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.916 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.05 47.57 0.2 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 232' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -129.64 22.67 5.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.752 0.311 . . . . 0.0 110.925 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 51.7 mtp180 -92.6 39.86 1.04 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.872 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 65.3 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.105 179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.5 mmt . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.813 0.34 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.36 126.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.4 p -94.32 39.35 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.778 ' HB3' ' HD3' ' A' ' 5' ' ' PRO . . . -70.84 -59.68 3.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.559 0.695 . . . . 0.0 111.103 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 4' ' ' ALA . 54.0 Cg_endo -69.72 -41.51 4.26 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.683 2.255 . . . . 0.0 112.372 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -56.41 -41.86 77.04 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -52.5 -59.88 3.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.722 ' O ' HD12 ' A' ' 12' ' ' ILE . 4.1 mm? -54.98 -43.03 73.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -53.13 -37.41 61.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.888 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -78.32 -28.83 47.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 mtm -77.59 -30.98 52.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.858 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 8' ' ' LEU . 3.2 mt -80.19 -51.75 15.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.193 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.57 ' OD1' HD12 ' A' ' 17' ' ' LEU . 6.9 t-20 -52.49 -34.84 51.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.871 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 55.6 m -48.26 -33.18 8.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.2 t -65.57 -64.37 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.862 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.586 ' HA ' HD12 ' A' ' 19' ' ' ILE . 66.0 mt -56.9 -36.2 49.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.093 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.95 HD22 HD11 ' A' ' 21' ' ' ILE . 1.4 mt -69.11 -51.91 33.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.898 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 23.3 mt -58.96 -35.25 72.84 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.858 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.638 HG22 HD12 ' A' ' 23' ' ' ILE . 19.0 mt -63.64 -57.95 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.135 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.592 ' O ' HG23 ' A' ' 24' ' ' VAL . 0.1 OUTLIER -64.46 -43.88 92.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.95 HD11 HD22 ' A' ' 17' ' ' LEU . 73.9 mt -58.08 -51.98 64.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.137 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -68.43 -51.74 40.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.913 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.638 HD12 HG22 ' A' ' 19' ' ' ILE . 24.4 mt -48.08 -49.76 11.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 20' ' ' PHE . 70.8 t -58.91 -51.21 75.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.114 179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 25' ' ' LEU . 10.5 mt -58.73 -51.41 70.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.929 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.19 -47.67 62.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.872 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.624 ' HA ' ' HB2' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -67.3 -46.89 82.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.112 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -52.36 -34.03 45.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -98.39 -19.01 17.98 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.624 ' HB2' ' HA ' ' A' ' 27' ' ' ILE . 10.3 mm-40 -70.56 -3.79 19.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.843 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 125.71 51.39 0.18 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.493 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -115.87 20.26 14.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.796 0.332 . . . . 0.0 110.945 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.07 38.72 1.29 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.87 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 64.5 mt . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' MET . . . . . . . . . . . . . 13.2 mmt . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.788 0.328 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.89 126.89 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' SER . . . . . . . . . . . . . 58.5 p -93.18 41.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.841 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ALA . . . . . 0.755 ' HB3' ' HD3' ' B' ' 105' ' ' PRO . . . -69.5 -59.22 5.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.594 0.711 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' PRO . . . . . 0.755 ' HD3' ' HB3' ' B' ' 104' ' ' ALA . 53.4 Cg_endo -69.77 -39.85 6.0 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.695 2.263 . . . . 0.0 112.322 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -58.05 -42.62 85.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.853 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -53.31 -58.65 6.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.899 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' LEU . . . . . 0.724 ' O ' HD12 ' B' ' 112' ' ' ILE . 4.1 mm? -56.44 -43.78 79.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -52.73 -36.75 58.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -79.88 -27.0 40.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' MET . . . . . . . . . . . . . 1.5 mtm -79.71 -27.98 40.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.868 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ILE . . . . . 0.724 HD12 ' O ' ' B' ' 108' ' ' LEU . 3.2 mt -84.29 -57.33 4.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.12 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -50.99 -51.18 55.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' THR . . . . . 0.476 HG22 HD12 ' B' ' 118' ' ' LEU . 94.1 m -56.5 -39.26 72.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' SER . . . . . . . . . . . . . 1.3 t -62.3 -62.5 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' ILE . . . . . 0.577 ' HA ' HD12 ' B' ' 119' ' ' ILE . 62.8 mt -50.17 -47.59 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.14 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . 0.995 HD22 HD11 ' B' ' 121' ' ' ILE . 1.3 mt -63.18 -57.22 11.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.476 HD12 HG22 ' B' ' 114' ' ' THR . 26.3 mt -52.75 -32.46 43.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.888 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . 0.577 HD12 ' HA ' ' B' ' 116' ' ' ILE . 19.8 mt -64.17 -57.36 11.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.137 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' PHE . . . . . 0.645 ' O ' HG23 ' B' ' 124' ' ' VAL . 7.4 t80 -63.77 -43.05 97.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.89 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' ILE . . . . . 0.995 HD11 HD22 ' B' ' 117' ' ' LEU . 22.4 mt -61.76 -52.75 57.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.172 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' PHE . . . . . . . . . . . . . 11.1 t80 -65.6 -47.99 73.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' ILE . . . . . 0.506 HD12 HG22 ' B' ' 119' ' ' ILE . 13.0 mt -49.77 -44.61 20.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' VAL . . . . . 0.645 HG23 ' O ' ' B' ' 120' ' ' PHE . 70.6 t -63.71 -52.03 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' B' ' 125' ' ' LEU . 16.8 mt -59.77 -47.3 86.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.929 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.52 -47.5 63.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ILE . . . . . 0.595 ' HA ' ' HB2' ' B' ' 130' ' ' GLU . 0.9 OUTLIER -66.83 -48.94 78.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.154 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' HIS . . . . . 0.412 ' HA ' ' CB ' ' B' ' 132' ' ' TRP . 4.0 t60 -51.5 -33.52 31.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.826 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -97.81 -19.67 18.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.86 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' GLU . . . . . 0.595 ' HB2' ' HA ' ' B' ' 127' ' ' ILE . 10.8 mm-40 -70.8 -3.9 21.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.862 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' GLY . . . . . . . . . . . . . . . 126.37 50.55 0.17 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.465 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' TRP . . . . . 0.412 ' CB ' ' HA ' ' B' ' 128' ' ' HIS . 0.6 OUTLIER -119.32 20.32 12.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.768 0.318 . . . . 0.0 110.903 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.27 39.6 1.08 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.871 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.113 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 201' ' ' MET . . . . . . . . . . . . . 13.6 mmt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.823 0.344 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 202' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -169.18 125.95 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.859 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 203' ' ' SER . . . . . . . . . . . . . 59.7 p -94.7 39.71 1.1 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.889 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 204' ' ' ALA . . . . . 0.776 ' HB3' ' HD3' ' C' ' 205' ' ' PRO . . . -69.32 -59.55 4.88 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.592 0.71 . . . . 0.0 111.118 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 205' ' ' PRO . . . . . 0.776 ' HD3' ' HB3' ' C' ' 204' ' ' ALA . 54.0 Cg_endo -69.75 -40.32 5.48 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.736 2.291 . . . . 0.0 112.363 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -57.89 -40.82 81.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.864 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -53.69 -58.87 5.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 208' ' ' LEU . . . . . 0.706 ' O ' HD12 ' C' ' 212' ' ' ILE . 4.1 mm? -55.34 -44.72 76.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.935 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 209' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -51.71 -38.88 57.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.847 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 210' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -76.84 -28.41 55.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 211' ' ' MET . . . . . . . . . . . . . 1.4 mtm -77.55 -28.79 51.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 212' ' ' ILE . . . . . 0.706 HD12 ' O ' ' C' ' 208' ' ' LEU . 3.3 mt -80.06 -45.08 22.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.118 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 213' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -50.41 -62.19 1.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 214' ' ' THR . . . . . . . . . . . . . 97.2 m -53.31 -38.84 63.54 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.174 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 215' ' ' SER . . . . . . . . . . . . . 1.1 t -63.03 -63.01 1.32 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 216' ' ' ILE . . . . . 0.6 ' HA ' HD12 ' C' ' 219' ' ' ILE . 69.7 mt -51.46 -39.54 22.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.118 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 217' ' ' LEU . . . . . 0.997 HD22 HD11 ' C' ' 221' ' ' ILE . 1.0 OUTLIER -67.99 -59.22 3.43 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.901 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 218' ' ' LEU . . . . . . . . . . . . . 25.3 mt -51.26 -30.59 18.27 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.887 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 219' ' ' ILE . . . . . 0.6 HD12 ' HA ' ' C' ' 216' ' ' ILE . 24.2 mt -68.15 -59.72 3.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.131 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 220' ' ' PHE . . . . . 0.528 ' O ' HG23 ' C' ' 224' ' ' VAL . 0.1 OUTLIER -62.52 -37.87 87.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 221' ' ' ILE . . . . . 0.997 HD11 HD22 ' C' ' 217' ' ' LEU . 96.0 mt -63.62 -53.89 39.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 222' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -67.62 -52.11 42.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 223' ' ' ILE . . . . . 0.586 HD12 HG22 ' C' ' 219' ' ' ILE . 16.0 mt -46.8 -53.2 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.19 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 224' ' ' VAL . . . . . 0.891 HG21 HG21 ' A' ' 21' ' ' ILE . 55.8 t -57.12 -49.64 78.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 225' ' ' LEU . . . . . . . . . . . . . 12.5 mt -59.58 -54.34 47.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.901 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 226' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.83 -45.95 59.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 227' ' ' ILE . . . . . 0.542 ' HA ' ' HB2' ' C' ' 230' ' ' GLU . 0.9 OUTLIER -68.4 -52.71 34.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 228' ' ' HIS . . . . . 0.4 ' HA ' ' HB3' ' C' ' 232' ' ' TRP . 11.7 t60 -49.69 -31.49 11.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.857 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 229' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -96.66 -23.03 16.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 230' ' ' GLU . . . . . 0.542 ' HB2' ' HA ' ' C' ' 227' ' ' ILE . 12.5 mm-40 -71.38 -2.5 16.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . 126.16 46.67 0.21 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.492 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 232' ' ' TRP . . . . . 0.4 ' HB3' ' HA ' ' C' ' 228' ' ' HIS . 0.7 OUTLIER -131.98 19.52 4.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.787 0.327 . . . . 0.0 110.887 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 233' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -97.89 38.85 1.26 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.894 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.133 179.948 . . . . . . . . 0 0 . 1 stop_ save_